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1. Summary 
In this study, the role of histone-like proteins in gene regulation in uropathogenic Escherichia 
coli isolate 536 was monitored. The histone-like nucleoid structuring protein H-NS is a global 
regulator in Escherichia coli that has been intensively studied in non-pathogenic strains. No 
comprehensive study on the role of H-NS and its homolog StpA on gene expression in a 
pathogenic E. coli strain has been carried out so far. Moreover, we identified a third, so far 
uncharacterized member of the H-NS-like protein family in uropathogenic E. coli isolate 536, 
which was designated Hlp (H-NS-like protein). 
Hlp is a 134-amino acid protein, which shares 58 % sequence identity with H-NS. The gene 
coding for the Hlp protein, hlp, was found in several uropathogenic E. coli variants, but not in 
non-pathogenic E. coli K-12. In UPEC strains 536 and CFT073, Hlp is encoded on a possibly 
horizontally acquired 23-kb genomic region inserted into the serU locus. Studies on hlp 
transcription revealed that the gene is transcribed monocistronically from a single promoter 
and that expression is repressed by H-NS. Purified Hlp protein was binding to its own and to 
the hns promoter, thereby mediating negative auto- and crossregulation. Furthermore, Hlp and 
H-NS were directly interacting, resulting in the formation of stable heteromers. 
Complementation studies with hns mutant strains in a K-12 background revealed that the Hlp 
protein had in vivo activity, being able to complement the lack of H-NS in terms of motility, 
growth, and repression of the proU, bgl, and clyA genes. 
When analyzing the role of the histone-like proteins in expression of virulence-associated 
genes by using DNA arrays and classical phenotypic assays, most of the observed effects 
were mediated by the H-NS protein alone. Expression profiling revealed that transcript level 
of more than 500 genes was affected by an hns mutation, resulting in increased expression of 
α-hemolysin, fimbriae and iron-uptake systems, as well as genes involved in stress 
adaptation. Furthermore, several other putative virulence factors were found to be part of the 
H-NS regulon. On the other hand, no effect of StpA alone was observed. An hns stpA double 
mutant, however, exhibited a distinct gene expression pattern that differed in great parts from 
that of the hns single mutant. This suggests a direct interaction between the two homologs and 
the existence of distinct regulons of H-NS and an H-NS/StpA heteromeric complex. 
1. Summary 
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Although the H-NS protein has – either as homomer or in complex with StpA – a marked 
impact on gene expression in pathogenic E. coli strains, its effect on urovirulence is 
ambiguous. At a high infection dose, hns mutants accelerated lethality in murine UTI and 
sepsis models relative to the wild type, probably due to increased production of α-hemolysin. 
At lower infectious dose, however, mutants lacking H-NS were attenuated through their 
impaired growth rate, which can only partially be compensated by the higher expression of 
numerous virulence factors. 
As seen with StpA, an hlp single mutant did not exhibit a notable phenotype under standard 
growth conditions. A severe growth defect of hns hlp double mutants at low temperatures, 
however, suggests a biological relevance of H-NS/Hlp heteromers under certain 
circumstances. Furthermore, these mutants expressed more capsular polysaccharide and curli 
fimbriae, thereby indicating a distinct role of H-NS and Hlp in regulation of these surface 
structures. The H-NS paralogs Hlp and StpA also modulated H-NS-mediated regulation of 
fimbrial adhesins, and are oppositely required for normal growth at low or high temperatures, 
respectively. 
Finally, expression levels of the three histone-like proteins H-NS, StpA and Hlp itself varied 
with different temperatures, thereby suggesting a flexible composition of the nucleoid-
associated protein pool. Hence, we propose a similar biological role of Hlp and StpA, which 
does not rely on a distinct function of the single protein, but rather on their interaction with 
the global regulator H-NS. 
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1. Zusammenfassung 
In dieser Studie wurde die Rolle von Histon-ähnlichen Proteinen bei der Genregulation im 
uropathogenen Escherichia coli (UPEC) Isolat 536 untersucht. Das Histon-ähnliche Protein 
H-NS (engl. histone-like nucleoid structuring protein) ist ein globaler Regulator in E. coli, der 
in apathogenen Stämmen eingehend untersucht worden ist. Im Gegensatz dazu liegen noch 
keine umfassenden Studien zur Rolle von H-NS und des homologen Proteins StpA in einem 
pathogenen E. coli Stamm vor. Zudem konnten wir ein drittes, bis jetzt noch nicht 
charakterisiertes Mitglied der Familie von H-NS-ähnlichen Protein im uropathogenen E. coli 
Isolat 536 identifizieren, das Hlp benannt wurde (für H-NS-like protein). 
Hlp ist ein aus 134 Aminosäuren bestehendes Protein, dessen Sequenz zu 58 % identisch mit 
der des H-NS Proteins ist. Das Gen, das für das Hlp Protein kodiert, hlp, konnte in 
zahlreichen uropathogenen und Fäkalisolaten nachgewiesen werden, jedoch nicht im 
apathogenen E. coli K-12. In den UPEC Isolaten 536 und CFT073 ist das hlp Gen auf einer 
23-kb großen genomischen Insel lokalisiert, die in den serU Lokus inseriert ist und 
möglicherweise über horizontalen Gentransfer erworben wurde. Untersuchungen zur 
Transkription des hlp Gens ergaben, dass das Gen monocistronisch von einem einzigen 
Promotor transkribiert, und dessen Expression durch H-NS reprimiert wird. Rekombinantes 
Hlp Protein war befähigt, sowohl an seinen eigenen, als auch an den hns Promotor zu binden, 
was zu negativer Auto- und Kreuzregulation führte. Zudem konnte gezeigt werden, dass Hlp 
und H-NS direkt miteinander interagieren, was zu stabilen Heteromeren führte. 
Komplementierungsstudien in hns Mutanten einiger K-12 Stämme ergaben, dass das Hlp 
Protein über in vivo Aktivität verfügt, was es befähigte, die Abwesenheit von H-NS bei 
zahlreichen Phänotypen wie z.B. Motilität, Wachstum, und Repression der proU, bgl und 
clyA Gene zu komplementieren. 
Die Rolle der Histon-ähnlichen Proteine bei der Expression von Virulenz-assoziierten Genen 
wurde mittels DNA Array Technologie, sowie klassischen phänotypischen Tests analysiert. 
Dabei wurden die meisten der beobachteten Effekte einzig durch das H-NS Protein bedingt. 
Die Expressionsstudien ergaben, dass über 500 Gene von einer hns Mutation beeinflusst 
wurden, was eine verstärkte Expression des α-Hämolysins, mehrerer Fimbrien und 
Eisenaufnahmesysteme sowie von Genen, die in Stress-Antworten involviert sind, bedingte. 
 
1. Zusammenfassung 
 
16 
 
 
Des Weiteren konnten zahlreiche putative Virulenzfaktoren dem H-NS-Regulon zugeordnet 
werden. Andererseits konnten keine Effekt durch StpA beobachtet werden. Eine hns stpA 
Doppelmutante wies jedoch ein eindeutiges Expressionsmuster auf, das in großen Teilen von 
dem der hns Einzelmutante abwich. Dies legt nahe, dass beide Proteine direkt miteinander 
interagieren, was das Auftreten von unterschiedlichen Regulons zur Folge hat, die entweder 
durch H-NS oder einem heteromeren H-NS/StpA Komplex beeinflusst werden. 
Obwohl das H-NS Protein – entweder als Homomer oder als Komplex mit StpA – einen sehr 
starken Einfluss auf die Genexpression pathogener E. coli Stämme nimmt, bleiben dessen 
Effekte auf die tatsächliche Virulenz im Urogenitaltrakt unklar. In einem experimentellen 
Mausmodell der aufsteigenden Harnwegsinfektion bewirken hns Mutanten, in hoher Dosis 
verabreicht, eine rasch eintretende Lethalität, was vermutlich der verstärkten Produktion von 
α-Hämolysin zuzuschreiben ist. In verringerter Dosis verabreicht, sind diese Mutanten durch 
ihre langsameren Wachstumsraten jedoch attenuiert, was nur teilweise durch die vestärkte 
Expression zahlreicher Virulenzfaktoren kompensiert werden kann. 
Wie schon bei StpA beobachtet, besitzt eine hlp Mutante keinen offensichtlichen Phänotyp, 
zumindest unter Standard-Wachstumsbedingungen. Jedoch macht sich in hns hlp 
Doppelmutanten ein starker Wachstumsdefekt bei erniedrigten Temperaturen bemerkbar, was 
eine biologische Relevanz von H-NS/Hlp Heteromeren unter bestimmten Bedingungen nahe 
legt. Des Weiteren exprimierten diese Mutanten erhöhte Mengen an Kapsel-Polysacchariden 
und Curli-Adhesin, was als Indiz für eine besondere Rolle für H-NS und Hlp bei der 
Regulation dieser Oberflächenstrukturen dienen kann. Zudem hatten beide H-NS-Paraloge 
Hlp und StpA einen modulierenden Effekt bei der H-NS-vermittelten Regulation weiterer 
Fimbrien-Adhesine und waren in gegenläufigen Maßen für normales Wachstum bei erhöhten 
bzw. erniedrigten Temperaturen notwendig. 
Zuletzt variierte das Expressionsniveau der drei Histon-ähnlichen Proteine H-NS, StpA und 
Hlp bei unterschiedlichen Temperaturen, was auf eine flexible Zusammensetzung verfügbarer 
Nucleoid-assoziierter Proteine hindeutet. Dies alles impliziert, dass Hlp eine ähnliche 
biologische Relevanz wie StpA aufweist, die nicht auf gesonderten Funktionen des einzelnen 
Proteins beruht, sondern vielmehr auf deren Interaktionen mit dem globalen Regulatorprotein 
H-NS. 
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2. Introduction 
2.1. Regulation of gene expression 
Like all organisms, bacteria are facing the problem of high energetic costs for biosynthesis of 
every single protein. In order to minimize these costs, only those proteins that are required 
under a certain condition are produced. Therefore, bacteria possess highly developed sensory 
systems to detect environmental conditions and cellular response systems in order to adapt 
their protein synthesis pattern to the stimulus. This is of special importance for pathogenic 
bacteria, which have to express additional traits, the so-called virulence factors, during 
colonization of their host. Since these virulence factors impose high energetic costs upon the 
cell, virulence-associated genes are only expressed when bacteria are in contact with their 
host and not in the environmental reservoir [for reviews see Gross (1993) or Finlay and 
Falkow (1997)]. Thus, studies on regulation of virulence-associated genes are an important 
prerequisite for understanding infection processes, and might also provide targets for new 
anti-infective treatments by inhibiting expression of virulence factors in the host. 
The amount of a given protein can be regulated at various steps, such as transcription, 
translation, or stability of both mRNA and the protein itself. Transcriptional regulation is the 
most economic mechanism for the cell, since it automatically prevents all later stages, and it 
is also the most rapid way of adaptation to a new stimulus. Furthermore, it allows 
simultaneous regulation of several genes at a time, reflected in the operon concept (Dorman, 
1994). In this context, one has to distinguish between regulation of transcription initiation and 
of transcription elongation/termination. Here, we will focus on regulation of transcription 
initiation. 
Transcription begins with binding of RNA polymerase holoenzyme (R = ßß’α2σ) to the -35 
promoter site (P), which is recognized by a specific σ-factor. This results in the formation of 
the initial closed complex RPc1 and, after further interactions of the RNA polymerase with 
extended regions of the promoter, of closed complex RPc2. Reversible opening of 10- to 15-bp 
of the DNA helix driven by binding of free energy then results in open complexes RPo1 and 
RPo2. Thus, the initial ribonucleotide can bind at the opened +1 site, then called ternary 
initiated complex, followed by promoter clearance and dissociation of the σ-factor after 
synthesis of the first 7 to 12 bases of messenger-RNA. 
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The ternary transcribing complex consisting of the core RNA-polymerase then continues with 
elongation of transcription (Record et al., 1996). 
Several factors influence this process: First, the sequence at the initiation site determines the 
promoter strength, i.e. initiation velocity, via σ-factor recruitment. Each σ-factor recognizes a 
specific consensus sequence. For instance, a typical σ70-site is TTGACA at -35 and TATAAT 
at –10, with a 17-bp spacer region inbetween. Therefore, the strength of a promoter correlates 
with its homology to this consensus sequence (Record et al., 1996). 
Second, more than one σ-factor exist, each with their own consensus sequence. These 
alternative σ-factors compete for the RNA polymerase, and are themselves regulated by 
environmental signals. For instance, mRNA of the heat-shock sigma factor, σ32, exhibits 
enhanced stability at elevated temperatures, thereby outcompeting the standard sigma factor 
σ70 under heat-shock conditions and thus resulting in transcription of the heat-shock genes 
(Straus et al., 1987). 
Moreover, transcription is affected by DNA supercoiling. Supercoiling can occur in circular 
DNA, when the free ends of the strands are rotated with respect to each other before 
covalently closing the circle. Depending on the direction of rotation, either new helical turns 
will be introduced, which is referred to as overwound DNA (or positive supercoiling), or 
existing turns are removed, which is then called underwound DNA (or negative supercoiling). 
This also introduces torsional strain into the DNA molecule, resulting in changes in the 
number of base pairs per helix turn (Travers and Muskhelishvili, 2005). In nature, most DNA 
is negatively supercoiled. 
Supercoiled molecules possess free energy, which can facilitate open complex formation at 
the promoter. Furthermore, it might help to realign the –35 and –10 sites of the promoter 
when the spacer length is suboptimal. Supercoiling can also indirectly affect transcription by 
stabilizing DNA looping or bending. Changes in superhelicity can both have positive and 
negative effects on transcription [for reviews see Dai and Rothman-Denes (1999) or Perez-
Martin et al. (1994)]. In Shigella flexneri, stress induced changes in supercoiling have been 
reported to affect transcription of some virulence-associated genes such as porins or type 1 
fimbriae (Dorman et al., 1990). 
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Finally, there are additional transcription factors that either induce or repress transcription 
initiation. The concept of inducers/repressors is known since more than 40 years, when it was 
first described for the lac operon by Jacob and Monod (1961), and will not be discussed 
further. However, there are other activating proteins, which do not bind to an operator 
sequence, but instead interact with the RNA polymerase, e.g. via the σ-factor or via the 
carboxyterminal domain of its α-subunit (α-CTD), thereby enhancing transcription. 
Prominent examples are the cyclic AMP receptor protein CRP, the osmoregulator OmpR of 
the EnvZ/OmpR two-component system, or the oxidative stress regulator OxyR (Ishihama, 
1993). 
These are just a few examples for the variety of transcriptional regulation mechanisms, and 
most of them do not work separately, but rather in highly complex regulatory networks. In 
this study, however, the focus was set on a more global regulation of gene expression 
mediated by histone-like proteins, which will be presented in the next section. 
2.2. Histone-like proteins  
2.2.1. Histone-like proteins of Escherichia coli 
Histones in eukaryotic cells are positively-charged proteins, thus being able to bind negatively 
charged DNA and resulting in the formation of nucleosomes. This way, the degree of negative 
supercoiling of DNA is increased, mediating compactation of the chromosomes by a factor of 
up to 10,000 during mitosis (Lewin, 2002). 
Prokaryotic cells are facing the same problem: the linear chromosome of the bacterium 
Escherichia coli has a length of 1.6 mm, which has to fit into a cell of 2 x 1 µm in size 
(Dame, 2005). In contrast to the eukaryotic chromosome, half of the DNA supercoils are 
protein free, i.e. unconstrained, and formed by the action of the DNA topoisomerases (Hardy 
and Cozzarelli, 2005). The other half of supercoils is found in unstable complexes with 
proteins that have similarities to eukaryotic histones. However, this similarity is not based on 
amino acid identities, but rather on protein function. Bacterial histone-like proteins are 
characterized by their DNA-binding activity, by a relatively low molecular mass, and by their 
usually high abundance (Dorman and Deighan, 2003). In E. coli, there are twelve major 
species of nucleoid-associated proteins, which are listed in Table 1. 
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Table 1: Molecular properties of E. coli histone-like proteins. Adapted after Talukder and Ishihama (1999) and Talukder et al.  (1999) 
Protein Name MW 
(kDa) 
DNA-binding specificity Maximal expression 
(monomers/cell) 
Native protomer 
CbpA Curved DNA-binding protein A 33.4 curved DNA late stationary phase 
 (15,000) 
homodimer 
CbpB Curved DNA-binding protein B; also: Rob 33.0 curved DNA exponential phase  
(10,000) 
monomer 
DnaA DNA-binding protein A 53.0 sequence specific mid-exponential phase 
 (900-2,700) 
monomer 
Dps DNA-binding protein from starved cells 19.0 non-sequence specific late stationary phase 
 (180,000) 
dodecamer 
Fis Factor for inversion stimulation 11.2 +/- sequence specific exponential phase  
(60,000) 
homodimer 
Hfq Host factor for phage Qß 11.2 curved DNA exponential phase 
 (55,000) 
monomer/hexamer 
H-NS Histone-like nucleoid structuring protein 15.4 curved DNA constant expression 
 (20,000) 
homodimer/heterodimer 
tetramer 
HU Heat-unstable nucleoid protein 9.2+9.2 non-sequence specific 
(kinked DNA, junctions) 
exponential phase  
(60,000) 
heterodimer 
IciA Inhibitor of chromosome initiation A 33.5 sequence specific exponential phase  
 (800) 
homodimer 
IHF Integration host factor 11.2+10.7 sequence specific early stationary phase 
 (55,000) 
heterodimer 
Lrp Leucine-responsive regulatory protein 19.0 sequence specific exponential phase  
 (2,600) 
homodimer 
StpA Suppressor of td-phenotype A 15.3 curved DNA exponential phase  
 (200) 
homodimer/heterodimer, 
multimers 
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DNA-binding either requires a specific binding sequence, as observed for IHF, Lrp, or Fis, or 
happens in a non-sequence specific manner, e.g. with HU, H-NS, or Dps (Talukder and 
Ishihama, 1999). Binding of histone-like proteins can either result in DNA compactation by 
affecting superhelicity, in bridging of adjacent DNA stretches, or in introduction of sharp 
bends into the DNA (Dame, 2005). 
Another difference between the nucleoid-associated proteins is their abundance in the cell. 
For instance, Dps is expressed at high levels in stationary phase only, whereas HU is most 
abundant during exponential growth (Talukder et al., 1999). Furthermore, many histone-like 
proteins are regulated by environmental stimuli. To mention a few examples, Dps is induced 
upon starvation and stress situations, Lrp levels are elevated in minmal medium, and H-NS is 
cold-shock induced. Thus, the protein composition of the bacterial nucleoid is highly flexible, 
depending on many factors such as growth phase. As a result, the nucleoid becomes more 
compact during stationary phase, due to a decrease in superhelicity (Talukder et al., 1999). 
These changes in the status of the bacterial chromosome affect many other DNA processes 
such as replication, recombination, repair, and regulation of transcription (Dorman, 1994). 
2.2.2. Gene regulation by histone-like proteins 
Nucleoid proteins have been shown to be global regulators, affecting expression of many 
genes simultaneously. Regulated genes include those that are necessary for cell viability, such 
as genes involved in protein synthesis and metabolism. Moreover, histone-like proteins often 
mediate changes in the expression pattern in response to environmental signals (McLeod and 
Johnson, 2001). 
Regulation by histone-like proteins can be both negative and positive, and relies on several 
distinct mechanisms: Repression can be the result of protein binding within the –35 to -10 
regions, thereby occluding the RNA polymerase from the promoter and inhibiting 
transcription. This mechanism is quite common for histone-like proteins with specific binding 
sites. An example is the Fis protein, which binds to extended regions between –16 and –68 bp 
of the gyrA promoter (Finkel and Johnson, 1992). Moreover, repression can also be the result 
of competition of histone-like proteins and a specific activator for the same binding site, as it 
was observed for Fis and cAMP-CRP at the bglG promoter (Caramel and Schnetz, 2000). 
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In contrast to this more or less specific repression, histone-like proteins can also inhibit 
transcription by a mechanism called transcriptional silencing (Rine, 1999). During this 
process, the regulatory protein binds to a so-called silencer region, which is often AT-rich and 
can be remotely located from the promoter. The silencer region serves as nucleation site, from 
which more proteins bind in a cooperative manner along the DNA, resulting in sequestration 
of DNA and preventing binding of other proteins, such as transcriptional activators or the 
RNA polymerase itself (Yarmolinsky, 2000). Again, the bgl operon encoding the enzymes for 
utilization of ß-D-glucosides can serve as an example. The histone-like protein H-NS is 
binding to a ~100-bp AT-rich silencer region upstream of the CRP binding site and 
polymerizes along the DNA, probably involving high order multimerization, as proposed by 
Williams and Rimsky (1997). This process does not require direct interactions with the RNA 
polymerase, and neither point mutations, small insertion, nor shifting of the silencer region 
resulted in relieved repression (McLeod and Johnson, 2001; Yarmolinsky, 2000). However, 
other DNA-binding proteins like CRP can act as anti-silencers by binding between the 
silencer region and the promoter, functioning as a roadblock to H-NS polymerization 
(Mukerji and Mahadevan, 1997). 
On the other hand, there are also many examples for an activation of transcription by histone-
like proteins. The first mechanism requires direct interactions with the RNA polymerase, as 
seen for Fis-mediated activation of the ribosomal operon rrnB (Bokal et al., 1997). Fis was 
shown to assist both in the recruitment of the RNA polymerase and in closed complex 
formation. This activation of rrnB transcription is counteracted by H-NS binding to the –25 
promoter region (Afflerbach et al., 1998). 
In contrast to the previous example, where Fis functions as direct activator of transcription, 
activation by histone-like proteins can also result from an architectural role. Since some 
histone-like proteins are able to introduce sharp bends into the DNA, regulatory effects result 
from a local change in DNA topology. For instance, after bending the Pseudomonas putida 
Pu promoter, IHF was shown to facilitate the recruitment of the RNA polymerase by bringing 
an upstream α-CTD binding site into the correct position (Bertoni et al., 1998). The ability of 
many proteins such as H-NS to constrain negative supercoils also has to be taken into account 
due to the influence of superhelicity on transcription, as mentioned before. 
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Moreover, many histone-like proteins possess, in addition to the DNA-binding domain, an 
oligomerization domain. Therefore, two proteins bound to different sites of the chromosome 
can interact via their oligomerization domain, resulting in bridging of adjacent DNA stretches 
(Dame et al., 2005; Esposito et al., 2002). 
The combined effects of DNA-bending and DNA-bridging proteins and the consequences for 
a dynamic bacterial chromosome are depicted in Fig. 1. 
 
Fig. 1: Schematic representation of the bacterial nucleoid. The organization of the supercoiled loops and 
the relative orientation of sites within are affected by the binding of nucleoid-associated proteins such as HU, 
H-NS, IHF and Fis. The organization within loops is important for DNA compaction and can also play a role 
in the modulation of transcription. DNA is depicted in cyan. Green spheres correspond to H-NS; red spheres 
correspond to HU; the grey sphere corresponds to a DNA bending protein, such as IHF, Fis or HU. (B) starting 
configuration: H-NS bridging and HU ridgifying DNA. (A) and (C) binding of other proteins in the vicinity 
results in reconfiguration of the loop. In the first example (A), this loop is bound by a protein that bends DNA 
(e.g. IHF), which imposes relocation of the bound protein to the tip of the loop. In parallel, other bound 
proteins within the loop will become relocated. In the second example (C), HU becomes co-operatively bound 
to the binding site. It is energetically unfavourable for a rigid tract of DNA to find itself located within the tip 
of a loop and therefore it moves away into the stem. From Dame (2005). 
Thus, histone-like proteins modulate the function of the bacterial chromosome by strongly 
modifying its structure. A more detailed introduction to the mechanism of generegulation by 
histone-like proteins will be presented in the next section about the histone-like nucleoid 
structuring protein H-NS. 
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2.2.3. Histone-like nucleoid structuring protein (H-NS) 
The H-NS protein   The H-NS protein was originally identified as a major component of the 
bacterial nucleoid (Varshavsky et al., 1977), and therefore was termed histone-like nucleoid 
structuring protein (Lammi et al., 1984). H-NS is a 137-amino acid protein with a molecular 
weight of 15.4 kDa. Three isoforms with around neutral pI values do exist in the cell (Spassky 
et al., 1984), which is the result of post-translational modifications. 
The protein consists of two domains: an N-terminal oligomerization domain and a C-terminal 
DNA-binding domain connected by a flexible linker (Renzoni et al., 2001; Ueguchi et al., 
1997). Fig. 2 depicts the two-domain structure and the functions assigned to each domain or 
specific residue, as well as the predicted secondary structure. 
 
Fig. 2: Predicted structure of the H-NS protein. Numbers designate the amino acid residues of the 
137-amino acid protein. Upper panel: Two-domain structure after Dorman (2004); Lower panel: predicted 
secondary structure after Schroder&Wagner (2002). See text for further details. 
The DNA-binding domain encompasses residues 90 to 137, and is highly conserved in all 
H-NS-like proteins (Dorman et al., 1999). Sequence alignments of these proteins gave the 
degenerate consensus motif TWTGXGRXP. The three-dimensional structure of the domain 
has been solved by NMR measurements, and results from an antiparallel ß-sheet structure 
composed of two short ß-strands, ß1 and ß2, reaching from residues 96-100 and 105-108 
(Shindo et al., 1995). 
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After a loop structure, an α-helix, H4, stretching from residue 116-124, and a very short 
310-helix from residues 129-132 follows the structure. The DNA-binding motif is located in 
loop 2, and most loss-of-function mutations are also mapping this loop structure (Williams 
and Rimsky, 1997). This indicates, that the structurally variable loop structures of H-NS-like 
proteins confer DNA-binding, whereas the rigid ß-sheet and α-helices mainly have an 
architectural role (Schroder and Wagner, 2002; Shindo et al., 1999). 
The minimal dimerization domain stretches from residues 1-64 and consists of three 
α-helices, H1 to H3, comprising residues 1-8, 12-20, and 22-53, respectively (Renzoni et al., 
2001). The longest helix H3 is predicted to form the core of a coiled-coil structure in a 
homotrimer, whereas the other two helices have stabilizing functions. 
The two domains are connected by a protease-sensitive linker region, encompassing residues 
65 to 90 (Cusick and Belfort, 1998). Recent studies revealed, that the flexible linker is 
required for higher-order oligomerization (Stella et al., 2005). However, the amino acid 
composition of the region is very divergent among H-NS-like proteins, and so far, no loss-of-
function mutation has been isolated. 
Several studies suggest that H-NS monomers predominantly oligomerize into tetramers and, 
to a lesser extend, into homodimers (Ceschini et al., 2000; Stella et al., 2005). However, 
oligomerization states up to 20-mers have been reported (Smyth et al., 2000). A proposed 
mechanism for oligomerization is depicted in Fig. 3. For the S. typhimurium H-NS protein, 
the α-helices of the N-terminus were found in an antiparallel configuration with the helices of 
the corresponding molecule in the dimer (Esposito et al., 2002), whereas in E. coli, the helices 
of the same molecule interacted in a “handshake” manner (Bloch et al., 2003). In the 
schematic model, dimerization requires interactions between the N-terminus and the linker 
region, and serves as basis for formation of tetramers via dimer-dimer interactions. The 
process of tetramerization depends on interactions between two C-terminal domains (and the 
linker) of each dimer, as well as linker-linker interactions (Stella et al., 2005). However, data 
on H-NS oligomerization is a much disputed topic and the answer still remains unclear. 
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Fig. 3: Schematic models for H-NS dimerization and tetramerization. (A) 3D-structures of isolated 
H-NS domains: dimeric N-domain of S. typhimurium (a) and E. coli (b); monomeric C-domain of E. coli (c).  
A schematic representation of the two N-domains is shown to the right of the structures from which they are 
derived; spheres represent the C-terminus Ct, rectangles represent the three α-helices of the N-terminus. 
 (B) Hypothetical, schematic models of the H-NS structures: (a) monomer; (b) dimer; (c) tetramer and (d) an 
alternative 'dimer' generated by removing a monomer from each dimer of the tetramer. In the scheme, the 
protein−protein interactions found to be important for oligomerization are highlighted: in 'b', a black oval 
encircles the linker−N-domain interaction contributing to dimerization and in 'c', the large black circle 
encompasses the C-domain−C-domain (with a contribution of the linker) and the small black circles indicate the 
linker−linker interactions contributing to tetramerization. [Stella et al. (2005)]. 
Nevertheless, it is evident that the state of oligomerization affects the regulatory activity of 
H-NS. Truncated proteins consisting of the C-terminus only are able to bind DNA, but with 
much lower affinities than the native protein (Shindo et al., 1995), and inhibition of 
oligomerization abolishes repression of some target genes such as proU and bgl (Ueguchi et 
al., 1996; Ueguchi et al., 1997; Williams et al., 1996). 
H-NS binds to DNA in a non-sequence-specific manner, but with a preference for intrinsically 
curved, double-stranded DNA, which is generally AT-rich (Spurio et al., 1992; Yamada et al., 
1991). This might also explain the the tendency to form oligomers, since inside the DNA 
bend, the monomers are more likely to find interaction partners (Dame et al., 2001).However, 
H-NS was also shown to bind RNA, resulting in post-transcriptional regulation of certain 
genes (Deighan et al., 2000; Yamashino et al., 1995). 
2. Introduction 
 
27 
 
 
Binding is either specific for AT-rich nucleation sites, which requires only low protein 
concentrations and promotes cooperative binding to lower affinity sites, resulting in 
transcriptional silencing (see section 2.3.2.). At high protein concentrations, non-specific 
binding can be observed, which results in polymerization of H-NS at the DNA (Rimsky et al., 
2001). However, a physiological role of such unspecific binding is improbable. 
H-NS binding results in compactation of the chromosome (Spassky et al., 1984) and 
therefore, overexpression of H-NS even has a lethal outcome (Spurio et al., 1992). Moreover, 
subsequent interactions of the oligomerization domains of two bound H-NS molecules result 
in bridging or looping of DNA as depicted in Fig. 4.(Dame et al., 2005; Dorman, 2004). 
 
     Fig. 4: Schematic models for repression -mechanisms by H-NS. 
(A) DNA bridging via oligomerization; SFM micrographs of H-NS-DNA samples (a), two possible 
mechanisms assuming binding of H-NS dimers to different DNA-strands (b) or to the same strand (c) prior 
to oligomerization. [Dame (2005)]. 
(B) H-NS-mediated trapping of RNA polymerase at the rrnB promoter and antagonism by Fis. H-NS 'zips 
up' the DNA flanking the promoter, producing an H-NS−polymerase−DNA ternary complex that prevents 
the escape of RNA polymerase into the elongation phase of transcription. Fis disrupts this complex. 
(C) H-NS-mediated repression of the virF virulence gene promoter in S. flexneri. Formation of a repressive 
complex at low temperatures after DNA looping is antagonized at higher temperatures (a), or after Fis-
mediated destabilization of the complex due to DNA bending. [Dorman (2004)]. 
This DNA binding and reorganization activity of H-NS certainly has consequences for any 
DNA-depending process. Therefore, the two-domain structure of the H-NS protein accounts 
for its unique and global regulation mechanisms. 
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The hns gene 
The hns gene, also known as osmZ, drdX or bglY, was initially isolated by Pon et al. (1988) 
and maps at 27 min of the E. coli chromosome between the galU and tdk genes. It is 
transcribed monocistronically from a single promoter (La Teana et al., 1989). 
Expression of hns is activated by the Fis protein and repressed by autoregulation. The binding 
sites for Fis and H-NS at the hns promoter are overlapping, and therefore, Fis is stimulating 
hns transcription both directly and indirectly via counteracting autorepression (Falconi et al., 
1993). Furthermore, autoregulation is coupled to DNA synthesis, resulting in a constant ratio 
of H-NS to DNA in the cell (Free and Dorman, 1995). Finally, hns expression is 2-4 fold 
increased at low temperatures mediated by the major cold shock protein CspA (La Teana et 
al., 1991). This correlates with the finding that H-NS is required for adaptation to a cold 
environment (Dersch et al., 1994). Some studies also report that expression of hns increases 
after entering stationary phase; however, other studies could not confirm this result. 
The H-NS regulon 
The effects of H-NS have been studied in detail in non-pathogenic E. coli, where it is 
considered a global regulator of gene expression (Atlung and Ingmer, 1997; Hommais et al., 
2001; Ussery et al., 1994). Mutation in the hns gene affect several cellular processes 
including recombination, transposition and deletion events (Falconi et al., 1991; Kawula and 
Orndorff, 1991; Rouquette et al., 2004; Shiga et al., 2001) and leads to a highly pleiotropic 
phenotype. In general, hns mutants grow more slowly than the wild type, especially at lower 
temperatures (Barth et al., 1995), exhibit a mucoid phenotype, and are non-motile and serine-
sensitive. 
Two-dimensional gelelectrophoresis revealed, that more than 30 proteins are affected in 
E. coli K-12 by a mutation in the hns gene (Barth et al., 1995; Bertin et al., 1990; Laurent-
Winter et al., 1995; Yamada et al., 1991). Later on, more data was obtained from expression 
profiling using DNA arrays. This approach confirmed the global effects of H-NS on the gene 
expression pattern, since ~ 5 % of all genes in E. coli K-12, i.e. about 250 genes, were directly 
or indirectly altered in an hns mutant (Hommais et al., 2001), with increased expression of 
more than 80 % of all deregulated genes [for a complete list of deregulated genes see Table 1 
of the original publication]. 
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To summarize, 21 % of the deregulated genes were involved in transcription and translation, 
30 % encoded components of the cell envelope, and about the same number of genes were of 
yet unknown function. The affected cell envelope components included genes involved in 
motility (fli genes), in adhesion (type 1 fimbriae, fim, and the curli adhesin, csgA), or the outer 
membrane porin ompX, all of which exhibited an upregulated expression in the hns mutant. 
Moreover, H-NS was found to predominantly affect genes whose encoded products are 
involved in adaptation to a changing environment, such as osmolarity, pH and anaerobiosis, 
thereby indicating a central role of H-NS for adaptability of bacterial cells. For instance, many 
genes normally induced by oxygen starvation (e.g. cytochrome oxidases), by carbon 
starvation (e.g. gnd, slp), or in minimal medium (e.g. the DNA-binding protein Lrp) were 
induced in the absence of H-NS. The same result was obtained for genes induced by acid 
stress, such as the lysine decarboxylase cadBA, the arginine decarboxylase adiA, and the 
glutamate decarboxylases gadAB, which resulted in increased viability of the hns mutant at 
low pH compared to the wild type. 
Other examples are osmoregulated genes, such as the outer membrane porin-encoding genes 
ompC and ompF, or the proU operon, which were also upregulated in strains lacking H-NS. 
Effects of H-NS on proU expression have been intensively studied. The operon encodes a 
glycine-betaine/proline transport system, that is up to 100-times induced at high osmolarity 
(Lucht and Bremer, 1994), probably due to an increase in intracellular potassium glutamate 
concentration and/or an increase in DNA supercoiling (Higgins et al., 1988). Mutations in hns 
lead to a moderately increased proU expression even at low osmolarity, thereby indicating 
that H-NS is able to represses proU transcription. Indeed, H-NS was found to bind upstream 
of the proU promoter, as well as to a curved downstream regulatory element (DRE) (Lucht et 
al., 1994). However, osmoregulation of proU is not abolished in an hns mutant, which 
suggests, that a combination of direct effects of supercoiling, and an indirect effect of 
osmolarity on H-NS mediated repression is involved in osmoregulation of proU. 
Another group of H-NS-regulated genes codes for components of the transcription and 
translation apparatus defining growth phase or growth rates. The mechanism of H-NS 
mediated repression of the ribosomal RNA operon rrnB has been described before (see also 
Fig 4B). 
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However, most of these studies have been performed in non-pathogenic E. coli K-12 strains. 
The overall effect of H-NS for virulence of pathogenic bacteria was so far only studied in 
some strains. 
Beloin and Dorman (2003) and Falconi et al. (1998) report, that H-NS mainly affects 
invasiveness of Shigella flexneri and enteroinvasive E. coli by repressing the expression of the 
plasmid-encoded regulators VirF and VirB, which are required for expression of the invasion-
associated genes ipa (Dagberg and Uhlin, 1992). The mechanism for H-NS-mediated 
thermoregulation and repression at the virF promoter can be seen in Fig. 4c. VirF is required 
for activation of VirB, which then activates the ipa genes. In Salmonella enterica, H-NS was 
found to repress the spv virulence locus, which is required for intracellular survival (O'Byrne 
and Dorman, 1994). H-NS also affects the transcriptional regulator hilA, which activates the 
type III secretion system encoded on the Salmonella pathogenicity island 1, under low 
osmolarity conditions (Schechter et al., 2003). In enteropathogenic E. coli, H-NS mediates 
thermoregulation of heat-labile enterotoxin (LT) synthesis by interacting with the DRE of the 
gene encoding the LT subunit A at low temperatures, thereby resulting in maximum 
expression of LT at 37 °C, i.e. body temperature (Trachman and Maas, 1998). 
For other pathogenic E. coli strains, only some selected virulence-associated genes were 
tested for H-NS-regulated expression, such as P-, K88-, and K99 pili, as well as toxins HlyA 
and ClyA (Westermark et al., 2000; White-Ziegler et al., 2000). For most of these virulence 
factors, H-NS was found to mediate temperature-regulated expression. For instance, the di-
galactoside binding pyelonephritis-associated pili encoded by the pap operon are only 
produced at 37 °C, but not at lower temperatures (Göransson et al., 1990). This is the result of 
H-NS binding to the papBA promoter region, where it inhibits both transcription and DNA 
methylation at two sites involved in phase-variation of the pili (Blomfield, 2001). The same 
temperature-dependent expression is described for the α-hemolysin determinant hly, which is 
more effectively repressed by H-NS at low temperatures due to increased affinity of H-NS for 
the promoter region at 25 °C compared to 37 °C (Madrid et al., 2002). 
However, not all pathogenic variants do produce the same virulence factors. For instance, the 
uropathogenic E. coli isolate strain 536 used in this study, does not express K88-, and 
K99-pili at all, but instead possesses several other fimbrial determinants such as the pix 
cluster, where no transcriptional studies have been carried out so far. 
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2.2.4. The H-NS paralog StpA 
In addition to H-NS, Escherichia coli cells express an intraspecies homolog, i.e. a paralog, 
called StpA, which was first discovered as a multicopy suppressor of a thymidilate synthase-
negative phenotype in a T4 phage (Zhang and Belfort, 1992; Zhang et al., 1996). 
StpA is a 133-amino acid protein, which shares 58 % sequence identity to the H-NS protein 
and has a similar domain structure (Cusick and Belfort, 1998). Identity to H-NS is greater in 
the C-terminus (73 %) than in the N-terminus (51 %). StpA can bind DNA with even higher 
affinity than H-NS (Sonnenfield et al., 2001), where it is able to constrain supercoils. 
However, StpA also displays an additional RNA chaperone activity (Zhang et al., 1996) and 
is able to stimulate complementary RNA strand annealing and in vitro trans-splicing of a 
model intron (Cusick and Belfort, 1998; Zhang et al., 1995). 
Like H-NS, StpA is able to form homodimers, as well as higher order oligomers (Johansson et 
al., 2001). Overexpression of StpA can in some parts complement the lack of H-NS, as shown 
for the regulatory effect on the arginine decarboxylase gene adi, as well as on proU and pap 
genes, and the hns gene itself (Shi and Bennett, 1994; Sonden and Uhlin, 1996; Zhang et al., 
1996). Mutations in the stpA gene, however, do not result in a notable phenotype under 
standard growth conditions. 
The lack of phenotype can be partly explained by the low level of stpA expression in wild 
type cells, yielding in approximately 200 monomers of the StpA protein per cell, whereas 
H-NS is usually present in 20,000 monomers per cell (Spassky et al., 1984). Transcription of 
stpA is negatively regulated by StpA itself and by H-NS (Zhang et al., 1996). However, the 
level of StpA increases during growth in minimal media due to the action of Lrp, or after 
temperature upshift and increase in osmolarity, whereas carbon starvation results in repression 
of stpA transcription (Free and Dorman, 1997; Sonden and Uhlin, 1996). Thus, StpA is 
strongly regulated by environmental conditions. 
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2.2.5. Interactions between H-NS and StpA 
H-NS and its paralog StpA are interacting at several levels. At the transcriptional level, 
interactions include cross-regulation between H-NS and StpA, as already described before. 
Therefore, StpA levels are increased in a hns mutant, and, to a lesser extend, higher H-NS 
amounts are found in strains lacking StpA. In the first case, derepression of StpA in the hns 
mutant can compensate some of the effects of the mutation (Sonden and Uhlin, 1996), 
therefore StpA is considered as a molecular backup for H-NS. 
Moreover, interactions occur at the protein level, since both proteins were found to form 
heteromers (Johansson et al., 2001; Williams et al., 1996). Heteromerization involves the 
middle portions as well as the C-terminus of H-NS and seems to rely on a different 
mechanism to H-NS homodimerization. As part of this heteromeric complex, StpA is 
protected from degradation by the Lon protease (Johansson and Uhlin, 1999), which depends 
on a phenylalanine residue at position 21 of the StpA protein (see Fig. 2). This suggests, that 
the biologically relevant form of StpA is the heteromer with H-NS. Indeed, Free et al. (1998) 
reported, that StpA can act as molecular adaptor for truncated H-NS protein lacking the C-
terminus. Via heteromerization, intact StpA can direct truncated H-NS to DNA, resulting in 
repression of the bgl operon. In this way, StpA was shown to take part in the regulatory 
network of DNA-binding proteins. 
2.2.6. Other H-NS-like proteins 
The H-NS protein can be found among many Enterobacteriaceae, such as E. coli, Shigella 
flexneri, Salmonella typhimurium, Serratia marcescens, or Proteus vulgaris (see Fig. 5), but 
also in the related Haemophilus genus (Atlung and Ingmer, 1997). Many of those species also 
possess the StpA protein, which is thought to result from gene duplication. 
H-NS-like proteins with lower homology were identified outside the Pasteurella group of 
γ-proteobacteria, like in Vibrio cholerae, Yersinia pestis, or Photorhabdus luminescens [for a 
review see Table 1 of Tendeng and Bertin (2003)]. Even some intracellular symbionts such as 
Buchnera aphidicola and Wigglesworthia glossinidia, which are characterized by their 
reduced genome size, encode an H-NS protein, thereby suggesting that it has a necessary 
function in the cell. 
2. Introduction 
 
33 
 
 
Interestingly, Pseudomonas species do not have any proteins with amino acid sequence 
similarity to H-NS. However, there is a family of MvaT proteins, which exhibit structural 
similarity to H-NS, thereby being able to complement some hns phenotypes, and also to 
bridge stretches of DNA (Dame et al., 2005; Tendeng et al., 2003b). 
H-NS proteins are not restricted to γ-proteobacteria. Some representatives of the group of 
ß-proteobacteria, such as Ralstonia spp. or Bordetella pertussis also encode H-NS-related 
proteins. In the latter, the protein is termed BpH3, and has been shown to restore hns 
phenotypes such as motility, mucoidity, or serine susceptibility. The same is true for the HvrA 
protein of the α-proteobacterium Rhodobacter capsulatus, which is involved in regulation of 
the photosystems (Bertin et al., 1999). These two proteins share only 30 % amino acid 
identity to H-NS, and especially the N-terminus is not well conserved. Nevertheless, the 
secondary structure still is predicted to be mainly α-helical, thereby being able to oligomerize 
via coiled-coil formation. The C-terminus, including the DNA-binding motif, is quite 
conserved, resulting in DNA-binding activity of both HvrA and BpH3. 
 
 
 
 
 
 
 
 
 
   Fig. 5: Cladogram of H-NS-homologs 
in various bacterial species. 
From Beloin et al (2003) 
 
2. Introduction 
 
34 
 
 
Proteins with 40 % amino acid identity to HvrA were also found in a psychrotrophic 
Actinobacter spp. isolated in Siberia, and a psychrophilic Psychrobacter spp. from Antarctica 
(Tendeng et al., 2003a). In the latter, H-NS-related functions were only observed at 
temperatures below 30 °C, due to thermal instability of the α-helical conformation of the 
N-terminus at 37 °C. 
Moreover, there are proteins with homology to the C-terminus of H-NS only, thereby being 
able to bind to DNA, but lacking oligomerization ability. Examples are a transcription factor 
of Rhodobacter sphaeroides, SPB, the virulence regulator of Xanthomonas oryzae, XvrA, or 
the pleitropic regulator of Vibrio cholerae, VicH (Bertin et al., 1999). Interestingly, many of 
these homologs are encoded on plasmids, such as the KorB protein encoded on plasmid 
pKM101 of E. coli, or ORF4 of the IncM plasmid R446 of E. coli  (Dorman et al., 1999). 
There are also proteins with homology only to the N-terminus of H-NS. The most prominent 
example is the Hha protein, which mediates thermoregulation of hemolysin expression in 
E. coli (Nieto et al., 2000). The 8-kDa protein is able to form heteromers with H-NS, and can 
be considered as an independent oligomerization domain of H-NS (Nieto et al., 2002). An 
Hha homolog, YmoA, can be found in Yersinia enterocolitica, where it acts as a repressor of 
the virulence-associated yop genes (Cornelis et al., 1991). E. coli encodes a recently 
discovered Hha homolog, YdgT, which also interacts with H-NS (Paytubi et al., 2004), and 
even more Hha homologs can be found on conjugative plasmids (Madrid et al., 2002). 
The fact that many H-NS homologs are encoded on plasmids, suggests, that they might have 
been acquired by horizontal gene transfer. Beloin and co-workers (2003) discovered a third 
member of the H-NS-like protein family in Shigella flexneri, the Sfh protein. Sfh shares about 
60 % amino acid homology with H-NS and StpA, and it has DNA-binding activity. Sfh is able 
to interact with both H-NS and StpA, forming heteromeric complexes (Deighan et al., 2003). 
Furthermore, it is able to complement an hns mutation and affects virulence gene expression 
when overexpressed (Beloin et al., 2003). The same authors reported, that the protein is 
encoded on a high-molecular-weight plasmid similar to the self-transmissable plasmid R27 of 
Salmonella typhi, and is only found in S. flexneri strain 2a 2457T, but not in strains 5a, 2a 
Sf301, or any other serotype. This suggests, that the protein has been acquired only recently. 
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The same situation might have occurred in uropathogenic E. coli strains. Plasmid p24-2 
encodes a protein termed MdbA, which exhibits full-length homology to H-NS after a 
mutational frameshift (Dorman et al., 1999). Another example for horizontal gene transfer is 
the H-NS-like protein Ler. This Ler protein is encoded on the LEE pathogenicity island of 
enteropathogenic E. coli, where it activates the expression of virulence genes (Haack et al., 
2003). This situation can serve as an example of a piece of extragenetic material that encode 
its own regulatory proteins. 
Recently, Williamson and Free (2005) described a truncated H-NS-homolog in 
enteropathogenic E. coli. The protein termed H-NST is lacking the C-terminal DNA-binding 
domain. However, due to the homology to the N-terminus of H-NS, both proteins are able to 
interact. This interaction interferes with the repressive function of H-NS on transcription of 
some genes. Therefore, H-NST might be considered as an anti-H-NS factor. Like the Ler 
protein mentioned before, H-NST is encoded on a genomic island only present in the 
pathogenic variants. 
As a result, many strains express several H-NS-like proteins at a time, with up to 5 copies as 
seen in Shigella flexneri or Pseudomonas putida (Tendeng and Bertin, 2003), which then are 
able to interact with each other and modulate their function. Due to variation in the 
N-terminus, the specificity and affinity of the interaction might vary between the homologs, 
which leads to a complex network of histone-like proteins. With progress in genome 
sequencing, the multitude of identified H-NS homologs and possible ways of interactions will 
be further increased. Thus, acquisition of H-NS-like proteins, which are able to interact with 
H-NS and modulate its activity, might be an important step in fine tuning the regulatory 
network during evolution of a pathogen. 
Finally, it is worthwhile mentioning that the occurrence of H-NS-like proteins seems to be 
restricted to Gram-negative bacteria, since up to now, no H-NS-like protein has been 
identified in a Gram-positive organism. 
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2.3. Uropathogenic Escherichia coli 
The urinary tract is the most common site of bacterial infection in industrialized countries 
(Warren, 1996), and urinary tract infection (UTI) is also the leading nosocomial disease. UTI 
can be caused by several microbial pathogens. The most common agent for urinary tract 
infections, however, are uropathogenic E. coli (UPEC), which cause UTI in about 80% of all 
cases (Hooton and Stamm, 1997; Svanborg and Godaly, 1997) 
The urinary tract represents an usually sterile compartment, which is protected from bacterial 
infections by various mechanisms such as urine flow and immune responses. Furthermore, the 
urinary tract is a hostile environment in terms of supporting bacterial growth. The chemical 
composition, osmolarity, and pH of urine determine the rate of bacterial growth and the 
maximum population that can be supported, and can be very variable, depending on the diet. 
Normal urine constituents include amino acids and glucose, which are usually present at 
sufficient concentrations to support rapid bacterial growth. However, other components of 
urine, such as urea and organic acids, may inhibit growth, mainly by affecting pH and 
osmolarity (Asscher et al., 1966). Therefore, the ability of some pathogens to overcome these 
mechanisms and colonize the urinary tract is linked to the presence of virulence factors 
encoded by horizontally acquired genes not present in their non-pathogenic relatives. These 
factors include adhesins, cytotoxins, iron-uptake systems and extracellular polysaccharides 
such as lipopolysaccharide and capsules. For comprehensive reviews on virulence factors of 
uropathogenic E. coli see Emödy et al. (2003), Johnson (1991), Mühldorfer et al. (2001), or 
Oelschlaeger (2002). 
UPEC strain 536 (O6:K15:H31), a clinical isolate from acute pyelonephritis, expresses one or 
several types of each of the virulence factors mentionend above. Interestingly, most of those 
virulence factors are encoded on large, unstable regions of the chromosome, so-called 
pathogenicity islands (PAIs), which will be introduced in the next section. Table 2 lists all 
relevant virulence factors of UPEC strain 536. 
 
 Table 2: Virulence and fitness factors of uropathogenic E. coli isolate 536.  
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Virulence factor Function during infection Localization Genes Encoded on Regulators Refs * 
Adhesins        
Type 1 fimbriae Adhesion to glycoproteins with N-linked oligomannose chains on 
mucosal epithelium and tissue matrix; invasion; biofilm formation 
surface fim chromosome phase variation by FimB and FimE 
recombinases, Lrp, IHF, H-NS, 
tRNA5Leu; upregulated during UTI 
1 
P-related fimbriae Adhesion to α-D-Gal-(1-4)-ß-D-Gal receptors on mucosal 
epithelium and tissue matrix; cytokine induction 
surface prf PAI II536 PrfB, PrfI, PrfX (SfaB, SfaC) 
 
2 
S fimbriae Adhesion to α-Sialyl-(2-3)-ß-Gal receptors on mucosal and 
endothelial cells, and tissue matrix 
surface sfa PAI III536 SfaB, SfaC, (PrfB, PrfI), H-NS 
 
2, 3 
thin aggregative 
fimbriae (curli) 
Adhesion to unknown structures on fibrinonectin, laminin, and 
plasminogen of mucosal cells and matrix; biofilm formation 
surface csg chromosome CsgD, Crl, RpoS, H-NS; 
thermoregulation 
4, 5 
Toxins       
α-hemolysin Cytotoxicity, hemolysis; involved in renal failure secreted hly PAI I&II536 RfaH, tRNA5Leu, Hha, H-NS, 
thermoregulation 
6, 7, 8 
Iron-uptake systems      
Yersiniabactin Iron acquisition; fitness; (phenolate type) secreted ybt PAI IV536 YbtA, Fur; induced under iron 
limitation 
9 
Salmochelin Iron acquisition; fitness; urovirulence (catecholat type) secreted iro PAI III536 Fur; induced under iron limitation 10 
Hemin receptor Iron acquisition; fitness secreted chuA genomic islet RfaH; Fur; induced under iron 
limitation 
11, 12 
Enterobactin Iron acquisition; fitness; (catecholat type) secreted fep chromosome Fur, induced under iron limitation 13, 14 
Ferrichrome Iron acquisition; fitness; (hydroxamat type) secreted fhu chromosome Fur, induced under iron limitation 15 
Extracellular polysaccharides      
O6-antigen (LPS) Cytokine induction; serum resistance; immunoadjuvant surface wa*,wb* genomic islet RfaH  6 
K15-antigen 
(capsule) 
Antiphagocytic anticomplement effect; serum resistance; evasion 
of immune recognition 
surface kps PAI V536 RfaH, H-NS, IHF, BipA; 
thermoregulation (for K5 capsules) 
6, 16 
M-antigen 
(colanic acid) 
Protection of cells under conditions of membrane perturbations; 
adhesion; biofilm formation 
surface cps chromosome RcsA, RcsB, RcsF, RcsC, Lon, H-NS 
(indirectly); thermoregulation 
 17 
Others       
Flagella Motility; adaptation; fitness surface fli, flg chromosome Crp, H-NS, OmpR 18 
Ag43 Autotransporter mediating cell-cell interactions; autoaggregation; 
biofilm formation 
surface agn43 PAI III&V536 phase variation by OxyR and Dam, 
RfaH (indirectly) 
19 
* Selected references on regulation: 1=Blomfield (2001), 2=Morschhäuser et. al. (1994); 3=Morschhäuser et al. (1993); 4=Gerstel et al. (2003); 5=Olsen et al. (1993a); 6=Nagy et al. (2002); 7=Nieto et al. 
(2000); 8=Dobrindt et al. (2002b); 9=Carniel (2001); 10=Russo et al. (2002); 11=Nagy et al. (2001); 12=Torres&Payne (1997); 13=Ozenberger et al. (1987); 14=Escolar et al. (1998); 
15=Mademidis&Koster (1998); 16=Rowe et al. (2000); 16=Schneider et al. (2004); 17=Gottesman&Stout (1991); 18=Soutourina&Bertin (2003); 19=Schembri et al. (2003) 
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2.4. Pathogenicity islands 
Pathogenicity islands have been first described in UPEC strain 536 (Blum et al., 1994; Hacker 
et al., 1997; Knapp et al., 1986), but afterwards have been found in the genomes of many 
human, animal, and plant pathogens. The characteristics of a pathogenicity island are 
reviewed by Hacker and Kaper (2000). Similarly, there are DNA regions that do not contain 
virulence-associated genes, but nevertheless contribute to the fitness of the bacterium. These 
so-called genomic islands (GEIs) or fitness islands help microorganisms to live in the 
environment (Hacker and Carniel, 2001). Genomic islands represent (formerly) mobile DNA 
elements and are considered to have been acquired by horizontal gene transfer, thereby 
contributing to the evolutionary potential of bacteria (Dobrindt et al., 2004; Hacker et al., 
2003). Therefore, the bacterial chromosome can be divided into two gene pools: the “flexible 
gene pool” including the majority of horizontally acquired DNA, and the conserved “core 
gene pool”, which mainly represents essential genetic information for basic cellular processes 
such as DNA replication, protein synthesis, and key metabolic pathways (Dobrindt and 
Hacker, 2001). 
So far, six pathogenicity islands, as well as several smaller genomic islets encoding the hemin 
receptor (chu) or the O6-specific Lipopolysaccharide (wa*, wb*), have been identified in 
UPEC strain 536. Fig. 6 depicts the localization of those islands in the chromosome, as well 
as the encoded virulence factors. 
 
 
 
 
Fig. 6: Chromosomal 
map of uropathogenic E. 
coli strain 536. The map is 
based on the chromosomal 
map of E. coli K-12 strain 
MG1655, and depicts the 
chromosomal localization of 
the known PAIs and some 
other virulence-associated 
genes. [(Schneider, 2005)] 
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2.5. Aims of this study 
Although the effect of the histone-like proteins H-NS and StpA are well characterized in non-
pathogenic E. coli K-12 strains, their role in pathogenic strains has only been studied for some 
selected virulence traits. Using DNA macroarrays, RT-PCR and different phenotypic tests, we 
monitored the effects of histone-like proteins in an uropathogenic E. coli isolate on a larger 
scale and assessed their role for overall virulence in experimental murine models of ascending 
urinary tract infection and sepsis. 
Uropathogenic E. coli strain 536 can serve as a model organisms due to different reasons. The 
genome of strain 536 was sequenced recently, thereby enabling both genetic manipulations 
and bioinformatic analyzes. Moreover, most virulence factors are encoded on extragenetic 
material, the pathogenicity islands. This imposes the question, whether PAI-encoded genes 
are part of the “normal” regulatory network of the host cell, mediated by global regulators 
such as H-NS. Furthermore, many PAIs themselves encode known or putative regulators. We 
could also identify an H-NS homolog (Hlp) that is encoded on a putative genomic island. 
Therefore, another aim of this study was to assess, whether such a regulator only affects PAI-
encoded genes or also gene expression of the core genome. 
In summary, the aim of this study was to answer the central question, whether there is 
regulatory cross-talk between pathogenicity islands and the chromosome mediated by histone-
like proteins. 
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3. Material 
3.1. Strains 
All bacterial strains used in this study and their relevant genotype are listed in Table 3. 
Table 3: Bacterial strains used in this study. 
Strain Relevant properties Reference 
UPEC 536 clinical isolate from pyelonephritis; serotype 
O6:K15:H31 
(Berger et al., 1982) 
536 ∆stpA chromosomal deletion of CDS This study 
536 ∆hns chromosomal deletion of CDS This study 
536 ∆hlp chromosomal deletion of CDS This study 
536 ∆stpA ∆hns chromosomal deletions of CDS This study 
536 ∆stpA ∆hlp chromosomal deletions of CDS This study 
536 ∆hns ∆hlp chromosomal deletions of CDS This study 
536 ∆stpA∆hns∆hlp chromosomal deletions of CDS This study 
Nissle 1917 (DSM6601) Probiotic Escherichia coli strain; O6:K5:H1 Ardeypharm GmbH, 
Herdecke (Germany) 
E. coli MG1655 F-, λ-, ilvG, rfb-50 rph-1 (Blattner et al., 1997) 
BEU740 * MG1655 hns::cat Uhlin; unpublished 
BEU693 * GM37, trp::Tn 10. proU-lac Z (Sonden and Uhlin, 1996) 
BEU694 * BEU693 ∆hns (Sonden and Uhlin, 1996) 
E. coli DH5α F-, endA1, hsdR17 (rk-, mk-), supE44, thi-1, recA1, 
GyrA96, relA1, λ-, ∆(argF-lac)U169, Φ80dlacZ 
∆M15 
BRL, Bethesda Research 
Laboratories 1986 
E. coli RosettaTM E. coli K-12 Novagen 
E. coli BL21 ∆hns  * F- ompT hsdSB (rB- mB-) gal dcm (DE3) (Zhang et al., 1996) 
JGJ152  * MC4100 stpA60::KmR, hns::CmR (Johansson and Uhlin, 
1999) 
MC4100 F– araD139 ∆(argF-lac)U169 rpsL150 (Strr) relA1 
flbB5301 deoC1 ptsF25 rbsR 
(Silhavy et al., 1984) 
MC4100 ∆hns ∆stpA chromosomal deletions of (partial) CDS This study 
MC4100 ∆hns ∆lon chromosomal deletions of CDS This study 
MC4100∆hns∆stpA∆lon chromosomal deletions of (partial) CDS This study 
* kind gifts from B. E. Uhlin 
3.2. Plasmids 
All plasmids used and constructed during this study are listed in Table 4. Maps of the newly 
constructed plasmids are found in the appendix (Fig. 54). 
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Table 4: Plasmids used in this study. 
Plasmid Relevant properties Reference 
pKD46 repA101 (ts), araBp-gam-bet-exo (λ red recombinase 
under the contol of araB promotor), ApR (bla) 
(Datsenko and Wanner, 2000) 
pKD3 oriRγ, ApR, cat-gene flanked by FRT sites (Datsenko and Wanner, 2000) 
pKD4 oriRγ, ApR, npt-gene flanked by FRT sites (Datsenko and Wanner, 2000) 
pCP20 Yeast Flp recombinase gene (FLP, aka exo) ts-rep, ApR, 
CmR 
(Datsenko and Wanner, 2000) 
pASK75 expression vestor with aTc-inducible tet p/o promoter (Skerra, 1994) 
pASK75-HIShlp His6-tagged hlp subcloned in pASK75 This study 
pWKS30 low copy number cloning vector; bla (Wang and Kushner, 1991) 
pWKS30-hlp 750-nt subclone of the hlp locus in pWKS30 This study 
pYMZ80  * 1.6-kb subclone of the clyA locus in pUC18 (Westermark et al., 2000) 
pBSN2  * translational fusion hns in pMW156 (translational lacZ 
fusion vector, KmR) 
(Sonden and Uhlin, 1996) 
pGEM®-Teasy ApR, orif1, lacZ Promega, 1997 
* kind gifts from B. E. Uhlin 
3.3. Oligonucleotides 
The oligonucleotides used for gene disruption using the λRed-based method (Datsenko and 
Wanner, 2000), as well as the IRD800 labelled oligonucleotides were purchased from MWG-
Biotech (Ebersberg, Germany). All other oligonucleotides used for PCR verification of the 
mutants and RT-PCR were purchased from Sigma-Genosys (Steinheim, Germany). The 
sequences and the application of all oligonucleotides are listed in Table 5. 
Table 5: Oligonucleotides used in this study. 
Name Length Sequence (5’→3’) Application 
hns-1 69-mer AAA TCC CGC CGC TGG CGG GAT TTT AAG CAA GTG CAA 
TCT ACA AAA GAT TAG TGT AGG CTG GAG CTG CTT 
hns-2 76-mer ATT ATT ACC TCA ACA AAC CAC CCC AAT ATA AGT TTG AGA 
TTA CTA CAA TGC ATA TGA ATA TCC TCC TTA GTT CCT A 
disruption of hns gene 
hns-3 20-mer TTC GTC ATA ACA CCC TTG GC 
hns-4 20-mer GTC AGC CTA CGA TAA TCT CC 
confirmation of hns 
genotype 
stpA-1 69-mer AGA AGC GAC GCC GGA CGC GCC CTA GCA GCG ACA TCC 
GGC CTC AGT AAT TAG TGT AGG CTG GAG CTG CTT 
stpA-2 76-mer GCG ACG AAA TAC TTT TTT TGT TTT GGC GTT AAA AGG TTT 
TCT TTA TTA TGC ATA TGA ATA TCC TCC TTA GTT CCT A 
disruption of stpA gene 
(complete CDS) 
stpA-1B 64-mer GAT CAG GAA ATC GTC GAG AGA TTT ACC TTC TGC CAG 
CGC CTG AGC GTG TAG GCT GGA GCT GCT T 
stpA-2B 71-mer GTC CGT AAT GTT ACA AAG TTT AAA TAA CAT TCG CAC CCT 
CCG TGC CAT ATG AAT ATC CTC CTT AGT TCC TA 
disruption of stpA gene 
(partial deletion) 
stpA-3 20-mer GGA ATC AGC GGT TTT TGT GG 
stpA-4 20-mer GGA ATT AGC GAG CAG AGA GC 
confirmation of stpA 
genotype 
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Table 5 - continued  
Name Length Sequence (5’→3’) Application 
hlpII-1 69-mer GCA TT A TTT TTA TTA ATC GCC TAT TTT AAA ACA CCG GAT 
GAC ATA CTA TGG TGT AAG CTG GAG CTG CTT 
hlpII-2 71-mer CTG TTA TCT TGA GAA CAG TGA AGC CCG GAT ATG CTG 
TAG CGG TTA CAT ATG AAT ATC CTC CTT AGT TCC TA 
disruption of hlp gene 
hlp-3 20-mer CCA TCA AAC CAA AAG CGC AG 
hlp-4 20-mer GCT GCG TAT CAT TGG TGG CG 
confirmation of hlp 
genotype 
lon-1 64-mer GTC ATC TGA TTA CCT GGC GGA AAT TAA ACT AAG AGA 
GAG CTC TAT GGT GTA GGC TGG AGC TGC T 
lon-2 71-mer CCT GCC AGC CCT GTT TTT ATT AGT GCA TTT TGC GCG AGG 
TCA CTA CAT ATG AAT ATC CTC CTT AGT TCC TA 
disruption of lon gene 
lon-3 20-mer CTC GGC GTT GAA TGT GGG GG 
lon-4 20-mer CCG CCA TCT AAC TTA GCG AG 
confirmation of lon 
genotype 
hlp-primext 20-mer GCC TGT GCG CGA AGT GTA CG 5’IRD800-labeled oligo 
for primer extension 
XhoI-His-hlp 83-mer TGC TCT AGA TAG TAA AGG AAA AAC T ATG CAT CAC CAT 
CAC CAT CAC ATC GAG GGC AGG ATG AGT GAA GCT CTT 
AAG GCA CTG 
hlp-HindIII 30-mer TGC AAG CTT TTA GAT AGC AAA GTC TTC CAG 
amplification of 6xHis-
hlp fragment for cloning 
into pASK75  
hlp-fwHindIII 26-mer GCG AAG CCT CCA TCA AAC CAA AAG CG 
hlp-rv-XbaI 27-mer GCG TCT AGA GCT GCG TAT CAT TGG TGG 
amplification of native 
hlp fragment for cloning 
into pWKS30 
pASK75seq 23-mer CGA ATG GCC AGA TGA TTA ATT TCC sequencing primer for 
pASK75 constructs 
16S-I 19-mer TCT CCT GAG AAC TCC GGC A 
16S-II 19-mer CAG CGT TCA ATC TGA GCC A 
standardization of RT-
PCR reactions 
hns-RT1 20-mer CAG CTG GAG TAC GGC CTT GG 
hns-RT2 20-mer CGT ACT CTT CGT GCG CAG GC 
Amplification of hns-
transcript by RT-PCR 
stpA-RT1 20-mer GCA ATT GGC TTC GGT GTA CG 
stpA-RT2 20-mer TCG CGA ATT CTC CAT TGA CG 
Amplification of stpA-
transcript by RT-PCR 
hlp-RT1 20-mer CGT ACA CTT CGC GCA CAG GC 
hlp-RT2 20-mer CCA GTG TCT TAC CAG CTT CG 
Amplification of hlp-
transcript by RT-PCR 
c2410-fw 21-mer CAG ACA ACA GTG ATT TAA TCG 
c2410-rv 20-mer CTG CGC TTT TGG TTT GAT GG 
Amplification of orf 
upstream of hlp by RT-
PCR 
fimA-RT1 20-mer GTT GTT CTG TCG GCT CTG TC 
fimA-RT2 20-mer TCT GAA CTA AAT GTC GCA CC 
Amplification of fimA-
transcript by RT-PCR 
prfA-RT1 20-mer CCC CTC TTT TAC ATG GTT GC 
prfA-RT2 20-mer GGC AGT GGT GTC TTT TGG TG 
Amplification of prfA-
transcript by RT-PCR 
sfaA-RT1 20-mer GGT TAA TGG TGG TAC AGT TC 
sfaA-RT2 20-mer CCT ACA TTT GTT GCA CTA CC 
Amplification of sfaA-
transcript by RT-PCR 
hlyA-RT1 20-mer GCA CAC TGC AGT CTG CAA AG 
hlyA-RT2 20-mer GTG TCC ACG AGT TGG TTG AT  
Amplification of hlyA-
transcript by RT-PCR 
crp-RT1 20-mer GAG CAC GCT TAT TCA CCA GG 
crp-RT2 20-mer CCG GGT GAG TCA TAG CAT CC 
Amplification of crp-
transcript by RT-PCR 
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Table 5 - continued  
Name Length Sequence (5’→3’) Application 
fepA-RT1 20-mer CCT TCC AGA CCT TCA ACC AC 
fepA-RT2 20-mer CGT AGC CCG TAT TCA AAA GC 
Amplification of fepA-
transcript by RT-PCR 
fyuA-RT1 20-mer CGA CGT TTT ATA CCC ACA CC 
fyuA-RT2 20-mer CCA TAG GTA CGG TAA CGA CG 
Amplification of fyuA-
transcript by RT-PCR 
chuA-RT1 20-mer CCT GCT GCC CTT GAT AAC TG 
chuA-RT2 20-mer CCA AAC CCG AAC TTA CGT CC 
Amplification of chuA-
transcript by RT-PCR 
iroN-RT1 20-mer CCT GGT TGG GGT TGA ATA GCC 
iroN-RT2 20-mer CGC CCT CTT CGC TAC TTT CC 
Amplification of iroN-
transcript by RT-PCR 
csgA-RT1 20-mer GCT CTG GCA GGT GTT GTT CC 
csgA-RT2 20-mer CCA AAG CCA ACC TGA GTG AC 
Amplification of csgA-
transcript by RT-PCR 
kpsE-RT1 20-mer CGT ATC TGC GTG AGG ACG CT 
kpsE-RT2 21-mer CGA TTC CTG CGG CAA CTG TGG 
Amplification of kpsE-
transcript by RT-PCR 
orf70-RT1 20-mer CCA AGT CAT AAC CGA GTG GG 
orf70-RT2 21-mer GCA CTG TCA GCT TCA GCA ACC 
Amplification of orf70-
transcript by RT-PCR 
kpsM-RT1 20-mer GAA AGC CGC CGT TCA TGC TC 
kpsM-RT2 20-mer GCC CCT ATA GAC CGC GTA GC 
Amplification of kpsM-
transcript by RT-PCR 
hns-prom1 20-mer CCC TGC TCT TAT TGC GAC TG 
hns-prom2 20-mer CAC GAA GAG TAC GGA TGT TG 
Amplification of hns 
promoter region for gel 
shift (~350bp) 
stpA-prom1 20-mer GAC AGC AGA AAG CAC CAG TG 
stpA-prom2 20-mer ACG GAG GGT GCG AAT GTT AT 
Amplification of stpA 
promoter region for gel 
shift (~350bp) 
hlp-prom1 20-mer GCG ATG AAG AAA TAG TAG CC 
hlp-prom2 20-mer CGC GAA GTG TAC GAA TAT TG 
Amplification of hlp 
promoter region for gel 
shift (~350bp) 
kpsF-prom1 19-mer CAT CAC CAT TAT TTG CGT G 
kpsF-prom2 20-mer GTA CTG CTC TGG TCA TCA GG 
Amplification of kpsF 
promoter region for gel 
shift (~350bp) 
kpsM-prom1 20-mer GTT GGT AAT CAA TCG CGT GC 
kpsM-prom2 20-mer GCA TGA ACG GCG GCT TTC TG 
Amplification of kpsM 
promoter region for gel 
shift (~350bp) 
ORF72-prom1 22-mer CCA GAT AGT TGC GAT TAC ATT G 
ORF72-prom2 24-mer CTT TAC ATT CGT ACT CAT TAC ATG 
Amplification of ORF72 
promoter region for gel 
shift (~350bp) 
3.4. Chemicals and enzymes 
All chemicals and enzymes used in this study were purchased from the following companies: 
New England Biolabs (Frankfurt am Main), Invitrogen (Karlsruhe), MBI Fermentas 
(St. Leon-Roth), Roche Diagnostics (Mannheim), Gibco BRL (Eggenstein), Dianova 
(Hamburg), Difco (Augsburg), Merck (Darmstadt), Oxoid (Wesel), GE Healthcare/Amersham 
Biosciences (Freiburg), Roth (Karlsruhe), Serva and Sigma-Aldrich (Taufkirchen). 
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Radionucleotides were purchased from Amersham Biosciences (Freiburg). 
The following commercial kits were used: 
- Plasmid Mini and Midi kit, QIAGEN, Hilden 
- PCR purification kit, QIAGEN, Hilden 
- Gel extraction kit, QIAGEN, Hilden 
- RNeasy kit, QIAGEN, Hilden 
- MICROBExpress kit, Ambion, Huntingdon (UK) 
- Omniscript Reverse Transcriptase, OIAGEN, Hilden 
- Superscript III Reverse Transcriptase, Invitrogen, Karlsruhe 
- pGEM®-Teasy Vector System, Promega, Mannhein 
- SequiTherm EXCELL II DNA Sequencing Kit-LC, Epicentre, Oldendorf 
- ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction kit, Applied 
Biosystems, Foster City (USA) 
- ECLTM Direct Acid Labeling and Detection System, and ECLTM advance system, 
Amersham Biosciences, Freiburg 
- Protino Ni-1000 protein purification kit, Macherey-Nagel, Düren 
- Gelfiltration LMW calibration kit, Amersham Biosciences, Freiburg 
- Roti-Nanoquant, Roth, Karslruhe 
 
3.5. Antibodies 
The following antibodies were used for Immunoblotting: 
- polyclonal antibody against purified P-related fimbriae from rabbit (Dr. Salam Kahn) 
- polyclonal antibody against purified S fimbriae from rabbit (Dr. Salam Kahn) 
- polyclonal antibody against H-NS from rabbit (kind gift from B. E. Uhlin) 
- polyclonal anitbody against StpA/Hlp from rabbit (kind gift from B. E. Uhlin) 
- polyclonal anti-rabbit antiserum from donkey; HRP conjugated (Dianova) 
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3.6. Media, Agar-plates and antibiotics 
All media were autoclaved for 20 min at 120 °C, if not stated otherwise. Supplements for 
media and plates were sterile filtered through a 0.22 µm pore-filter and added after cooling 
down the media to <50 °C. 
3.6.1. Media 
LB medium (Luria-Bertani): (Sambrook et al., 1989) 
10 g tryptone from casein 
 5 g yeast extract 
 5 g NaCl    ad 1 l dH2O 
MM9 minimal medium:  (Kalinowski et al., 2000) 
100 ml 10 x MM9 salts     3 g l-1 KH2PO4 
 5 g l-1 NaCl 
10 g l-1 NH4Cl 
100 ml 0.5 M Tris (pH 6.8) 
100 ml 10 % (w/v) casamino acids 
  20 ml 20 % (w/v) glucose 
    2 ml 1 M MgSO4 
0.1 ml 1 M CaCl2 
0.3 ml 10 mM thiamine   ad 1 l dH2O; sterile filtered 
M63B1 minimal medium:   
10 ml 20 % (w/v) (NH4)2SO4 solution 
13.6 g KH2PO4 
1 ml 10 % (w/v) MgSO4 solution 
1 ml 0.1 % (w/v) FeSO4 solution  ad 978 ml dH2O 
pH adjusted to 7 with KOH and autoclaved; then addition of 
2 ml 0.05 % (w/v) thiamine (sterile filtered) 
20 ml 20 % (w/v) glucose (sterile filtered) 
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MMA minimal medium:  (Silhavy et al., 1984) 
10.5 g K2HPO4 
  5.5 g KH2PO4 
     1 g (NH4)2SO4 
  0.5 g sodium-citrate x 2H2O 
    1 g casamino acids 
20 ml 20 % (w/v) glucose 
 1 ml 1 M MgSO4 
 5 ml 0.4 % (w/v) tryptophane 
60 ml 5 M NaCl   ad 1 l dH2O; sterile filtered 
3.6.2. Agar plates 
LB agar plates: 
LB medium + 1.5 % (w/v) agar (Difco Laboratories, Detroit, USA) 
Motility agar plates: 
LB medium + 0.3 % (w/v) agar 
Blood agar plates: 
LB plates containing 5 % (v/v) washed sheep erythrocytes 
 (Elocin Lab, Mühlheim a. d. Ruhr) 
bgl agar plates:    (Free et al., 1998) 
10 g tryptone from casein 
 5 g yeast extract 
 5 g NaCl 
15 g agar   ad 735 ml dH2O 
autoclaved and cooled to 50 °C, then addition of 
200 ml 2.5 % (w/v) salicin solution (sterile filtered) 
5 ml indicator solution (sterile filtered): 12.5 ml EtOH 
0.5 g bromophenol blue 
0.5 ml 10 N NaOH 
12 ml dH2O 
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Congo Red agar plates: 
1 l  autoclaved LB agar without salt 
1 ml 0.4 mg ml-1 Congo Red dye solution 
1 ml 0.2 mg ml-1 Coomassie brilliant blue R-250 
dye solutions were stirred for 1h at 50 °C and sterile filtered 
Fluostain agar plates:   (Solano et al., 2002) 
LB agar without salt 
200 µg ml-1 Fluostain 1 (Sigma) 
CAS agar plates:   (Schwyn and Neilands, 1987) 
I) Basal agar medium: 
30.24 g PIPES; dissolved in 250 ml dH2O + 12 ml 50 % NaOH 
100 ml 10 x MM9 salts     3 g l-1 KH2PO4 
 5 g l-1 NaCl 
10 g l-1 NH4Cl 
autoclaved and cooled to 50 °C; 
15 g agar dissolved in 500 ml dH2O 
autoclaved, cooled to 50 °C and mixed with first solution; then addition of 
30 ml 10 % (w/v) casamino acids solution (sterile filtered) 
10 ml 20 % (w/v) glucose solution (sterile filtered) 
II) CAS indicator solution: (100 ml) 
60.5 mg Chrome azurole S (CAS; Sigma) dissolved in 50 ml dH2O 
10 ml iron III solution: 27 mg FeCl3 x 6 H2O 
83.3 µl 37 % HCl 
ad 100 ml dH2O 
To the above solution, 72.9 mg hexadecyltrimethyl ammonium bromide (HDTMA) dissolved 
in 40 ml distilled water was added slowly under stirring. The resultant dark blue solution was 
sterile filtered, heated to 50 °C and added very slowly along the glass walls to the basal agar 
medium before pouring approximately 25 ml into each plate. 
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3.6.3. Antibiotics 
When appropriate, media and plates were supplemented with the antibiotics listed in Table 6 
in the indicated concentrations. Stock solutions were sterile filtered and stored at –20 °C until 
usage. 
Table 6: Antibiotic substances used in this study. 
Antibiotic Stock concentration Solvent Working concentration 
Chloramphenicol (Cm) 50 mg ml-1 EtOH 20 µg ml-1 
Ampicillin (Ap) 100 mg ml-1 dH2O 100 µg ml-1 
Kanamycin (Km) 50 mg ml-1 dH2O 50 µg ml-1 
anhydro-Tetracycline (aTc) 2 mg ml-1 EtOH 0.2 µg ml-1 
Spectinomycin (Spec) 100 mg ml-1 dH2O 100 µg ml-1 
3.7. DNA and Protein Markers 
To determine the size of DNA fragments in agarose gels, the “GenerulerTM” 1-kb DNA ladder, 
purchased from MBI Fermentas, was used (Fig 7 A). As a reference in denaturing agarose 
gels for Northern blotting, both the low-range RNA marker from Peqlab, as well as the 0.24-
9.5-kb RNA ladder from Invitrogen were used (Fig 7 B and C, respectively). To determine the 
molecular weight of protein fractions separated by polyacrylamide gel electrophoresis, 
“Rainbowmarker” (RPN800) purchased from Amersham Biosciences was used (Fig 7 D). 
 
Fig. 7: DNA and protein markers used for electrophoresis. (A) Generuler 1-kb DNA ladder 
(Fermentas); (B) Low range RNA ladder (Peqlab); (C) 0.24-9.49-kb RNA ladder (Invitrogen); (D) 
Rainbowmarker (Amersham Biosciences). 
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3.8. Technical Equipment 
Balances IL-180, Chyo Balance Corp 
 Kern 470 
 Ohaus Navigator 
Autoclaves Integra Bioscience, H+P Varoclav 
Incubators Memmert Tv40b (30°C, 43°C) 
Heraeus B5050E (37°C) 
Clean bench NUAIRE, Class II, type A/B3 
Electrophoresis systems BioRad 
Electroporator Gene Pulser, BioRad 
FPLC Amersham Pharmacia 
Hybridization oven HybAid Mini 10 
Centrifuges (cooled) Beckmann J2-HC → JA10 and JA20 rotors 
 Haraeus Sepatech Megafuge1.OR 
Haraeus Sepatech Biofuge 13R 
Centrifuges (table top) Eppendorf 5415C 
Hettich Mikro20 
Magnetic stirrer Heidolf MR3001K 
Micropipettes Eppendorf Research 0.5-10 µl 
 Gilson pipetman 20 µl, 200 µl, 1000 µl 
Microwave AEG Micromat 
Power supplies BioRad Power Pac 300 
PCR-Thermocycler Biometra T3 
pH-meter WTW pH 525 
Documentation BioRad GelDoc2000 + MultiAnalyst Software V1.1 
Developer Agfa Curix 60 
Photometer Pharmacia Biotech Ultrospec 3000 
Phosphoimager Amersham Biosciences, Typhoon 4600 
Shakers Bühler TH30 SM-30 (37°C, 150 rpm) 
 Innova 4300, New Brunswick Scientific (37°C, 220 rpm) 
 Innova 4230, New Brunswick Scientific (30°C, 220rpm) 
Sonicator Bandelin Sonoplus HD70; Tip UW70 
Speedvac Savant SC110 
Thermoblocks Liebisch 
Vacuum Blotter Pharmacia + LKD Vacu Gene Pump 
Videoprinter Mitsubishi Hitachi, Cybertech Cb1 
Vortexer Vortex-Genie 2TM Scientific Industries 
UV-Crosslinker BioRad 
Waterbath GFL 1083, Memmert 
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4. Methods 
If not stated otherwise, all methods followed the instructions described in the CSH Laboratory 
Manual (Sambrook 1989). Centrifugations with no other indications were carried out in a 
table top centrifuge at 13,000 rpm. 
4.1. Manipulation of DNA 
4.1.1. Small scale isolation of plasmids 
While using the QIAGEN Plasmid Midi and Mini Kit, bacteria were collected from 100 ml 
over night cultures by centrifugation (6,000 rpm, 4 °C, 15 min) and resuspended in 4 ml 
buffer P1, according to the manufacturer’s recommendations. After 5 min incubation at room 
temperature, 4 ml buffer P2 were added for lysis of the cells. After clearing of the suspension, 
4 ml neutralization buffer P3 were added and samples were incubated for 10 min on ice. Cell 
debris and genomic DNA was removed by centrifugation (11,000 rpm, 4 °C, 30 min). Plasmid 
DNA containing supernatant was loaded on equilibrated columns by gravity flow. Columns 
were washed with buffer QC. Subsequently, plasmid DNA was eluted with 3.5 ml buffer QF 
and precipitated by addition of 0.7 vol isopropanol. After centrifugation (13,000 rpm, 4 °C, 
20 min), DNA pellets were washed with 70 % (v/v) ethanol, air-dried and resuspended in 
water. 
Plasmid isolation using the QIAspin mini kit were performed similarly with some 
modifications: bacteria were harvested from 1-10 ml over night cultures, buffer N3 containing 
guanidine hydrochloride was used for neutralization, and plasmid DNA was purified from the 
supernatant by using small spin columns, which were centrifuged at 13,000 rpm for 1 min 
DNA was eluted in a small volume of dH2O and directly used for further experiments. 
4.1.2. Isolation of chromosomal DNA 
Bacteria from 1 ml of an over night culture were harvested by centrifugation for 4 min in a 
1.5 ml reaction tube. After washing with 1 ml TNE buffer, cells were centrifuged for 4 min 
and resuspended in 270 µl TNE-X solution. 30 µl lysozyme (5 mg ml-1) were added and 
samples were incubated for 20 min at 37 °C. Afterwards, 15 µl proteinase K (20 mg ml-1) 
were added and further incubated for up to 2 h at 65 °C until the solution became clear. The 
genomic DNA was precipitated by addition of 0.05 vol 5 M NaCl (15 µl) and 500 µl ice-cold 
ethanol and then collected by centrifugation for 15 min. After washing two times with 1 ml 
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70 % (v/v) ethanol, DNA pellets were air-dried and redissolved in 100 µl sterile dH2O. (after 
Grimberg et al. (1989)) 
TNE: 10 mM Tris 
10 mM NaCl 
10 mM EDTA  pH 8.0 
TNE-X: TNE + 1 % Triton X-100 
 
4.1.3. Precipitation of DNA with alcohol 
DNA was either precipitated with ethanol or with isopropanol. In the first case, 0.1 vol 3 M 
Na-acetate (pH 4.8) were added to the samples before the addition of 2.5 vol ice-cold 
100 % (v/v) ethanol. For the precipitation with isopropanol, 0.7 vol were used. Samples were 
incubated for at least 1 h at –80 °C before centrifugation (13,000 rpm, 4 °C, >20 min). The 
DNA pellet was washed with 70 % (v/v) ethanol, dried in a Speedvac for 10 min and 
resuspended in dH2O. 
4.1.4. Determination of nucleic acid concentrations  
Nucleic acid concentrations were measured at 260 nm in quartz cuvettes with a diameter of 
1 cm. An absorption at 260 nm of 1.0 corresponds to 50 µg ml-1 double-stranded DNA or 
40 µg ml-1 RNA. The purity of the preparations was determined by measuring the absorption 
of the sample at 280 nm. DNA and RNA was considered sufficiently pure when the ratio 
A260 / A280 was higher than 1.8 or 2.0, respectively. 
4.1.5. Polymerase chain reaction (PCR) 
This method allows the exponential amplification of DNA regions in vitro by using a heat-
stable DNA polymerase from Thermophilus aquaticus (Taq). This way, even small amounts 
of template DNA can be amplified to high copy numbers and easily visualized during 
screening assays. Another application of PCR is site-directed mutagenesis by using 
oligonucleotides with adapted sequences, e.g. restriction sites. 
Standart PCR 
For routine PCR-amplification, Taq DNA polymerase kits of different suppliers (QIAGEN, 
Sigma) were used. Usually, the reaction was performed in a final volume of 20 µl. 
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Mix for one sample: 2 µl 10 × reaction buffer (QIAGEN) 
2 µl  20mM dNTP mix (Sigma) 
0.6 µl 25 mM MgCl2 
0.2 µl 100 pM primer solution 1 
0.2 µl 100 pM primer solution 2 
1 µl 100 ng µl-1 template DNA or boiled cells 
0.05 µl  Taq DNA polymerase (QIAGEN) 
14 µl dH2O 
For the Sigma Red Taq polymerase kit, both primers and template DNA were added to 8.6 µl 
dH2O and 10 µl 2x Red Taq ready mix (see the manufacturer’s instructions). 
The thermal profile was designed according to the annealing temperature of the individual 
primers and the length of the expected amplification product: 
Initial denaturation 2 min, 95 °C 
1. Denaturation  45 sec, 95 °C 
2. Annealing   45 sec (54-60 °C)  25-35 cycles 
3. Elongation   30 sec 0.5-5 min, 72 °C 
Final elongation  2 min, 72 °C 
PCR with proof-reading polymerases 
For site-directed mutagenesis using PCR products, a different polymerase with 3’→5’ proof-
reading activity had to be used in order to prevent misincorporations during extension. The 
composition of a typical PCR mix for the λRed-Mutagenesis (see section 4.1.11) is given 
below: 
Mix for 1 sample: 5 µl 10 × Opti buffer (Eurogentec) 
5 µl  20mM dNTP mix (Sigma) 
3.5 µl /kb 50 mM MgCl2 
1 µl 100 pM primer solution 1 
1 µl 100 pM primer solution 2 
1 µl 100 ng µl-1 template plasmid DNA 
0.5 µl DAP Goldstar polymerase (Eurogentec) 
      ad 50 µl dH2O 
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After amplification, PCR products were eventually purified using a commercial PCR 
purification kit (QIAGEN). For this purpose, 5 vol buffer PB were added to the PCR samples 
and the mixture was loaded onto the spin columns. Washing and elution was performed as 
described for the gel extraction kit (see section 4.1.8.). 
4.1.6. Enzymatic digest of DNA with restriction endonucleases 
The DNA was dissolved in dH2O and mixed with 0.2 vol 10 × reaction buffer and 1 U of 
restriction enzyme per µg DNA, so that the final volume of the sample was 15 µl for plasmid 
DNA and 50 µl for genomic DNA. The mixture was incubated at 37 °C, depending of the 
specific requirements of the enzyme indicated on the product sheets. Whereas plasmid DNA 
was digested for one to two hours, digestion of genomic DNA was carried out over night. The 
reaction was stopped by adding 0.2 vol stop-mix (see following section 4.1.7.). When 
appropriate, inactivation of the restriction enzyme was carried out by heating the samples for 
20 min at 65 °C.  
4.1.7. Horizontal Gel Electrophoresis 
For routine analytical and preparative separation of DNA fragments, horizontal gel 
electrophoresis was performed using agarose gels under non-denaturing conditions. 
Depending on the size of the DNA fragments to be separated, the agarose concentration 
varied between 1 and 2 % (w/v) in running buffer (1 × TAE). In order to have a visible 
running front and to prevent diffusion of the DNA, 0.2 vol loading dye was added to the 
samples before loading. The electrophoresis was carried out at a voltage in the range between 
16-120 V. The gels were stained in an ethidium bromide solution (10 mg ml-1), washed with 
water and photographed under a UV-transilluminator. 
50x TAE buffer:      2 M Tris 
6 % (v/v) acetic acid (99.7 %) 
50 mM EDTA (pH 8.0) 
ad 1 l dH2O 
6x loading dye: 0.25 % bromophenol blue 
0.25 % xylenecyanol FF 
15 % Ficoll (Type 400, Pharmacia) 
30 % glycerol 
ad 50 ml dH2O 
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4.1.8. Isolation of DNA fragments from agarose gels 
DNA was purified from agarose gels using the QIAquick Gel Extraction Kit (QIAGEN). 
Agarose pieces containing the DNA fragment of interest were cut out of the gel and 
subsequently melted for 10 min at 50 °C in QG buffer (supplied by the manufacturer). The 
DNA was separated from the rest of the solution by applying the mixture to QIAquick spin 
columns followed by centrifugation for 1 min. The columns were then washed with 750 µl PE 
buffer (supplemented with ethanol). Residual PE buffer was removed by centrifugation 
(2 × 1 min). Finally, the DNA was by eluted from the column with 20-50 µl sterile dH2O. 
4.1.9. Ligation of DNA fragments 
Linearized vector and insert DNA after restriction digest can be ligated either due to the 
presence of sticky ends or by blunt-end ligation. The modifying enzyme for ligation process 
was a T4-DNA ligase (New England Biolabs). Best efficiencies were obtained using a 
insert/vector ratio of 3/1. Reactions were performed over night at 16 °C in a final volume of 
15 µl containing 1.5 µl 10 x ligation buffer and 50 U T4 ligase. 
4.1.10. Transformation of bacterial cells 
Preparation of CaCl2 competent bacterial cells and heat-shock transformation 
A 100 ml LB culture was inoculated with 1 ml of an over night culture. Cells were grown to 
an OD600 of 0.6-0.8 and cooled on ice. The culture was centrifuged for 5 min at 3,500 × g at 
4 °C and the pellet was resuspended in 50 ml ice-cold 0.1 M CaCl2 and incubated on ice for 
30 min. After a second centrifugation, the cells were resuspended in 2 ml ice-cold 0.1 M 
CaCl2 and either used immediately for transformation, or prepared for freezing at –80 °C by 
addition of 50 % (v/v) glycerol to a final concentration of 15 %. 200 µl of competent cells 
were thawed on ice and ~ 100 ng of plasmid DNA were added for transformation. After 
incubation on ice for 30 min, the cells were incubated at 42 °C for 90 sec and then again 
placed immediately on ice for 5 min. 1 ml LB was added and the cells were incubated at 
37 °C for 1 h, allowing the expression of the selection marker before the mixture was plated 
on selective LB agar plates. 
Preparation of electrocompetent cells and electroporation 
50 ml LB medium were inoculated with 500 µl of an over night culture of the strain of interest 
and grown OD600 of 0.6-0.8. The cells were collected by centrifugation for 10 min at 
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2,000 × g at 4 °C. The pellet was left on ice for 30 min and then washed with 50 ml ice-cold 
dH2O. After a second centrifugation step at the same conditions, the pellet was resuspended in 
25 ml 10 % (v/v) glycerol, centrifuged again and finally resuspended in 600 µl 10 % glycerol. 
The cells were stored as 40 µl aliquots at -80 °C. For electroporation, one aliquot was thawed 
on ice and mixed with ~ 0.5 µg DNA. The mixture was applied into a “Gene pulser” cuvette 
(BioRad) with a distance between the electrodes of 0.1 cm and incubated for 10 min on ice. 
The cells were electroporated using a Gene pulser transfection apparatus (BioRad) at the 
following conditions: 2.5 kV, 25 µF, and 600 Ω for linear fragments or 200 Ω for plasmids. 
Immediately after electroporation, 1 ml LB medium was added to the cuvettes. The mixture 
was transferred into a new tube and incubated at 37 °C (or 30 °C for temperature-sensitive 
plasmids) for 1 h before the cells were plated on selective agar plates. 
4.1.11. Gene inactivation by λ Red recombinase-mediated mutagenesis using 
linear DNA fragments 
The construction of the mutants was performed using linear DNA for recombination, as 
described by Wanner and Datsenko (2000). This method relies on the replacement of a 
chromosomal sequence with an antibiotic marker that is generated by PCR using primers with 
homology extensions to the flanking regions of the target sequence. Recombination is 
mediated by the Red recombinase derived from the λ phage. This recombination system 
consists of three genes (γ, β, exo), which encode the phage recombinases and an inhibitor of 
the host RecBCD exonnuclease V, which normally mediates degradation of linear DNA in the 
cell. A schematic overview of the procedure is depicted in Figure 8. 
Briefly, a linear DNA fragment containing an antibiotic marker cassette flanked by FRT sites 
and 45-nt homologous extensions to the target genes (up- and downstream of hns, hlp, and 
stpA, respectively) was amplified by PCR as described in section 4.1.5.2.. The proof-reading 
Dap Goldstar polymerase (Eurogentec) was used for amplification of the linear fragments 
with plasmids pKD3 (harboring a cassette) or pKD4 (harboring a kanamycin resistance 
cassette) as template in a total volume of 400 µl. The annealing temperature for all primers 
was 54 °C using 30 cycles of amplification. PCR products were purified using the QIAquick 
PCR purification kit, ethanol precipitated and resuspended in 10 µl dH2O. 
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Fig. 8: Strategy for inactivation of chromosomal genes using PCR products  
(Datsenko and Wanner, 2000) 
Meanwhile, 536 wild type cells were first transformed with the pKD46 helper plasmid by 
electroporation (see section 4.1.10.2.). Transformants were selected at 30 °C on agar plates 
containing 100 µg ml-1 ampicillin. Of these transformants, electrocompetent cells were 
prepared from 50 ml LB cultures supplemented with ampicillin and 3 ml of an 0.1 M 
arabinose solution to induce the Red recombinase on the helper plasmid. 40 µl competent 
cells were transformed with 5 µl of the linear PCR fragment by electroporation. After the 
addition of 1 ml LB medium to the cuvette, cells were allowed to recover by incubation for 
2 h at 30 °C with aeration. In contrast to normal electroporation, the cultures were then taken 
out of the incubator and left standing on the bench top over night at room temperature. In the 
next morning, cells were spun down, resuspended in 300 µl LB medium and distributed onto 
three agar plates supplemented with the appropriate antibiotic (Cm or Km, respectively). 
Transformants with confirmed allelic exchange were also re-streaked onto ampicillin-
containing agar plates at 37 °C to confirm loss of the temperature-sensitive helper plasmid 
pKD46. 
The antibiotic marker could be removed with the help of the FLP recombinase (encoded on 
plasmid pCP20), which mediates recombination between the two FRT sites flanking the 
antibiotic cassette, thus leaving behind a complete deletion of the open reading frame. 
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Electroporation was performed as described in section 4.1.10.2.. Transformants were first 
selected on ampicillin-containing agar plates at 30 °C, and then re-streaked onto LB agar 
plates with no antibiotic. These plates were incubated at 37 °C in order to induce the loss of 
the second helper plasmid pCP20. The deletion mutants now could be used to introduce a 
second or third mutation by starting the whole procedure from the beginning. All mutations 
were confirmed by both PCR and Southern hybridization. 
4.1.12. Southern Blot analysis 
Vacuum blotting 
For Southern blot analysis, 10 µg chromosomal DNA were restricted with an appropriate 
endonuclease, harboring 1 to 5-kb DNA fragments containing the target gene. The DNA 
fragments were separated by horizontal gelelectrophoresis (see section 4.1.7.). Meanwhile, a 
nylon membrane (Nytran Super Charge; pore size 0.45 µm; Schleicher&Schuell, Dassel, 
Germany) of appropriate size was shortly preincubated in dH2O and then soaked for 10 min in 
20 × SSC. Afterwards, DNA was transferred from the agarose gel to the membrane using a 
vacuum blotter (Amersham-Pharmacia) by applying a 50 mbar vacuum. The following 
solutions were applied on the surface of the agarose gel during the blotting procedure: 
Depurinization solution (0.25 N HCl)     8 min 
Denaturation solution (0.5 N NaOH; 1.5 M NaCl)   8 min 
Neutralization solution (0.5 M Tris-HCl, pH 7.5; 1.5M NaCl)  8 min 
20 × SSC (0.3 M Na-citrate, pH 7.0; 3 M NaCl)   >50min 
After DNA transfer, the nylon membrane was incubated for 1 min in 0.4 N NaOH and 1 min 
in 0.25 M Tris-HCl, pH 7.5 for neutralization. The membrane was then shortly dried and the 
DNA was crosslinkd to the membrane by exposure to UV light. 
Probe labelling (ECLTM Kit, Amersham Biosciences) 
For labelling of DNA probes, the ECLTM-Kit (enhanced chemoluminescence) was used. The 
binding of a DNA probe to the complementary sequence on the nylon membrane was detected 
by chemoluminescence. Positively charged horseradish peroxidase molecules were mixed 
with the negatively charged DNA probe. Addition of glutaraldehyd covalently linked the 
horseradish peroxidase molecules with the DNA probes. Reduction of H2O2 by the peroxidase 
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requires the oxidation of luminol which results in light emission, which can be detected by 
suitable light-sensitive films, e.g. the Hyperfilm ECL. 
For labeling of the probe, 100 ng DNA per ml hybridization buffer in a final volume of 10 µl 
in dH2O were denatured for 10 min at 90 °C and cooled for 5 min on ice. Subsequently, 10 µl 
labelling reagent and 10 µl glutaraldehyd were added. The mixture was incubated for 10 min 
at 37 °C and then added to the hybridization reaction. 
Hybridization and detection of the membrane 
Hybridization of the membrane was carried out over night at 42 °C in hybridization solution 
(10-15 ml), after the nylon membrane had been pre-incubated at 42 °C in the hybridization 
solution for 1 h. The next day, the membrane was washed twice for 20 min at 55 °C with 
wash solution I and two times for 10 min at RT with wash solution II. The membrane was 
placed on Whatman paper to remove the rest of the wash solution, and then incubated for 
5 min in 5-10 ml detection solution I and detection solution II provided with the kit and mixed 
immediately (1:1) before application to the membrane. The membrane was superficially dried 
on Whatman paper and packed in saran wrap avoiding air bubbles on the top surface of the 
membrane. Chemoluminescence was detected by exposure of the membrane to Hyperfilm 
ECL. The exposure time depended on the signal intensity. 
Wash solution 1: 0.5 × SSC; 0.4 % (w/v) SDS 
Wash solution 2: 2 × SSC 
4.1.13. Sequence analysis 
The nucleotide sequences of mutagenized chromosomal genes or plasmid constructs was 
determined using fluorescent dye terminators (ABI prism BigDye terminator kit, Applied 
Biosystems). The sequencing-PCR mix for one sample was: 
30 ng PCR product (or: 0.5 µg plasmid DNA) 
1.5 µl 10 pM primer 
2 µl 5 x buffer (kit component) 
2 µl premix (kit component)  ad 10 µl ABI-H2O 
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The thermal profile for the PCR reaction was: 40 cycles of denaturation at 96 °C for 30 sec, 
annealing at ≤ 60 °C for 15 sec, and extension at 60 °C for 4 min, followed by final extension 
at 60 °C for 2 min. Sequencing products were purified by ethanol precipitation (see section 
4.1.3.) and analyzed in a ABI prism sequencer (Perkin Elmer). 
4.2. Manipulation of RNA 
For working with RNA, special care had to be taken in order to prevent contamination of the 
samples with exogenous RNases. Gloves were worn throughout the experiment and double 
autoclaved pipette tips and reaction tubes were used. For all buffers and solutions, water was 
pre-treated over night with 0.1 % (v/v) diethylpyrocarbonate (DEPC) at 37 °C. 
4.2.1. Isolation of total RNA with hot phenol 
20 ml LB cultures were grown to mid-log phase, i.e. to an optical density at 600 nm of 0.6. 
Cells were harvested by centrifugation (4,000 rpm, 4 °C, 10 min) and then resuspended in 
1 ml ice-cold KMT buffer. 600 µl each of the suspension were tranferred to two 2 ml safe-
lock caps containing a mixture of 200 µl acid phenol (pH 4) and 400µl NEMST buffer pre-
heated to 90 °C. For cell lysis, samples were incubated at 90 °C for 5 min, and then chilled on 
ice for another 5 min. After centrifugation in a table top centrifuge for 2 min at 13,000 rpm, 
phase separation occurred, resulting in an RNA containing aqueous phase and an acid phenol 
phase containing cell debris, proteins and DNA. The upper aqueous phase was carefully 
transferred to fresh tubes. Two additional phenol extractions and three chloroform extractions 
were performed before precipitation of total RNA with 0.7 vol isopropanol over night at –
20 °C. After centrifugation, the RNA pellet was washed with 70 % (v/v) ethanol and 
resuspended in 100 µl nuclease-free water. RNA preparation were stored at – 80 °C. [Chuang 
et al. (1993)] 
 
KMT buffer: 10 mM KCl 
   5 mM MgCl2 
 10 mM Tris 
ad 200 ml DEPC-H2O 
    adjust pH to 7.4 and autoclave 
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NEMST buffer:   0.4 M NaCl 
 40 mM EDTA 
 20 mM Tris 
ad 190 ml DEPC-H2O 
    adjust pH to 7.4 and autoclave 
 
  + 8 ml 25 % SDS solution 
  + 2 ml ß-mercaptoethanol 
4.2.2. Removal of contaminating DNA by DNase treatment and RNA cleanup 
Contaminating DNA was removed from total RNA preparations by DNase I digestion. 15 µg 
RNA in a final volume of 85 µl were mixed with 10 µl 10 x OnePhorAll plus buffer 
(Amersham Biosciences) and 5 µl RNase free DNase I (Roche Diagnostics). Samples were 
incubated for 1 h at 37 °C, followed by RNA cleanup using the RNeasy Mini kit (QIAGEN). 
According to the manufacturer’s instructions, 350 µl RLT buffer supplemented with 
10 µl ml-1 ß-mercaptoethanol and 250 µl 100 % (v/v) ethanol were added to the DNase treated 
RNA samples, before loading them onto the purification columns. After brief centrifugation, 
the columns were transferred to fresh collection tubes and washed twice with 500 µl RPE 
buffer. Finally, RNA was eluted from the column in 60 µl nuclease-free water. 
As a control for successful removal of all DNA from the samples, 2 µl of the DNase treated 
RNA or 1 µl DNA as positive control were used as template in a PCR reaction with primers 
binding within the coding sequence of the α-hemolysin gene hlyA. The DNase digest was 
considered as complete if no product could be amplified from the RNA samples. 
4.2.3. Enrichment of bacterial mRNA 
Total RNA preparations consist of a mixture of ribosomal RNA (23 S, 16 S, and 5 S rRNA), 
transfer RNAs (tRNA), messenger RNA (mRNA), and small RNAs. The most abundant 
components are both the 23 S and 16 S rRNA, which therefore might interfere with 
downstream applications such as transcription studies. 
Commercial kits like the MICROBExpress kit from Ambion are available, which can be used 
to remove rRNA from total RNA samples, thereby resulting in an enrichment of the 
messenger RNA. The principle of this method is a so called sandwich capture hybridization. 
Capture-oligonucleotides are used that can hybridize to the 16 S and 23 S rRNA molecules 
due to short complementary sequences. The other end of the capture oligo is complementary 
4. Methods  -  RNA manipulations 
 
61 
 
 
to short oligonucleotide sequences coupled to a magnetic bead (so called Oligo MagBeads), 
which then binds the capture-oligo/rRNA hybrid molecules. The beads can then be retained in 
a magnetic stand, leaving only mRNAs, tRNA, 5 S rRNA and small RNAs in the supernatant. 
The procedure was performed following the manufacturer’s instructions. 10 µg of DNase-
treated RNA in a final volume of 12 µl in nuclease-free water were mixed with 3 µl 10 mM 
EDTA in order to chelate divalent cations, which might cause hydrolysis of RNA. 
Subsequently, 200 µl binding buffer and 4 µl of the capture-oligo mix were added to the RNA 
samples with vortexing and brief centrifugation. The samples were then incubated at 70 °C 
for 10 min to denature the secondary structure of the RNA. Annealing of the capture-oligos to 
rRNA was performed for 1 h at 37 °C. In the meantime, 50 µl Oligo MagBeads per sample 
were prepared by washing them with water and resuspending them in binding buffer. After 
the annealing reaction was completed, 50 µl Oligo MagBeads, which have been pre-warmed 
to 37 °C, were added to the RNA samples and incubated for 15 min at 37 °C for binding of 
the beads to the oligo/rRNA hybrids. Removal of the magnetic beads was performed by 
placing the reaction tubes into a magnetic stand for > 3 min, during which time the beads 
were pulled to the side of the tubes. The clear supernatant containing the enriched mRNA was 
then transferred to a new tube and stored at –20 °C. 
10 µg total RNA typically yielded in 2-3 µg enriched mRNA, which then was used for 
expression profiling (see section 4.3.). 
4.2.4. Reverse transcription (RT) for cDNA synthesis 
For cDNA synthesis, the Superscript III reverse transcription kit (Invitrogen) was used. 4 µg 
of total RNA in a final volume of 10 µl were mixed with 1 µg of random hexamer primers 
(Amersham Biosciences). Primer annealing was carried out at 65 °C for 5 min. After brief 
cooling, 9 µl of a reverse transcription mixture were added to the samples. The composition 
of the RT-mix for 1 sample was: 
 2 µl 25 mM deoxynucleotide mix 
1 µl 0.1 M dithiothreitol (DTT; kit component) 
4 µl 5 x first strand buffer (kit component) 
1 µl 40U µl-1 RNase OUT recombinant RNase inhibitor (Invitrogen) 
1 µl 200U µl-1 Superscript III reverse transcriptase (kit component) 
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cDNA synthesis was performed at 52 °C for 60 min, followed by heat inactivation of the 
transcriptase at 70 °C for 15 min. 
4.2.5. Semi-quantitative reverse-transcription PCR (RT-PCR) 
cDNA samples derived from reverse transcription were 20x diluted in water and directly used 
for PCR amplification. As a control for DNA contaminations, a second PCR reaction was 
performed using total RNA without any reverse transcription reaction. DNA served as 
positive control for the PCR reaction. For adjustment of cDNA amounts, 16 S rRNA (rrsA) 
was used as internal standard using 35 cycles of amplification. The RT-PCR primers were 
selected with the FastPCR software version 3.6.28 (Ruslan Kalendar, Institute for 
Biotechnology, University of Helsinki, Finland) with the following primer options: product 
length range from 350 – 400-nt; annealing temperature range from 57 - 59 °C. The sequences 
of all oligonucleotides used are listed in Table 5. 
For the PCR reaction, Red Taq polymerase ready mix (Sigma) was used (see section 4.1.5.1.). 
The 2 x concentrated mix contained all necessary components for PCR, thereby minimizing 
pipetting errors. 10 µl of the ready mix were mixed with 4.6 µl water and 0.2 µl of each 
100 pM RT-primer. This mixture was then added to the adjusted cDNA in a final volume of 
5 µl and placed into the thermal cycler. 
Thermal profile:  Initial denaturation 2 min, 95 °C 
1. Denaturation  30 sec, 95 °C 
2. Annealing   30 sec, 57-59 °C  25-35 cycles 
3. Elongation   30 sec, 72 °C 
Final elongation  2 min, 72 °C 
Since the PCR ready mix already contained a loading dye for gelelectrophoresis, 10 µl of the 
PCR samples were directly loaded on a 2 % agarose gel and analyzed after ethidium bromide 
staining. To keep the PCR amplification in linear range, i.e. to prevent over-saturation of the 
PCR products, the cycle number of amplification was altered, whereas the template amount 
was always kept constant. 
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4.2.6. Northern hybridization 
For Northern blotting, RNA was separated by denaturing electrophoresis. A 1.2 % agarose/ 
formaldehyde gel was prepared by mixing 1.95 g agarose and 96 ml DEPC-treated H2O. The 
agarose was dissolved by heating in a microwave, mixed well, and cooled to 60 °C. In a fume 
hood, 11.05 ml of 37 % formaldehyde, and 13.3 ml freshly prepared 10 x MOPS buffer were 
added, mixed well and poured into the gel casting device. 
20 µg DNase-treated RNA in a final volume of 10 µl were mixed with an equal volume of 
2 x RNA loading buffer and denaturated at 55 °C for 15 min. The RNA samples were then 
loaded onto the formaldehyde gel and separated in 1 x MOPS running buffer at 4 V / cm 
electrode distance for 4-5 hours, until the Bromophenol blue dye had migrated three-quarters 
of the way down the gel. After electrophoresis was completed, the gel was stained with 
ethidium bromide and photographed to record the electrophoretic separation of the loaded 
RNA. 
RNA was transferred to a nylon membrane by vacuum blotting as described earlier for 
Southern hybridization (see section 4.1.12.), with minor modifications: RNA transfer does not 
need depurinization, and the composition of the denaturation- and neutralization buffers 
differed slightly. Transfer was performed at 50 mbar for 4 - 5 h. The nylon membrane was 
prepared for hybridization as described for Southern hybridization analysis. 
DNA probes were amplified by PCR using the same primers as for RT-PCR, followed by 
ECL-labeling, and hybridization to the membrane over night at 42 °C. After washing with 
0.4 x SSC/0.1 % SDS, transcripts were detected using the ECL advance nucleic acid detection 
kit (Amersham Biosciences) following the manufacturer’s recommendations. 
 
10 x MOPS buffer: 200 mM MOPS (pH 7.0) 
 50 mM Na-Acetate 
 10 mM EDTA 
ad 1 l DEPC-H2O 
 
2 x RNA loading buffer: 6.5 ml Formamide 
 1.2 ml Formaldehyde 
   2 ml 10 x MOPS 
0.4 ml 50 % sucrose 
0.02 g Bromophenol blue 
0.02 g Xylene cyanol 
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Denaturation solution: 0.05 N NaOH; 0.01 M NaCl 
Neutralization solution: 0.1 M Tris-HCl, pH 7.5 
4.2.7. Identification of the hlp transcription start site by primer extension 
To determine the transcription start site of hlp, primer extension was performed, using an 
IRD800-labeled primer (hlp-primext) binding 35 bp downstream of the translational start 
codon of Hlp. 2 pM primer was annealed to 20 or 40 µg DNase-treated RNA isolated from the 
536 hns/stpA mutant (see sections 4.2.1 and 4.2.2.) in a total volume of 15 µl, using a 
stepwise decrease in temperature. 
Thermal profile for primer annealing:    90 °C – 2 min 
80 °C – 7 min 
65 °C – 7 min 
45 °C – 7 min 
30 °C – 7 min 
Subsequently to primer annealing, reverse transcription to cDNA was performed for 90 min at 
54 °C using the Superscript III reverse transcription kit (Invitrogen) as described in section 
4.2.4. Specifically, 15 µl of the following mixture were added: 
RT-mix for 1 sample:   4 µl 20 mM dNTP mix 
6 µl 5 x first strand buffer 
1.5 µl 0.1 M DTT 
1.5 µl RNase OUT ribonuclease inhibitor (Invitrogen) 
2 µl Superscript III reverse transcriptase 
After reverse transcription, residual RNA was removed by RNaseA digest for 20 min at 37 °C 
in RNase buffer (3 ng µl-1 RNaseA in 0.2 M EDTA, pH 8). Subsequently, cDNA was ethanol-
precipitated and resuspended in 3 µl loading dye (Epicenter). Of each sample, 0.5 µl and 
1.5 µl were loaded onto the sequencing gel. 
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Simultaneously, a sequencing reaction with UPEC 536 wild type chromosomal DNA was 
performed using the same primer and the Seqitherm Excel II sequencing kit (Epicenter). 
200 ng DNA was mixed with 2 pM IRD800-labeled primer, 7.2 µl 3.5x sequencing buffer and 
1 µl polymerase in a final volume of 17 µl. 4 µl of this mixture were added to four 
independent PCR caps containing 2 µl of either A-, C-, G-, or T- termination nucleotides, and 
the caps were overlayed with one drop of light mineral oil. Amplification was carried out 
using a thermal profile consisting of an initial denaturation step at 95 °C for 5 min followed 
by 30 cycles of denaturation at 95 °C for 30 sec, annealing at 57 °C for 15 sec, and extension 
at 70 °C for 1 min. After thermocycling has been completed, 3 µl loading dye were added, 
and 1.5 µl of each reaction were loaded on the fluorescent sequencing gel. 
Sequencing and extension products were separated by electrophoresis through 6 % 
polyacrylamide-7.5M urea gels and analyzed by a LiCor DNA sequencer Model 2400 
(MWG-Biotech). 
 
4.3. Expression profiling using DNA arrays 
Expression profiling is a technique to study the relative amounts of all transcripts at a given 
time of sample collection, thereby allowing to monitor the expression level of every single 
gene spotted on the array membrane. 
4.3.1. Membrane Layout 
For expression profiling, an E. coli K12-specific array (Panorama E. coli gene arrays from 
Sigma-Genosys, Cambridge, United Kingdom) and the E. coli “pathoarray” (Dobrindt et al., 
2003) were used in combination. Therefore, by using both types of arrays, it was possible to 
measure expression levels of all housekeeping genes as well as most of the known virulence-
associated genes of UPEC strain 536. 
4.3.2. RNA isolation and cDNA labeling 
Total RNA was prepared from mid-log phase cultures grown in LB at 37 °C followed by 
DNase treatment and enrichment of mRNA, as described in sections 4.2.1.-4.2.3. 
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Reverse transcription was performed similarly as described for RT-PCR (see section 4.2.4.), 
but with using the Omniscript reverse transcriptase (QIAGEN) and a radionucleotide for 
labelling of the cDNA. Primer annealing was performed for 5 min at 93 °C using the 
following mixture: 
1.5 µg enriched mRNA 
 3 µl 0.5 µg µl-1 random hexamer primers (Amersham) 
ad 26 µl  nuclease-free water 
After primer annealing, samples were briefly chilled on ice and 12 µl of the reverse 
transcription mixture were added. 
RT mix for 1 sample: 4 µl 5 mM dCTP-, dGTP-, dTTP-mix (Sigma) 
2 µl 10µCi µl-1 [α-33P]-dATP (Amersham Biosciences) 
4 µl 10 x reverse transcription buffer (kit component) 
0.5 µl 40U µl-1 RNase OUT ribonuclease inhibitor (Invitrogen) 
2 µl 4 U µl-1 Omniscript reverse transcriptase (kit component) 
Reverse transcription was performed at 42 °C for 2 h. Subsequently, unincorporated 
nucleotides were removed from labeled cDNA using Microspin G-50 columns (Amersham 
Biosciences). Samples passed through the gel-filtration column by centrifugation at 4,000 rpm 
for 4 min, leaving salts and unincoporated nucleotides in the matrix, whereas the labelled 
cDNA was found in the eluate. 
Incorporation rates of labelled nucleotides were determined by measuring radioactivity of the 
cDNA in the eluate (equals incorporated radionucleotides) and of the radioactivity retained in 
the column (equals unincorporated radionucleotides). 
)(
)(
eluatecolumncounteradioactiv
eluatecounteradioactiv
rateionIncorporat
+
=  x 100 
The obtained value can be used as a marker for the quality of reverse transcription and should 
be > 50 %. In our cases, the incorporation rates used to range from 58 – 65 %. 
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4.3.3. Hybridization an detection 
Hybridization of the labelled cDNA to the membranes was performed as recommended in the 
technical protocol for the Panorama E. coli K-12 array (Sigma Genosys). After 10 min 
denaturation at 93 °C in hybridization buffer, labelled cDNA from step 4.3.2. was added to 
the pre-hybridized membranes and incubated for 16 h at 65 °C in a hybridization oven. 
Membranes were washed three times for 3 min in washing solution at room temperature, 
followed by three additional washing steps for 20 min at 65 °C. After washing, the 
membranes were sealed in plastic bags and exposed to a PhosphoImager screen (Molecular 
Dynamics) for 48 h. Membranes could be re-used up to 10 times after stripping (see 
Panorama-Array manual). 
Hybridization buffer:    5 x SSPE 
2 % SDS 
1 x Denhardt’s reagent 
100 µg ml-1 sonicated, denatured salmon testes DNA 
Washing solution: 0.5 x SSPE 
 0.2 % SDS 
20 x SSPE:  3.6 M NaCl 
  0.2 M NaH2(PO4); pH 7.7 
20 mM EDTA 
100 x Denhardt’s reagent: 2 % Ficoll (MW 400,000) 
  2 % polyvinylpyrrolidone (PVP; MW 40,000) 
  2 % BSA 
4.3.4. Intensity reading 
Exposed PhosphoImager screens were scanned on a Typhoon 8600 variable mode imager 
(Molecular Dynamics) at 50 µm resolution. Spot intensities were measured with the 
ArrayVision software (Imaging Research, St. Catharines, Canada) using the overall spot 
normalization function of the program.  
The exact settings are listed in Table 7. 
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Table 7: Parameters of the Arrayvision pre-set protocols (Wizard) used for reading intensity values. 
Parameter E. coli K-12 array: E. coli pathoarray 
Array type Radio-isotopic array Radio-isotopic array 
Analysis type Expression Expression 
# of arrays 4 4 
# of extra channels 1 1 
Measure type MTM density MTM density 
Array organization 3 levels (18432 total spots) 2 levels (1536 total spots) 
Level 1 (Spots) 4 x 4 4 x 4 
Level 2 (Spot groups) 16 x 24 8 x 12 
Level 3 (sub-arrays) 3 x 1 - 
Spot shape Circle Circle 
Start position Defined Not defined 
Alignment Not aligned Not aligned 
Labels Custom Custom 
Replication On On 
Background Corners between spots (average) Corners between spots (average) 
Reference All spots All spots 
Segmentation: Off Off 
Anchors: None None 
Mean values were calculated from the duplicate spots of each gene. Only values with 2-fold 
higher intensities than the background were included into the analysis. 
4.3.5. Data analysis 
For each mutant, four independent hybridizations were performed, each in pair with the wild 
type. For the calculation of intensity ratios, spot intensities in the mutants were directly 
compared to the intensities in the wild type of the corresponding co-hybridization experiment. 
As indicator for the reproducibility of the procedure, the four wild type experiments from 
each set of data were compared to each other during analysis in order to validate the quality of 
the hybridizations. 
Statistical analysis was performed using the SAM software (Statistical analysis of 
microarrays; Stanford university). Data sets were composed as two-class, unpaired data in 
four blocks for each experiment. Two-class unpaired groups are two sets of measurements, in 
which the experiment units are all different in the two groups. For example, control and 
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treatment groups, with samples from different patients, or in our case, wild type and mutant 
from different rounds of hybridization, which were defined as separate blocks. This allow 
permutations of the samples within each of the blocks, but not across the different data sets, in 
order to correct for hybridization differences. 
After running the analysis, all genes which were significantly deregulated were listed by the 
program. The output is hereby depending on two variables: the fold-change and the false 
discovery rate. The False Discovery Rate (FDR) is computed as median (or 90 th percentile) 
of the number of falsely called genes divided by the number of genes called significant. Here, 
we chose a fold change of ± 2. Deregulation was considered significant, if the false discovery 
rate was at least <10 % for each gene.  
Further statistical analysis was performed using the SPSS software Version 11.5 or the 
GeneData Expressionist software. 
 
4.4. Working with Protein 
4.4.1. Denaturing polyacrylamide gel electrophoresis (PAGE) 
Protein samples were separated and analyzed in denaturing polyacrylamide gels as described 
by Laemmli (1970). This is done using the detergent sodium dodecylsulfate (SDS), which 
binds to proteins and leaves them unfolded and negatively charged. Therefore, the protein 
mixture can be separated in the meshwork of the polyacrylamide gel due to variable migration 
speed depending on the size of the protein. Since most of the proteins of interest in this study 
were about 15 kDa in size, a 15 % resolution polyacrylamide gel was used. The size of the 
gels was 10 × 10 × 0.5 cm, and electrophoresis was performed at room temperature at 16 mA 
per gel in 1 x electrophoresis buffer. The samples were loaded onto the gel after heating for 
10 min at 90 °C in 1 × loading buffer. 
The acrylamide gel consists of two parts: a lower part mediating the separation of the 
proteins, and an upper part, which is used for concentration of the sample in a single running 
front after entering the gel. The mixture sufficient for 4 mini gels was: 
 
4. Methods  -  Working with Protein 
 
70 
 
 
15 % separation gel:         15 ml 30 % acrylamyde:bis-acrylamide (37.5:1) 
   5 ml 1.5 M Tris-HCl, pH 8.8 
 10 ml dH2O 
300 µl 10 % (w/v) SDS 
250 µl 10 % (w/v) ammonium persulfate (APS) 
    8 µl TEMED 
 
5 % collecting gel:         1.96 ml 30 % acrylamyde:bis-acrylamide (37.5:1) 
2.8 ml 0.5 M Tris-HCl, pH 6.8 
 4.6 ml dH2O 
112 µl 10 % (w/v) SDS 
  32 µl 10 % (w/v) APS 
  16 µl TEMED 
 
10 x running buffer:          30 g Tris 
144 g glycine 
  10 g solid SDS 
    ad 1 l dH2O 
 
4 x SDS-loading buffer:  2.5 ml 1 M Tris-HCl, pH 6.8 
   4ml 50 % (v/v) glycerol 
 0.8 g solid SDS 
0.1 ml ß-mercaptoethanol 
0.02 g bromophenol blue 
     ad 10 ml dH2O 
4.4.2. Visualization of proteins in acrylamide gels by Coomassie staining 
After electrophoresis, the polyacrylamide gels were incubated for 15 min in Coomassie 
staining solution. Protein bands were visualized after removing unbound Coomassie dye by 
incubating the gel in destaining solution I for 30 min, followed by incubation in destaining 
solution II for > 2h. 
Staining solution:      1 g Coomassie Brilliant Blue R-250 
0.25 g Coomassie Brilliant Blue G-250 
238 ml ethanol 
  50 ml acetic acid  
      ad 500 ml dH2O 
Destaining solution I: 10 % (v/v) acetic acid; 50 % (v/v) ethanol 
Destaining solution II: 7.5 % (v/v) acetic acid; 5 % (v/v) ethanol 
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4.4.3. Immunoblotting 
For the preparation of crude cell extracts, 800 µl bacterial culture were centrifuged for 2 min 
at 13,000 rpm in a table top centrifuge and the pellet was resuspended in ¼ vol of the 
measured optical density of the culture in 1 x Laemmli buffer (e.g. 250 µl for a sample with 
OD600nm = 1). After heating the samples for 10 min at 90 °C, 15 µl were used for PAGE (see 
section 4.4.1.). After PAGE, separated proteins were transferred to a nitrocellulose membrane 
(Optitran BA-S85 Reinforced NC; pore size 0.45 µm; Schleicher&Schuell). The transfer of 
the proteins was carried out between two graphite plates in a semi-dry western blotting 
apparatus, using 12 Whatman paper slices, soaked with Anode buffer I, II or Cathode buffer. 
The membrane was incubated for 5 min in Anode buffer II. The lower graphite plate (anode) 
was moistened with water and covered with 6 slices of Whatman paper soaked with Anode 
buffer I, followed by 3 slices of Whatman papers soaked with Anode buffer II. The 
nitrocellulose membrane was laid on top of the Whatman papers, followed by the 
polyacrylamide gel and 3 slices of Whatman paper soaked in Cathode buffer. Air bubbles 
were carefully removed before laying the second graphite plate at the top (cathode). The 
transfer was carried out by applying an electric current of 0.8 mA cm-2 for 1 h. 
Anode buffer I: 0.3 M Tris, 20 % methanol 
Anode buffer II: 25 mM Tris, 20 % methanol 
Cathode buffer: 25 mM Tris, 40 mM ε-amino-n-capronic acid, 20 % methanol 
After transfer of the proteins, the membrane was incubated over night at 4 °C (or 1 h at room 
temperature) in TBS-T solution (0.05 M Tris-HCl, pH 7.5; 0.15 M NaCl; 0.1 % Tween 20) 
supplemented with 5 % fat-free dry milk. Subsequently, the blot was incubated with the 
primary antibody for 1 h at room temperature. The concentration of the primary antibody 
depended on the titre, but the dilution usually ranged between 1:1000 to 1:5000 in TBS-T 
supplemented with 5 % dry milk. After washing the membrane with TBS-T three times for 
5 min, the secondary peroxidase-conjugated antibody (1:5000 diluted in TBS-T) was added 
and incubated for 1 h at room temperature. Finally, the membrane was washed three times for 
10 min with TBS-T at room temperature. Signal detection using the ECL kit (Amersham 
Biosciences) was performed as described before (see section 4.1.12.3.). 
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4.4.4. Purification of His-tagged protein 
Overexpression of recombinant protein 
Escherichia coli strain BL21(DE3) ∆hns was used for overexpression of recombinant Hlp 
protein from plasmid pASK75-Hishlp. 800 ml LB-cultures were grown at 37 °C with aeration 
to OD600nm =0.2, before adding the inducer anhydro-tetracycline at a final concentration of 
0.2 µg ml-1. Protein synthesis was carried out for 6 h. 
Preparation of cleared lysate 
Cells were pelleted by centrifugation (6,000 rpm, 4 °C, 20 min) and resuspended in 10 ml of 
LEW buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8) containing protease inhibitor cocktail 
(Complete Mini, Roche). Cells were lysed by sonication for 10x 20 sec pulses with 20 sec 
cooling periods in between. Cell debris was then removed by two rounds of centrifugation at 
18,000 g for 20 min at 4 °C. The cleared lysate was stored on ice until further use. 
Affinity chromatography 
His-tagged proteins can easily be purified by immobilized metal ion affinity chromatography 
due to the interactions of the polyhistidine tag and immobilized Ni2+ ions in the columns. 
After loading onto the prepacked column, retained recombinant protein can be eluted from the 
column in a buffer containing imidazole. We were using Protino Ni 1000 columns 
(Macherey-Nagel), following the manufacturer’s recommendations. The cleared lysate was 
loaded onto the equilibrated columns by gravity flow. After two washes in 1x LEW buffer, 
bound protein was eluted with elution buffer (i.e. 1x LEW buffer containing 250 mM 
imidazole) in 3 x 1.5 ml fractions. 
Eluted protein was dialysed into storage buffer [150 mM NaCl, 50 mM Tris-HCl (pH 8), 
1 mM EDTA, 0.5 mM DTT, 20 % glycerol] and concentrated using Vivaspin 10,000 columns 
(Vivascience, Hannover, Germany). Eventually, the His-tag was removed by factor XA digest 
(New England Biolabs, Frankfurt, Germany) over night at room temperature prior to dialysis. 
Size-exclusion chromatography 
After factor XA treatment, the protease should be removed from the samples by size-
exclusion chromatography. This procedure is based on differences of the proteins of a mixture 
in their migration speed through a gel matrix depending on the size of the protein. 
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Small proteins have to pass through the pores of the matrix, whereas big proteins are excluded 
from the pores and only have to migrate though the interstitial spaces, thereby traveling faster. 
Concentrated protein samples in a total volume of 1 ml were loaded onto a HiLoad Superdex 
75 prep grade column (Amersham Biosciences) and eluted with a buffer containing 150 mM 
NaCl, 50 mM Tris-HCl (pH 7.5) in 2 ml fractions. A commercial gelfiltration calibration kit 
(Amersham Biosciences) was used to estimate the approximate sizes of the proteins in the 
various fractions. 
4.4.5. Determination of protein concentrations 
Protein concentrations were determined using Roti-Nanoquant solution (Roth) following the 
manufacturer’s instructions. 200 µl protein samples were mixed with 800 µl 1 x assay 
solution, and absorbance was measured at 590 nm and 450 nm. Protein concentrations were 
then calculated using the following formula (based on a BSA calibration curve): 
A590nm / A450nm – 0.4475 µg protein  = 
0.1132 
4.4.6. Chemical crosslinking 
Homomeric and heteromeric interactions between Hlp, H-NS and StpA were analyzed by 
chemical crosslinking for 20 min at room temperature using glutaraldehyde in a final 
concentration of 2.5 mM. Crosslinked products were analyzed by Western immunoblotting. 
4.4.7. Electrophoretic mobility shift assay (EMSA) 
DNA-protein interactions were studied by a gel retardation assay using recombinant His-Hlp 
protein purified from E. coli BL21 ∆hns. As substrate for binding, 350-bp PCR products 
containing the promoter regions of hlp, hns, and stpA were used. poly(dIdC) was used as non-
specific competitor DNA. 
Mix per sample:  2 µl 5 x binding buffer 
1 µl 1 µg µl-1 poly(dIdC) 
0.5 µl 1 M KCl 
100 ng target DNA fragment 
4 µl protein dilution  ad 10 µl dH2O 
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Samples were incubated for 20 min at room temperature and then loaded onto a 6 % Tris-
glycine gel. DNA was visualized by ethidium bromide staining. 
5 x binding buffer:  125 mM  HEPES acid, pH 7.3 
 0.5 mM EDTA 
  25 mM DTT 
      50 %  glycerol 
5 x Tris-glycine buffer:  125 mM  Tris, pH 8.5 
 0.5 mM glycine 
 
4.4.8. in vivo protein stability assay 
To determine the intracellular stability of Hlp, the recombinant protein from pASK75-Hishlp 
and pWKS30-hlp, respectively, was expressed in an stpA background in the presence or 
absence of H-NS and/or the Lon protease. The assay was performed as described by 
Johansson and Uhlin (Johansson and Uhlin, 1999). Briefly, 20 ml cultures were grown to 
OD600nm = 0.4 in LB medium (for strains harbouring the pASK75-Hishlp plasmid, medium 
was supplemented with the inducer anhydro-tetracycline). Further protein synthesis was 
inhibited by the addition of 100 µg ml-1 spectinomycin. Samples for Western blotting were 
taken before and 160 min after the addition of spectinomycin. 
 
4.5. Analysis of lipopolysaccharides (LPS) 
4.5.1 Isolation of LPS 
For analysis of the LPS composition, cells from agar plate or pellets of liquid cultures were 
used. After weight measurement, the cells were resuspended in an adequate amount of water 
so that the concentration was 1 mg cells per 30 µl suspension. 30 µl sample (i.e. 1 mg cells) 
were mixed with 10 µl 4 x SDS-sample buffer (see section 4.4.1.) and incubated at 100 °C for 
10 min. After brief cooling, 20 µl 1 x SDS-sample buffer supplemented with 100 µg 
proteinase K were added to the samples, which then were incubated at 60 °C for 1 h for 
removal of proteins. 30 µl of the LPS preparations were used for electrophoresis. 
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4.5.2 Electrophoresis and staining with silver nitrate 
Separation of the LPS components was performed by denaturing polyacrylamide 
gelelectrophoresis as described earlier for proteins (see section 4.4.1.). 15 % separation gels 
were used in a format of 20 x 20 cm, and electrophoresis was carried out over night at 8 mA 
at room temperature. 
After electrophoresis, the polyacrylamide gels were stained with AgNO3. All used devices 
were carefully washed with double destilled water, and gloves were worn throughout the 
experiment. The gels were fixed over night in 100 ml 1 × fixation solution. The next day, the 
solution was replaced by 100 ml 1 × periodate solution and the gels were incubated for 5 min 
for oxidation. Subsequently, the gels were washed three times for 30 min with dH2O, and then 
incubated for 10 min in silver nitrate solution. After three more washes for 10 min with dH2O, 
the gels were developed in developing solution preheated to 60 °C. As soon as the intensity of 
the appearing bands was satisfying, the reaction was stopped by incubation in 50 mM EDTA 
solution for 10 min. [Tsai and Frasch (1982)] 
 
2 × fixation solution: 250 ml Isopropanol 
  70 ml acetic acid 
ad 500 ml in dH2O 
 
Periodate solution: 0.87 g Na-m-periodate (NaIO4) 
100 ml 1 × fixation solution 
 
Silver nitrate solution: 1.4 ml 1 M NaOH 
   1 ml NH3 (33 %) 
 70 ml dH2O 
1.25 ml 20 % (w/v) AgNO3 
 
Developing solution: 100 ml 2.5 % (w/v) Na2CO3 
   27 µl formaldehyde (40 %) 
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4.6. Phenotypic assays 
4.6.1. Measurement of ß-galactosidase activity 
The ß-galactosidase activity of lacZ reporter strains was determined as described by Miller 
(1972). Samples were taken from mid-log phase cultures, i.e. after reaching an optical density 
between 0.4 and 0.5. Experiments were performed in triplicate from independent cultures, 
with three separate measurements for each sample. Strains containing the hns-lacZ (pBSN2) 
fusion were grown in LB medium supplemented with 50 µg ml-1 kanamycin and 100 µg ml-1 
ampicillin. For the assay of ß-galactosidase activity in the chromosomal proU-lacZ strains 
(BEU693 and BEU694) cultures were grown in minimal medium A supplemented with 
20 ng ml-1 tryptophane, 0.3 M NaCI and 100 µg ml-1 ampicillin. 
In brief, samples were incubated on ice for 20 minutes. In the meantime, assay solutions were 
prepared by adding 2.7 µl ß-mercaptoethanol per ml Z-buffer, and by dissolving 4 mg ml-1 
o-Nitrophenyl-ß-galactopyranoside (ONPG) in this ready-to-use Z-buffer. 
If the expected expression levels were high, 0.1 ml of the samples were mixed with the 0.9 ml 
Z-buffer using autoclaved glass tubes; in case of low expression levels, 0.5 ml sample and 
buffer were used. Cells were lysed by the addition of 15 µl toluol, followed by vigorous 
vortexing for 10 sec. Subsequently, open glass tubes were incubated for 40 min at 37 °C with 
shacking to remove the toluol, and after that placed into a 28 °C water bath. After 5 min of 
equilibration, 200 µl of the ONPG solution were added to each samples to start the reaction. 
After sufficient yellow color has developed, 500 µl stop-solution (1 M Na2CO3) were added 
to the tubes, while the time of the reaction was recorded using a stopwatch. Then, the 
reaction-liquids were tranfered to cuvettes, and absorption was measured at both 420 nm and 
550 nm. Growth medium was used as negative control, and as blank for the absorption 
measurement. 
ß-galactosidase activity (in Miller units) was calculated using the following formula: 
1000 x (OD420nm - 1.75 x OD550nm) 
ß-galactosidase activity = 
t (min) x sample volume (ml) x OD550nm 
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Z-buffer  (-ß-ME): 8.51 g Na2HPO4 
  5.5 g NaH2PO4 xH2O 
0.75 g KCl 
0.12 g MgSO4 ad 1 l in dH2O 
pH adjusted to 7; stored at +4 °C 
4.6.2. Detection of secreted α-hemolysin 
Hemolytic activity was studied both on 5 % (v/v) blood agar plates as well as in a liquid 
hemolysis assay as described by Nagy et al. (2002), with minor modifications. Briefly, 20 ml 
LB cultures from late-log phase grown at 30 °C were centrifuged at 6,000 rpm for 20 min at 
4 °C. The supernatant was carefully transferred to a new tube and stored on ice. Meanwhile, 
1 ml fresh bovine erythrocytes was washed twice in 20 ml PBS before resuspending the cells 
in 15 ml of a solution containing 150 mM NaCl and 20 mM CaCl2. The blood suspension was 
further diluted (usually 10 times) in the same solution. 1 ml of the dilution was transferred to 
a 1.5 ml cap to which a small amount of the detergent saponin was added for complete 
hemolysis. After brief centrifugation, absorbance was measured at 545 nm, which 
corresponds to the absorbance of hemoglobin. The obtained value should be around 0.8 
(equals 100 % hemolysis), otherwise the blood had to be diluted again. For the assay, the 
bacterial culture supernatants were diluted in LB medium in a final volume of 500 µl per 
dilution. Samples were mixed with an equal volume of the adjusted erythrocytes and 
incubated for 30 min at 37 °C prior to centrifugation. The amount of hemoglobin released 
during hemolysis was measured at A545nm, using erythrocytes incubated with 500 µl LB 
medium as blank. 
Hemolytic activity is defined as the dilution at which 50 % hemolysis occurred, which means 
A545nm equals 0.2 (due to the 2 x dilution of the samples with the blood suspension). 
4.6.3. Detection of siderophores in culture supernatants 
The production of siderophores was assessed in a chrome azurole S (CAS) liquid assay as 
described by Schwyn and Neilands (1987). Bacteria were grown over night in MM9 medium 
at 37 °C with aeration. The next morning, the chelator 2,2’-dipyridyl was added to the 
cultures in a final concentration of 0.1 mM, resulting in iron depletion during 3 h of 
incubation at 37 °C. 
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Cells were removed by centrifugation (6,000 rpm, 4 °C, 20 min) and supernatants were mixed 
with an equal volume of CAS assay solution. This solution contained a blue Fe-CAS 
complex, which turned red when siderophores are present. The degradation of the complex 
was monitored photometrically at A630nm. 
CAS assay solution I: 6 ml 10 mM HDTMA 
44 ml dH2O 
1.5 ml FeIII - solution 
7.5 ml 2 mM CAS solution (slowly added under stirring) 
 
CAS assay solution II:   4.307 g anhydrous piperazine 
40 ml dH2O 
6.25 ml 12 M hydrochloric acid (carefully added) 
CAS assay solutions I and II were mixed and brought to a final volume of 100 ml with dH2O. 
After sterile filtration, the solution could be stored for several months at 4 °C if protected 
from light. 
4.6.4. Detection of autoaggregation 
In order to study cell to cell interactions, an autoaggregation assay was performed. Cells were 
first grown over-day in 5 ml LB medium at 37 °C. In the evening, 100 µl of the culture were 
used to inoculate 5 ml M63BI medium supplemented with 0.4 % glucose. These minimal 
medium cultures were grown over night at 37 °C with aeration. The next day, optical densities 
of the cultures were measured at 600 nm, and all cultures were adjusted to OD600nm = 1.5 with 
M63BI medium. 3 ml of the adjusted cultures were incubated statically at room temperature. 
Every hour, a 200 µl sample was taken 1 cm below the surface and mixed with 600 µl M63BI 
medium. Again, the optical density of the samples was measured at 600 nm, in order to 
quantitate the aggregation of cells at the bottom of the tubes. 
4.6.5. Detection of biofilm forming abilities 
Biofilm formation was assessed in a microtiter plate assay modified after O’Toole and Kolter 
(1998). Bacteria were grown over-day in 3 ml LB medium at 37 °C with aeration. In the 
evening, 3 ml of various minimal media were inoculated with 20 µl of the LB cultures and 
incubated over night at 37 °C with aeration. 
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The next morning, 100 µl of fresh minimal medium were distributed in a microtiter plate 
(8 wells per strain) and inoculated with 10 µl of the over night cultures. The plates were 
incubated statically at 30°C for 24 h and 48 h, respectively. Subsequently, the wells were 
washed trice very carefully with 1 x PBS and dried for 1 h at 80 °C. The biofilm was stained 
with 0.1 % crystal violet for 1 h. The staining solution was discarded and the plates were 
rinsed trice with water. Pictures of the biofilm were taken by cutting the front row of wells 
from the microtiter plate. To quantitate the biofilm, the wells were destained with 200 µl 
destaining solution (80 % ethanol / 20 % acetone) for 30 min. Remaining biofilm was 
dissolved by pipetting the solution up and down several times, before diluting the solution 
10 times in dH2O and measuring absorbance at 570 nm. 
4.6.6. Survival at high osmolarity 
Bacteria were grown over night in LB medium at 37 °C with aeration. The next morning, cells 
were diluted 1:1000 in fresh LB medium or medium supplemented with 3 M NaCl and 
incubated for 1 h at 37 °C before plating serial dilutions onto LB agar plates. Colony forming 
units (CFU) were counted after 16 h at 37 °C. Survival rates were calculated as CFU +NaCl 
divided by CFU 
-NaCl. 
4.6.7. Serum resistance 
Serum resistance of E. coli strains was analyzed by incubating the bacteria in 90 % human 
serum. Bacteria were grown in LB medium to mid-log phase and then washed in saline. The 
cultures were diluted 1:10 in human serum and incubated at 37 °C. Samples were taken at 0, 
0.5, 1, 2, 3, and 4 h, respectively. Viable cell counts were determined by plating aliquots onto 
LB plates and incubating over night at 37 °C. The assay was performed both with normal and 
heat-inactivated (56 °C for 30 min) serum. Triplicates were used for each strain, and assays 
were repeated three times. 
4.6.8. In vivo virulence assay 
All in vivo assays were performed by Gabor Nagy and György Schneider at the Institute of 
Medical Microbiology and Immunology, University of Pécs Medical School, Hungary. 
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Lung toxicity assay 
The assay was performed as described by Hacker and co-workers (Hacker et al., 1986). 
Briefly, 3-week-old CFLP mice (Gödöllõ, Hungary) weighting 10 to 12 g were infected 
intranasally under superficial ether anesthesia with 50 µl of a bacterial suspension 
(3 x 109 CFU ml-1) grown over night in LB medium. Five mice were treated for each strain. 
The animals were observed for 24 h and death rates were recorded. 
Ascending urinary tract infection model 
Intravesical infection of 3 to 4-day-old CFLP mice (Gödöllõ, Hungary) was performed as 
described by Allison et al. (1994). Bacteria were grown over night at 37 °C in LB medium, 
harvested by centrifugation, washed once, and normalized to the required inoculum density 
(109 or 108 CFU ml-1) in PBS by adjusting the suspension to the appropriate optical density at 
600 nm, justified by viable counts. A 25 µl aliquot of this bacterial suspension containing 
0.05 % Pontamin Sky Blue dye (Searle Pharmaceuticals, High Wycombe, United Kingdom) 
was introduced into the bladder directly through the abdominal wall. The stain, which had no 
toxic or antibacterial effects, served as an indicator for successful inoculation (i.e., the stain 
became localized only to the bladder, which was visible through the hairless skin). Dead mice 
were counted every 24 h. For every strain, 10 infant mice were injected simultaneously, and 
assays were repeated four times. 
4.7. In silico analysis 
For standard sequence comparison and similarity searches, the Basic Local Alignment Search 
Tool (BLAST) at the National Center for Biotechnology Information Homepage was used. 
For alignments of nucleotide and amino acid sequences, the BioEdit sequence alignment 
editor V7.0.1 was used (Hall, 1999). Genome comparison was performed using the Artemis 
Comparison Tool (ACT) Release 4 of the Sanger Institute. 
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5. Results 
5.1. Impact of H-NS and StpA on expression pattern of UPEC strain 536 
Although the effect of hns and stpA mutations are well characterized in non-pathogenic 
E. coli K-12 strains (Bertin et al., 2001; Hommais et al., 2001), the effects in pathogenic 
strains have only been studied for some selected virulence traits. Using DNA macroarrays, the 
role of H-NS and StpA on gene expression of a pathogenic isolate was studied on a larger 
scale, by monitoring the expression levels of both the “core”-genome, as well as the “patho” 
gene-pool encoded on extragenetic material. 
5.1.1. Construction of hns and stpA mutants 
For expression profiling, hns and stpA single mutants, as well as an hns/stpA double mutant 
were constructed in the uropathogenic E. coli isolate 536. The construction of the mutants was 
performed using linear DNA for recombination, as described by Wanner and Datsenko 
(2000). This method relies on the replacement of a chromosomal sequence with an antibiotic 
marker that is generated by PCR using primers with homology extensions to the flanking 
regions of the target sequence (see method section 4.1.11.). After allelic replacement of the 
target gene with the antibiotic resistance marker, the marker can be eliminated using the FLP 
recombinase, resulting in a complete deletion of the target sequence. These recombination 
events lead to a shift in the fragment size, which can be visualized by both PCR amplification 
and by Southern hybridization (see Fig. 9). 
 
Fig. 9: Verification of the hns and stpA mutations. (A) PCR verification using primers binding outside 
the coding sequences of hns and stpA; (B) Southern hybridization using EcoRV restricted chromosomal DNA 
and PCR generated DNA probes specific for stpA, hns, and cat fragments. M = Marker (“Generuler” 1 kb). 
A) B) 
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The results of PCR verification and Southern hybridization confirm that both the hns and/or 
the stpA loci were successfully mutagenized in UPEC strain 536. 
5.1.2. Expression profiling using DNA macroarrays 
Quality of the hybridizations and expression pattern of wild type UPEC strain 536 
For expression profiling, RNA was extracted from UPEC strain 536 and its isogenic hns and 
stpA mutants grown to mid-log phase (see method section 4.3.). After reverse transcription 
using radioisotopes, labelled cDNA was hybridized to a commercial E. coli K-12 array 
(Sigma-Genosys) and a E. coli pathoarray containing probes specific for most of the virulence 
factors encoded on pathogenicity islands I to IV of UPEC strain 536. Membranes were 
exposed to a Phosphoimager screen. An example of resulting hybridization signals can be 
seen in Fig. 10. 
 
Fig. 10: Example of hybridization signals obtained with cDNA of wild type strain 536 and 
its isogenic stpA/hns mutant. Phosphoimager screens were scanned at 50 µm resolution. Spots 
with obvious differences in signal intensities between the hns/stpA mutant and the wild type, i.e. 
deregulated genes, are marked with circles. 
K-12 array 
field 1 
field 2 
field 3 
pathoarray 
5. Results 
 
83 
 
 
For each mutant, four independent hybridizations were performed, each in pair with the wild 
type. As indicator for the reproducibility of the procedure, the averages of the four wild type 
experiments from each data set were compared to each other (see Fig. 11). 
 
Fig. 11: Scatter plots and trendlines for linear regression between different experiments. 
Data sets included the averages of the signal intensities of each gene on the E. coli K-12 array for wild 
type UPEC 536 in co-hybridization with its hns, stpA and hns/stpA mutants. 
In all three cases, the coefficient of linear regression exceeded 93 %, indicating a low level of 
variation between the experiments and therefore validates the quality of the hybridizations. 
As a second indicator for reproducibility, the genes of the wild type data sets were sorted 
according to their measured signal intensities. 43 genes were found among the 50 genes with 
highest expression in all the wild type co-hybridizations. This again infers a good 
reproducibility of hybridization. 
This approach also allowed to gain insight into the current gene expression status of a wild 
type cell under standard growth conditions (LB medium, 37 °C, mid-log phase). Therefore, 
average signal intensities of each gene were calculated from the three wild type data sets and 
sorted according to their expression level. The 50 genes with the highest signal intensities are 
listed in Table 17 in the appendix. The most abundant transcripts either encode proteins 
involved in translation, such as ribosomal proteins and elongation factors, enzymes involved 
in energy metabolism, or structural components of the cell wall, such as outer membrane 
proteins and transport proteins. These results are in good agreement with array data obtained 
with the uropathogenic E. coli isolate CFT073 (Snyder et al., 2004). 
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Expression pattern of hns and stpA mutants 
After analysis of the expression pattern of the wild type strain, those of the different mutants 
were studied. As expected from previous experiments with non-pathogenic E. coli K-12, lack 
of H-NS had a strong impact on the expression profile (Hommais et al., 2001). 
In the hns single mutant of UPEC strain 536, 551 of the 4290 translatable ORFs on the K-12 
array were assigned to be significantly deregulated compared to the wild type, i.e. the signal 
intensity ratio of mutant / wild type is greater 2 (upregulation) or less than 0.5 
(downregulation). Regarding the genes specific for the E. coli strain 536 detectable with the 
pathoarray, 31 of the 391 ORFs were significantly deregulated in the mutant. These results 
confirm the role of H-NS as a global regulator in E. coli, acting mostly as repressor of gene 
expression. 
In contrast, not a single gene appeared differently regulated in the 536 stpA single mutant. 
Therefore, genes, which may be regulated by StpA alone and finally might result in a notable 
phenotype, remain to be identified. 
In the 536 hns/stpA mutant, 389 genes of the K-12 genome were deregulated compared to the 
wild type. Like in the hns mutant, most of the affected genes had a higher expression level in 
the mutant, but there were also many downregulated genes (almost twice as many in the hns 
single mutant). The results on total numbers of deregulated genes is summarized in Table 8. 
Table 8: Total numbers of deregulated genes in the 536 hns and stpA mutants. 
      Results were obtained using the SAM software (see method section 4.3.5.) 
 E. coli K-12 array E. coli pathoarray  
       Mutant upregulated downregulated upregulated downregulated total 
536 stpA 0 0 0 0 0 
536 hns 515 36 31 0 582 
536 hns/stpA 323 66 42 0 431 
From these results, one could speculate that all differences in gene expression in the hns/stpA 
mutant might be due to the lack of H-NS. However, when comparing the data sets of the hns 
single mutant and the hns/stpA mutant, only a subset of genes was commonly altered in both 
mutants. For the E. coli K-12 array, only 248 of the deregulated genes were found in both 
mutants, whereas 33 genes were shared on the E. coli pathoarray. Consequently, the obvious 
differences between the hns and the hns/stpA mutant were investigated in more detail. 
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Finally, the coefficents for linear regression between mutant and wild type data sets were 
calculated as before (see Fig. 11). Both the hns and the hns/stpA mutants had a lower 
regression coefficient (R2 = 0.85 and R2 = 0.56, respectively) than the stpA mutant 
(R2 = 0.98), which also results from the different degree of deregulation in these mutants. 
To analyze the number of deregulated genes as well as the level of deregulation, the data sets 
from the hns single mutant and the hns/stpA double mutant were sorted according to the 
expression ratios. A list of the 50 genes with highest upregulation, and 37 genes with highest 
downregulated expression can be found in the appendix (Tables 13-16). Interestingly, only 
18 genes of this top-50 list of upregulated genes can be found in both mutants, and only 
21 genes of 37 are commonly downregulated. Moreover, the distribution of the deregulated 
genes into functional groups exhibited some major differences between the hns and the 
hns/stpA mutant (Fig. 12). 
 
Fig. 12: Distribution of the deregulated genes of the core genome into functional groups. 
Upper panel: hns mutant of strain 536; lower panel: 536 hns/stpA mutant. Upregulated genes are 
depicted as black bars, downregulated genes are presented in grey. 
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The distribution of the upregulated genes was quite similar in both mutants, with one 
exception: significantly more genes coding for proteins involved in translation and post-
translational modifications were upregulated in the hns mutant compared to the hns/stpA 
mutant (86 vs. 4 genes). This group included genes encoding ribosomal proteins and tRNA 
synthetases, thereby indicating a high level of protein synthesis in the absence of H-NS alone. 
The most prominent difference in the hns/stpA double mutant was the occurrence of a large 
number of downregulated genes. Most of these genes clustered in the group of genes coding 
for transport and binding proteins (10 genes), as well as genes whose encoded products are 
involved in all kinds of metabolic processes like energy metabolism and central intermediary 
metabolism (12 genes). This effect on metabolism was also reflected in the reduced growth 
rate of the double mutant. Growth experiments with UPEC strain 536 and its mutants at 37°C 
in LB medium revealed an impaired growth rate in the hns/stpA mutant compared to the wild 
type and the stpA single mutant (see Table 12). Interestingly, despite a prolonged lag phase, 
the generation time of the hns mutant turned out to be the same as that of the wild type. 
Finally, a cluster analysis was performed using the GeneData Expressionist software in order 
to quantify the differences in the expression patterns. As seen in Fig. 13, all wild type co-
hybridizations, as well as the hybridizations of the stpA mutant clustered closely together, 
thereby indicating similar expression patterns. Furthermore, the expression patterns of the hns 
and the hns/stpA mutant did not fall into one cluster, but were partly unrelated. 
 
Fig. 13: Cluster analysis of expression profiles of the wild type strain 536 and its derivatives. 
The cluster analysis was performed with the GeneData Expressionist software. 
Taken together, a very distinct expression profile of the hns single mutant and the hns/stpA 
double mutant was found. This suggest the existence of two different regulons, depending on 
either the H-NS protein alone, or a concerted action of H-NS and StpA. 
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5.1.3. Effect of H-NS on expression of  virulence-associated genes 
Despite the differences in metabolism and translation, the hns and the hns/stpA mutants 
behaved very similarly concerning the expression of virulence-associated genes. The 
expression pattern on the E. coli pathoarray revealed major overlaps in both mutants: all 
33 commonly affected genes on the E. coli pathoarray were upregulated compared to the wild 
type and included the major virulence factors of strain 536. 
All deregulated genes whose products are involved in fitness and virulence are listed in 
Tables 18-24 in the appendix. A schematic view of the expression levels of some selected 
virulence-associated genes is given in Fig. 14. Not unexpectedly, most of the factors were 
only mildly expressed in vitro in LB, especially the iron-uptake systems. However, the 
expression of some genes such as the sfa- and the α-hemolysin gene cluster reached very high 
levels in the absence of H-NS. 
 
Fig. 14: Expression levels of major virulence-associated genes in UPEC 536 and isogenic mutants. 
Measured signal intensities on hybridized arrays of three types of fimbrial adhesins (type 1, P-related and S-
fimbriae), the α-hemolysin determinant, and three types of iron-uptake systems (salmochelin, yersiniabactin, 
and ferrichrome receptors) encoded on the chromosome or on pathogenicity islands. Genes with significantly 
upregulated expression levels compared to the wild type are marked with an asterisk. 
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A more detailed analysis of the impact of H-NS on the expression of virulence-associated 
genes, and the confirmation of the array data by classical phenotypic assays and semi-
quanititative RT-PCR can be found in section 5.3.2.. 
However, it should be mentioned, that not all differences observed are not all ascribable to 
H-NS-mediated regulation alone, but most likely also result from indirect effects from other 
regulators. From our array data, we could identify more than 20 known or putative 
transcriptional regulators with altered expression in the hns mutants, and about 50 proteins 
with other regulatory functions. Among them were many two-component systems such as 
EvgAS or the PhoPQ system, or other pleiotropic regulators like the Hha protein or the the 
cyclic AMP receptor protein CRP, all of which are described to have a broad spectrum of 
target genes. Using semi-quantitative RT-PCR, we could at least confirm lower crp transcript 
levels in strains lacking H-NS (data not shown). 
To summarize, expression profiling revealed a downregulation of genes whose encoded 
products are involved in motility and chemotaxis, whereas the expression of many other 
virulence-associated genes, e.g. coding for S and P fimbriae, as well as for the α-hemolysin 
(transport) system and various siderophore receptors, was upregulated in both the hns and the 
hns/stpA mutant. This indicates, that H-NS might also contribute to the virulence of UPEC 
strain 536. 
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5.2. Characterization of the novel H-NS-homolog Hlp 
5.2.1. Identification of a novel H-NS-like protein in UPEC strain 536 
The sequencing project of the UPEC strain 536 genome was finished soon after the start of 
this thesis and therefore the genome became available for homology searches. Using the 
H-NS sequence of strain MG1655 (Accession No BAA36117) as query, the genome of strain 
536 was searched for proteins with homologies to H-NS by a Blast analysis. 
Like in the K-12 strain, UPEC strain 536 possesses both the hns equivalent (nucleotide 
sequence identity hnsK-12 / hns536 = 99.5 %) as well as the stpA homolog (nucleotide sequence 
identity stpAK-12 / stpA536 = 99.0 %). Interestingly, a third hit was obtained, annotated as a 
putative open reading frame (ORF) coding for a putative DNA-binding protein of 134 amino 
acids, which was now termed Hlp for H-NS-like protein. The nucleotide sequence identity 
between hlp536 and hnsK-12 was 57.2 %, which is about the same as the identity between hns536 
and stpA536. These results strongly suggested that UPEC strain 536 expresses a third, so far 
unknown member of H-NS-like proteins. 
When comparing the amino-acid sequences of all three proteins of UPEC strain 536, the 
strongest homology existed between Hlp and H-NS (57.7 % amino acid identity). The 
homology of Hlp to StpA was slightly lower (52.2 % amino acid identity), resembling the 
homology of H-NS to StpA (51.1 % amino acid identity). The result of a sequence alignment 
of all three nucleoid-associated proteins in UPEC strain 536 is represented in Fig. 15. 
 
Fig. 15: Sequence alignment of the three nucleoid-associated proteins of UPEC strain 536. 
Identical residues are depicted with light shading; dark shading shows residues with >50 % similarity. 
 The domain structure is indicated above the sequence; blue box = core DNA-binding motif. 
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By using the hlp sequence as query in an ordinary Blast search, the sequence occurred to be 
100 % identical to ORF c2411 of UPEC strain CFT073 (Accession No NP_754303), where it 
was termed hnsB by Williamson and Free (2005). 
The properties of the three histone-like proteins were predicted using the Protparam Tool 
(http://www.expasy.org/tools/protparam.html). The results are listed in Table 9. All three 
proteins share very similar properties, especially with regard to their size. Only the StpA 
protein differs in charge and therefore has a more basic pI. The only obvious differences 
between H-NS and Hlp is the hydropathicity, i.e. the amino acid composition according to 
their hydrophobicity. 
Fig. 16 depicts the outcome of a secondary structure prediction retrieved at http://npsa-
pbil.ibcp.fr using consensus mode. The N-terminus of all three proteins is predicted to be 
mostly α-helical. The linker region (residues 63 to 79) is not conserved and shows a variable 
structure. The C-terminus, on the other hand, is supposed to be highly conserved between 
H-NS-like proteins, consisting of an antiparallel ß-sheet, an α-helix, and one 310-helical 
structure. All these features were also found in the predicted secondary structures of Hlp and 
StpA. Moreover, a tertiary structure prediction of both the H-NS and the Hlp molecule 
resulted in a very similar outcome (data not shown). 
Table 9: Predicted protein parameters the three 
histone-like proteins of UPEC strain 536. 
 H-NS StpA Hlp 
No of amino acids 137 134 134 
Molecular weight (kDa) 15.54 15.36 15.05 
Theoretical pI 5.44 7.95 5.24 
Neg. charged residues 25 22 25 
Pos. charged residues 23 23 22 
Hydropathicity 
(GRAVY) 
-0.751 -0.755 -0.932 Fig. 16: Secondary structure prediction for H-NS, 
StpA, and Hlp (http://npsa-pbil.ibcp.fr) 
. 16:.bar code:   full = α-helix; intermediate = ß-sheet; 
 small = random coil 
The finding that UPEC isolates 536 and CFT073 carried identical copies of the hlp gene, led 
to the further investigation of the distribution of hlp in other strains. 
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5.2.2. Screening for the presence of the hlp gene in other E. coli isolates 
To study the distribution of the third H-NS-like protein-encoding gene in different E. coli 
sero- and pathotypes, 131 pathogenic and faecal isolates were tested by PCR for the presence 
of the hlp gene using primers binding within the hlp coding sequence. The strain collection 
comprised extraintestinal pathogenic E. coli isolates as well as intestinal pathogens and faecal 
isolates of healthy volunteers. The result of the screening is presented in Table 10.  
Table 10: Occurrence of the hlp gene in other E. coli variants. The presence of the hlp 
gene was monitored by PCR screening using primer binding within the coding sequence. In 
total, 131 clinical isolates were tested. Extraintestinal pathogens (ExPEC) included 
uropathogenic E. coli isolates (n=41), strains causing sepsis (n=15), and newborn meningitis 
(NBM; n=10); intestinal pathogens (IPEC) included enterotoxigenic E. coli (ETEC; n=4), 
enterohemorrhagic E. coli (EHEC; n=12), enteropathogenic E. coli (EPEC; n=4), 
enteroinvasive E. coli (EIEC; n=2), and enteroaggregative E. coli (EAEC; n=4). 
Variant hlp + hlp - % hlp + 
ExPEC (n = 66) 38 28 57.6 
whereof UPEC (n = 41) 32 9 78.1 
Faecal isolates (n = 38) 15 23 39.5 
IPEC (n = 27) 1 26 3.7 
Total (n = 131) 54 77 41.2 
 
A 355-bp PCR product could be amplified in 54 out of the 145 strains. Most of the hlp-
positive strains belonged to the group of extraintestinal pathogens, with UPECs as prevalent 
subgroup (32 positive isolates; including strains 536, CFT073, and J96). The hlp gene was 
also present in a high number of faecal strains. A detailed list of all tested strains is provided 
in the appendix (Table 25). However, the presence of the hlp gene did not correlate with a any 
specific serotype of the isolates. 
5.2.3. Chromosomal location of the gene encoding for Hlp 
To learn more about possible ways of acquisition of hlp, its chromosomal location was 
analyzed in UPEC strain 536 and CFT073. In both strains, the hlp gene is located 4.6-kb 
upstream of the tRNA locus asnT. This gene is the integration site of a 32-kb pathogenicity 
island. The island, in strain 536 termed PAIIV, represents the core of the so-called high 
pathogenicity island (HPI) of Yersinia [for exact description see Dobrindt et al. (2002a)].  
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The chromosomal sequence context (80-kb) in proximity to the asnT gene of UPEC strain 536 
was compared to the corresponding chromosomal region of strain MG1655 (Fig. 17). The 
nucleotide sequence of this region in UPEC strain 536 is very homologous to the one of 
UPEC strain CFT073 (data not shown). The absence of the 32-kb HPI in K-12 strain MG1655 
can be readily detected, depicted as white stretch of no-homology between the two sequences. 
Interestingly, a second white stretch is present upstream of the serU gene, indicating another 
insertion of 23,173 bases into the chromosomes of strain 536 (and CFT073). This putative 
genomic island has been described recently by Williamson and Free (2005) for strain 
CFT073. 
 
Fig. 17: Analysis of the chromosomal location of the hlp gene coding for Hlp. (A) Genome comparison of 
the asnT-region of UPEC strain 536 and non-pathogenic E. coli K-12 strain MG1655 retrieved by the ACT 
software (Sanger Center). Dark shading indicates regions of high homology. The location of the hlp gene, as well 
as both tRNA loci are marked within the sequences. The GC-content of the UPEC 536 sequence is depicted in a 
window size of 500-bp; (B) Schematic map of the hlp island according to the ORF annotation of Williamson and 
Free (2005). 
The question arose, whether the inserted region represents a so far uncharacterised 
pathogenicity island (PAI) in strain 536. PAIs are defined as large regions in the chromosome 
which are often flanked by direct repeats and encode virulence-associated genes as well as 
mobile genetic elements such as integrases, transposases, and phages. Moreover, PAIs exhibit 
a different GC-content compared to the rest of the chromosome, and are often associated with 
tRNAs (Hacker et al., 1997). 
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The 23-kb insertion containing the hlp gene was now analyzed for each of these 
characteristics. As already mentioned, the region is inserted at the serU locus. A short 14-bp 
duplication of the serU gene was found at the other end of the insertion, thereby forming a 
direct repeat structure. When analyzing the GC-content of the hlp island, it was obvious that 
the GC-content (37.7 % over the whole region) was much lower compared to that of the 
upstream chromosomal region or the downstream HPI. Furthermore, an ORF encoding a 
P4-like integrase (int), as well as a MobA-like conjugal transfer protein (mobA) and two 
phage proteins (alpA and Sfi 11) were found on the island. Therefore, the hlp-containing 
insertion might be considered as an additional genomic island. However, only genes with 
homology to ybaA, which encodes a conserved protein of the type 1a colicin plasmid, and 
pilV and pilS homologs, which are the minor subunit of type IV pili - long extracellular 
appendages used for attachment during conjugation - can be mentioned as possible virulence 
factors. Hence, the hlp-island can not be considered as pathogenicity island. 
Nevertheless, the results suggest that UPEC strain 536, as well as other pathogenic E. coli 
strains might have acquired an hlp containing genomic island by horizontal gene transfer. 
5.2.4. Analysis of hlp transcription 
hlp is transcribed monocistronically 
When taking a closer look at the sequence context of the hlp gene, a second ORF 
(corresponding to c2410 in CFT073) upstream of hlp is reading into the same direction as hlp. 
To explore, whether both ORFs are transcribed polycistronically, the transcription start point 
of hlp was identified by primer extension analysis. This revealed a single promoter starting at 
a thymine residue 37 bases upstream of the translation initiation codon of Hlp (see Fig. 18 A). 
However, no perfect consensus sequence of a typical E coli σ-factor could be identified. 
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Fig. 18: Analysis of hlp transcription. (A) Primer extension analysis using RNA extracted from 536 wt and 
primer hlp-primext; (B) hlp promoter sequence; the transcriptional start point is indicated in bold, the primer 
binding site is underlined; (C) RT-PCR for amplification of the hlp transcript (405-nt), the orf1910 transcript 
(479-nt), and a putative co-transcript (1042-nt). 
Transcript analysis by RT-PCR using primer combinations spanning hlp and/or the upstream 
region corroborated that hlp is not part of an operon with ORF1910 (Fig 18 C). Furthermore, 
Northern blotting revealed a transcript length of ~600 nucleotides, thereby also confirming a 
monocistronic hlp transcript (Fig. 19 A). 
hlp is subject to both auto- and crossregulation 
The expression level of hlp in the wild type strain 536 and its isogenic mutants was studied by 
semi-quantitative Northern blotting (Fig. 19 A). No transcript could be detected in the hlp 
mutants, whereas the 600-nt transcript was present in the wild type, as well as in the stpA and 
hns mutants. In the latter, the amount of hlp mRNA was increased compared to the wild type, 
especially in the hns/stpA double mutant. This suggests a repression of hlp expression by 
H-NS, and therefore in a derepression in strains lacking H-NS. 
The cross-regulating activity of all three DNA-binding proteins was further assessed by semi-
quantitative reverse transcription PCR (RT-PCR), using primers binding within the coding 
sequence of hlp, hns, and stpA. 
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Fig. 19: Influence of histone-like proteins on hlp, hns, and stpA transcript amounts.  
(A) Detection of hlp transcripts from 20 µg RNA by Northern blotting using an ECL-labelled DNA probe; 
(B) Semi-quantitative RT-PCR using primers binding within the coding sequence of hns, stpA, and hlp. 
Derepression of both hlp and stpA transcription occurred in the absence of H-NS, thereby 
confirming its role as a repressor. A slightly higher amount of hns transcript could be detected 
in the stpA mutant, as it was described before in E. coli K-12 (Sonden and Uhlin, 1996). Lack 
of StpA did not affect hlp transcription. On the other hand, expression of stpA was not altered 
in an hlp mutant, whereas a derepression of hns transcription occurred in the absence of Hlp 
(Fig. 19 B). These results suggest that all three histone-like proteins are able to mediate 
repression of at least one of their homologs, thereby forming a cross-regulatory network. 
To further confirm this cross-regulating activity, band shift assays were performed with 
purified Hlp, H-NS, and StpA proteins of strain 536 and K-12, respectively. For these 
experiments, ~350-bp PCR fragments containing the promoter regions of the hlp, hns, and 
stpA genes were used as target for protein binding. 
 
Fig. 20: Analysis of binding capacities of histone-like proteins to their own promoter regions. 
Electrophoretic mobility shift assay using ~350-nt PCR fragments containing the hlp (A), hns (B), and stpA (C) 
promoter regions. Concentrations of purified H-NS, StpA, and His-Hlp was 5.3 µM, 7.1 µM, 11 µM, and 21 µM. 
Binding of the StpA preparation could not be observed (Fig. 20 - middle lanes). On the other 
hand, H-NS was binding to all three promoter fragments with equal affinities, resulting in 
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very specific DNA-protein complexes (Fig. 20 – left lanes). Finally, Hlp was also binding to 
all fragments, with the weakest affinity for the stpA promoter and the highest affinity for its 
own promoter (Fig. 20 – right lanes). The latter finding suggests, that Hlp, like H-NS and 
StpA, is able to mediate both cross- and auto-regulation. 
Cross-regulation requires promoter regions, which are suitable for protein binding. Both 
H-NS and StpA have been shown to preferentially bind to AT-rich, intrinsically curved DNA 
sequences. Moreover, both the hns and the stpA promoter regions are predicted to have these 
features. Therefore, we also analyzed the hlp promoter region. The AT-content of the 400-bp 
upstream region was 63.77 %, which is even higher than for the hns and stpA promoters 
(AT-content 60.55 % and 63.52 %, respectively). Futhermore, the curvature prediction of the 
DNA fragment exhibited a strong curvature (see Fig. 52 in the appendix). This result further 
confirms, that the own promoter regions are possible targets for binding of histone-like 
proteins. 
5.2.5. Overexpression and purification of HLP 
For overproduction and purification of His-tagged Hlp, plasmid pASK75-Hishlp was initially 
introduced into E. coli strain RosettaTM. However, when the 16-kDa His-Hlp protein was then 
enriched from the cytoplasmic fraction by Ni-affinity chromatography, a second, slightly 
smaller protein was co-purified (Fig. 21 A). 
 
Fig. 21: Analysis of fractions during purification of His-tagged Hlp. Recombinant Hlp protein was 
overexpressed in E. coli RosettaTM and purified using Ni-affinity chromatography. (A) Coomassie stained 
denaturing polyacrylamide gel of purification steps. (B) Immunoblot of the same samples with antibodies 
recognizing Hlp (left panel) and H-NS (right panel). 
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The approximate molecular weight of the second protein (~15.5 kDa) suggested that it might 
be native Hlp protein. Since the hlp gene cloned after the His-tag still had its own translation 
start codon, un-tagged protein could have been co-synthesized and co-purified due to 
dimerization with His-Hlp. N-terminal sequencing of the smaller protein, however, resulted in 
the sequence SEALKILM, which matches the sequence of the H-NS protein. Immunoblotting 
with antiserum recognizing H-NS confirmed the presence of a 15.5-kDa band in all 
purification fractions (Fig. 21 B). When using an antiserum detecting both Hlp and StpA, both 
the 15.5-kDa band and a larger one corresponding to His-tagged protein appeared. This again 
strongly indicates, that H-NS is co-purifying with Hlp. 
We also wanted to determine the nature of the interaction between H-NS and Hlp that leads to 
co-purification. Therefore, the Ni-column was washed with increasing salt concentrations in 
the wash buffer prior to elution. Even with a potassium chloride concentration of as much as 
2 M, elution of H-NS due to dissociation of the complex was not observed (Fig. 22), thereby 
indicating hydrophobic interactions between the two proteins. 
 
Fig. 22: Analysis of the nature of the interaction between Hlp and H-NS. Recombinant 
Hlp protein was expressed and purified as seen in Fig. 21 A, but here the Ni-column was 
washed with increasing concentrations of KCl prior to elution with imidazole. 
Washing the column with up to 80 mM imidazole neither resulted in elution of any protein, 
thereby confirming that H-NS is not unspecifically retained in the column, but is rather bound 
in a specific H-NS/Hlp complex. 
Another indication that the biological form of Hlp is not a monomer was derived from gel 
filtration chromatography. The first intention for using this technique resulted from the 
contamination of the protein samples with proteinase factor XA after removing the His-tag. 
The proteinase consists of two subunits of 30 and 50 kDa. 
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Therefore it should be possible to separate the subunits from the 15-kDa Hlp protein in a gel 
filtration column. However, all Hlp protein eluted much earlier as expected (by comparing the 
Hlp run with a MW calibration run), namely in fractions 20 to 25 (Fig. 23 A). In the 
calibration run, bovine serum albumin with a molecular weight of 67 kDa eluted in fraction 
22, whereas ovalbumin with a molecular weight of 43 kDa eluted in fraction 26. This 
indicates, that Hlp migrated like a protein of approximately 60 kDa. 
 
Fig. 23: Analysis of native Hlp by gel filtration (A) UV measurements of the different fractions during gel 
filtration. Upper panel = Hlp sample; lower panel = MW calibration samples containing four different proteins. 
(B) Coomassie stained denaturing acrylamide gel of gelfiltration fractions. 
When analyzing the fractions by denaturing gel electrophoresis, we also found the 50-kDa 
subunit of the factor XA protease in the late fractions (Fig. 23 B). This result strongly 
suggests, that the biological form of Hlp is a tetramer – either as homomeric complex, or as 
heteromers with H-NS – wich adds up to a MW of 60 kDa, and therefore can not be separated 
from the protease by non-denaturing gel filtration chromatography. 
Finally, the heteromeric complex was directly detected by chemical crosslinking of proteins 
in the eluate with glutaraldehyde. Immunoblotting using antisera recognizing H-NS or Hlp 
revealed the presence of a 30-kDa H-NS/Hlp complex, as well as higher oligomers in the 
crosslinked fraction (Fig. 24 B). 
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Fig. 24: Analysis of in vitro oligomerization by chemical crosslinking. Recombinant Hlp 
protein was expressed in E. coli RosettaTM and purified using Ni-affinity chromatography. Proteins 
in the eluate were chemically crosslinked with glutaraldehyde and analyzed by denaturing 
polyaclyamide gelelctrophoresis (A) and immunoblotting (B) 
Taken together, these results infer direct protein-protein interactions between Hlp and H-NS, 
resulting in the formation of a stable heteromeric complex. 
5.2.6. Analysis of Hlp stability 
To obtain pure Hlp protein without co-purification of H-NS or StpA, strain JGJ152 (hns/stpA) 
was transformed with the expression plasmid pASK75-Hishlp. However, it was not possible 
to obtain any recombinant protein using the standard protocol for purification. Only when 
decreasing the period of protein synthesis induction to < 1 h (instead of 6 h), a small amount 
of His-Hlp could be purified (Fig. 25 A). 
 
Fig. 25: Alternative strategies for purification of recombinant Hlp protein. 
(A) Immunoblot of total extracts and eluted proteins after purification from strain JGJ152 
(MC4100 hns/stpA) after 1 h induction; (B) Coomassie stain of purification fractions from 
protease-negative E. coli expression strain BL21(DE3) hns. 
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Johansson and Uhlin (1999) reported that StpA is readily degraded by the Lon protease, if not 
protected by H-NS. If the same were true for Hlp, it would explain the failure to purify Hlp in 
an hns mutant strain like JGJ152, since any newly synthesized Hlp protein would be degraded 
by a host protease during induction. On the other hand, it should then be possible to purify 
Hlp in a hns mutant lacking any protease. Therefore, the expression plasmid was transferred 
into an hns mutant of the protease-negative expression strain BL21(DE3). Indeed, using this 
strain, we were able to obtain high amounts of His-Hlp without any contamination by H-NS 
(Fig. 25 B). This result indicates, that - as in case of StpA - H-NS might protect Hlp from 
degradation. 
To test this hypothesis, Hlp was expressed from either a low copy number plasmid 
(pWKS30-hlp) or from the inducible His-Hlp expression plasmid, and protein stability was 
assessed in E. coli MC4100 mutants lacking both StpA and H-NS, and/or the Lon protease. In 
case of the low copy number plasmid, no degradation of the native Hlp protein in an hns-
negative, protease-positive strain could be observed 3 h after stopping protein synthesis by 
addition of spectinomycin, thereby contradicting this hypothesis (Fig 26 A). 
 
Fig. 26: Analysis of Hlp stability. (A) Immunoblot for the detection of Hlp protein before and 3 h 
after inhibition of protein synthesis by addition of spectinomycin. Strains transformed with 
pASK75-Hishlp were grown in presence of the inducer a-Tc. (B) Growth curves of the transformants 
during the stability assay. Arrows indicate the time point of addition of spectinomycin (t0). 
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Interestingly, no recombinant protein expressed from plasmid pASK75-Hishlp could be 
detected at all in the hns stpA double mutants, while high amounts were synthesized in strain 
BL21(DE3) hns. Furthermore, the MC4100 mutants grew only poorly under standard growth 
conditions, and the growth defect was further enhanced in the presence of the inducer 
anhydro-tetracycline (Fig. 26 B). Therefore, this suggests that the failure to purify 
recombinant Hlp protein in strain JGJ152 was not a result of proteolytic degradation of Hlp, 
but rather caused by an insufficient expression level in the MC4100 background due to some 
sort of plasmid intolerance. 
5.2.7. Hlp has in vivo activity 
After successful overexpression and purification of the Hlp protein, it was tested, whether Hlp 
has any in vivo activity. Therefore, native protein was expressed from a low copy number 
plasmid (pWKS30-hlp) in hns mutants of the K-12 strains MG1655 and MC4100, and its 
ability to complement for the lack of H-NS was assessed for some well described hns 
phenotypes. 
As a first test system, E. coli K-12 strain MG1655 and its isogenic hns mutant BEU740 
harbouring plasmid pWKS30-hlp or the vector control were stabbed on swarming agar plates 
to assess their motility. The wild type strain with or without the plasmids exhibited swarming 
ability, whereas the hns mutant was completely non-motile. Expression of Hlp from plasmid 
pWK30-hlp, however, restored motility of the hns mutant to the same extent as the wild type 
(Fig 27 A). This indicates, that Hlp can assume activation of the flagella master operon flhCD 
in absence of the normal regulator H-NS. 
Next, expression of two determinants was analyzed which are usually silent in the wild type 
due to repression by H-NS, namely the cytolysin-encoding gene clyA and the bgl operon, 
which encodes enzymes for the utilization of ß-glucosides. Because of transcriptional 
silencing, E. coli K-12 wild type cells are non-hemolytic on blood agar plates, and white on 
agar plates containing the ß-glucosidase substrate X-Glu, whereas hns mutants exhibit a 
hemolytic phenotype and grow as blue colonies on X-Glu plates. When introducing the hlp-
plasmid into the hns mutant, it became non-hemolytic on blood agar and white on X-Glu 
plates, thereby resembling the wild type (Fig. 27 B and C). The same results were obtained 
with hns stpA mutants in an E. coli MC4100 background (data not shown). This indicates, that 
Hlp can silence the clyA and bgl determinants in the absence of H-NS independently of StpA. 
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Fig. 27: Analysis of complementing activity of Hlp in strains lacking H-NS. E. coli K-12 strain 
MG1655 and its isogenic hns mutant BEU740 were transformed with the low copy number plasmid 
pWKS30-hlp and the vector control, and changes in typical hns phenotypes were monitored. 
(A) Swarming ability on 0.3 % agar plates; (B) Expression of ß-glucosidases (bgl) on X-Glu plates; (C) 
Hemolytic activity on blood agar plates; (D) Electrophoretic mobility shift assay testing binding of Hlp 
and/or H-NS to EcoRI/DraI restricted plasmid pYMZ80 containing the clyA gene. 
However, when monitoring binding activity of Hlp to the clyA promoter by electrophoretic 
mobility shift assay as described by Westermark et al. (2000), no specific binding could be 
detected with the Hlp protein alone (Fig. 27 D). On the other hand, addition of small amounts 
of H-NS resulted in specific DNA-protein complexes, thereby suggesting possible effects of 
Hlp on clyA. However, since no functional ClyA protein is expressed in UPEC strain 536, this 
effect is off less significance in the wild type cells. 
Another typical hns phenotype is derepression of the osmotically inducible glycine-betaine 
transport system encoded by the proU operon. Using chromosomal proU-lacZ fusion strains 
in both an hns+ (BEU693) and hns - (BEU694) background, a higher ß-glucosidase activity 
was observed in the hns mutant transformed with the vector control than in the wild type 
(1040 vs. 777 Miller units, respectively). After complementation of the mutant with Hlp, 
proU transcription was reduced to wild type levels (Fig. 28 A). However, introduction of the 
hlp-containing plasmid into the wild type strain resulted in higher ß-galactosidase activity 
(1011 Miller units) compared to the vector control strain, thereby indicating, that Hlp might 
act as an anti-H-NS factor for proU repression in this test system. 
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Fig. 28: Effects of Hlp on transcription levels and growth rates of hns mutants. (A) ß-galactosidase 
activity of chromosomal proU-lacZ reporter strains; (B) ß-galactosidase activity of plasmid-encoded 
(pBSN2) hns-lacZ reporter strains; (C) Growth curves of strain MC4100 and isogenic hns/stpA double 
mutant at 37 °C; (D) Growth curves of strain MG1655 and isogenic hns single mutant (BEU740) at 37 °C. 
H-NS was shown to negatively affect its own transcription by autoregulation. To assess, 
whether expression of the Hlp protein can also mediate repression of hns expression, both the 
hlp-encoding plasmid and a plasmid-encoded hns-lacZ fusion (pBSN2) were introduced into 
strain MG1655 and its isogenic hns mutant, and ß-galactosidase activity was determined. 
As expected, hns transcription was derepressed in the hns mutant transformed with the vector 
control, thereby confirming negative autoregulation (Fig. 28 B). This effect was abolished 
when the mutant was complemented with Hlp, resulting in the same hns expression level as in 
the wild type. This result indicates that the Hlp protein is able to repress hns transcription, and 
further confirms transcriptional cross-regulation of the histone-like proteins. 
Strains lacking both H-NS and StpA have a growth defect even at normal growth conditions. 
This growth defect was partially restored after introducing the hlp-containing plasmid into an 
hns stpA double mutant of strain MC4100 (Fig. 28 C). Thus, Hlp can also substitute H-NS in 
terms of growth. 
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However, the growth curve of the complemented strain resembled more that of an hns mutant, 
and almost no complementation was observed in an hns single mutant (Fig 26 D). These 
results suggest that, in terms of growth, the presence of the StpA protein is of more 
importance than Hlp. 
To summarize, we provide evidence that UPEC strain 536 and other E.coli variants express a 
third histone-like protein with high homology to H-NS. The gene coding for Hlp is located on 
a so far uncharacterized genomic island of 23-kb in size inserted at the serU locus. Due to 
structural similarities at the N-terminus, H-NS and Hlp are directly interacting, thereby 
forming stable heteromers. In contrast to StpA, the Hlp protein is not proteolytically degraded 
by the Lon protease in absence of H-NS. The heteromer is supposed to be the biologically 
relevant form of Hlp. Moreover, Hlp exhibits in vivo activity, since it can complement for the 
lack of H-NS in terms of motility, repression of the bgl, clyA, and proU operons, and also has 
an effect on growth rates. However, these experiments were performed in a K-12 background, 
where Hlp does not naturally occur, and therefore do not answer the question for the 
biological role of the H-NS paralog. 
 
5.3. Role of the H-NS paralogs 
Due to the high homology between the histone-like proteins, one might speculate about the 
degree of redundancy in the cell. Does a similar structure also imply similar functions, or do 
the H-NS paralogs play separate roles in the gene regulation process? To answer this 
question, mutants deficient for one or several of the histone-like proteins were constructed 
and searched for differences in their phenotype. 
5.3.1. Construction of hlp mutants 
The construction of the hlp single, double and triple mutants was performed using the λRed 
method, as described for the hns and stpA mutants (see section 5.1.1.). The hns/stpA/hlp triple 
mutant was constructed by introducing a linear fragment containing a chloramphenicol-
resistance cassette with homology extension to hlp into the pre-existing hns/stpA mutant. 
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Fig. 29: Verification of the hlp mutations. (A) PCR amplification using primer 
combinations  I = hlp-3/4; II = hns-3/4; and III = stpA-3/4; (B) Southern hybridization using 
EcoRV restricted DNA and PCR generated DNA probes binding to hlp, hns, or stpA fragments. 
 
All mutation were confirmed by both PCR amplification of the target region and by Southern 
hybridization (Fig. 29). 
5.3.2. Role of H-NS and its paralogs on expression of virulence-associated genes 
The phenotypes of the newly constructed mutants were tested by classical physiological 
assays for typical virulence traits of uropathogenic E. coli. At the same time, these tests 
served to confirm the array data obtained with the hns and stpA mutants. 
Motility and chemotaxis 
The effect of H-NS on motility is a rare example for an activating role of H-NS and has 
already been described for several strains (Soutourina et al., 1999). This was also true for 
UPEC strain 536, where all H-NS deficient mutants were completely non-motile on swarming 
agar plates (Fig 30). 
5. Results 
 
106 
 
 
Fig. 30: Swarming ability of H-NS deficient mutants of E. coli 536 on swarming agar plates. 
This result is supported by the array data, where the expression of almost all genes of the 
flagellar operons was downregulated (see appendix - Table 18). Furthermore, the lack of 
motility seemed to coincide with a ceased expression of genes whose encoded products are 
involved in chemotaxis such as cheW, cheA, cheZ and cheY. In total, 32 genes of this 
functional group were downregulated. The strongest effect was observed for the flagellin gene 
fliC itself, where the expression was 12.6 times lower in the hns mutant and 9.3 in the 
hns/stpA mutant, respectively. Taken together, our results were in good agreement with 
previous observations for other E. coli strains, including K-12, and further confirm the 
positive regulation of motility by H-NS. 
Adhesins 
Strain 536 encodes at least three types of fimbrial adhesins, namely the chromosomally 
encoded type 1 fimbriae (fim), P-related fimbriae (prf) encoded on PAIII and S-fimbrial 
adhesin (sfa) encoded on PAIIII. Lack of H-NS affected expression of all three of them. 
The effect of H-NS on type 1 fimbriae expression is already described in the literature, where 
H-NS was shown to repress the recombinases fimB and fimE (Olsen and Klemm, 1994). Both 
recombinases are involved in the phase variation of an invertible DNA fragment containing 
the fimA promoter, therefore mediating switching between a fimbriated and a non-fimbriated 
state. In UPEC strain 536, the same effect of H-NS on expression of the recombinases was 
observed using the DNA arrays. Lack of H-NS resulted in a significant upregulation of fimB 
by factor >4 and of fimE by factor >2 in both hns and hns/stpA mutants (Fig 14; section 
5.1.3.). 
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Expression of the structural genes was not significantly altered at the transcriptional level. At 
least for the major fimbrial subunit fimA, this lack of regulation was confirmed by semi-
quantitative RT-PCR (Fig. 31 B). 
 
Fig. 31: Effect of histone-like proteins on production of fimbrial adhesins. 
(A) Immunoblot using antisera directed against purified S- and P-fimbriae; B) semi-quantitative 
RT-PCR for major fimbrial subunits. Samples were taken from liquid cultures in mid-log phase. 
S fimbriae are mainly found in uropathogenic E. coli and in strains causing newborn 
meningitis (Morschhäuser et al., 1993). Using the E. coli pathoarray, the expression level for 
each gene of the sfa gene cluster in an hns mutant strain could be monitored. All structural 
genes were significantly upregulated in the mutants when compared to the wild type (Fig. 14; 
section 5.1.3.). The most prominent derepression could be observed for the major subunit-
encoding gene sfaA. Expression of the sfaA gene was 27 times higher in the hns mutant 
compared to the wild type, and 12 times higher in the hns/stpA mutant, which ranked sfaA 
among the 10 most strongly affected genes sorted according to their expression levels (see 
appendix - Tables 13 & 14). When monitoring the expression of sfaA at the protein level 
using a specific antiserum against purified S fimbriae, or at the transcriptional level using 
semi-quantitative RT-PCR, we also saw a massive derepression in all hns mutants (Fig. 31 B), 
thereby confirming the results from transcriptional profiling. 
UPEC strain 536 expresses another type of fimbriae with similarities to the pyelonephritis-
associated P-pili. It could be shown that, like for the pap genes, H-NS also affects expression 
of those P-related fimbriae. Western blotting using PrfA specific antiserum revealed that 
expression of the major subunit was increased in H-NS deficient strains compared to the wild 
type, especially when taking samples from static cultures or from agar plates (Fig. 31 A). 
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When going back to the data from the E. coli pathoarray, derepression of prfA transcription 
was not as drastic as seen at the protein level (Fig 14; section 5.1.3.). However, when 
comparing signal intensities on the array, it was evident that the overall expression level of 
P-related fimbriae was very low under these conditions, i.e. mid-log phase samples from 
liquid cultures. Only the prfX gene encoding a putative regulator was significantly 
upregulated in both mutants, with expression ratios of 5.2 in the hns mutant and 3.7 in the 
double mutant. This gene encodes a 17-kDa protein, which is believed to be a putative 
regulator of the prf operon. 
To verify, whether derepression of the genes for both S- and P-fimbriae at the transcriptional 
level also resulted in increased biogenesis of fimbriae, cells grown on agar plate were fixed 
onto Mica platelets and analyzed by atomic force microscopy (AFM). As seen in Fig. 32, an 
hns mutant cell is heavily fimbriated in contrast to the wild type. 
 
Fig. 32: Analysis of fimbriae expression of wild type strain 536 and its isogenic mutants by AFM. 
(Tapping mode) 
This technique also resulted in the discovery of other interesting aspects of cell morphology, 
such as filamentous growth of hns mutants, or the seemingly increased production of outer 
membrane vesicles in strains lacking both H-NS and Hlp. More AFM micrographs of each 
mutant can be found in the appendix (Fig. 51). 
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With regard to the hyper-fimbriated phenotype, a higher expression of S- and P-pili was also 
found in the hns/hlp double mutant and the triple mutant. However, when comparing 
expression levels between the hns/stpA and the hns/hlp mutant, a clear difference was 
observed: As determined from the immunoblot, lack of StpA resulted in a less pronounced 
derepression of P-pili in the absence of H-NS, whereas expression of S-pili was even higher 
compared to the hns single and hns/hlp double mutants. 
Taken together, the results infer a major role of H-NS in regulating the expression of both 
P- and S-fimbriae, which are believed to be important virulence factors during urinary tract 
infections, whereas the H-NS paralogs Hlp and StpA do not seem to be of major importance. 
Nevertheless, both proteins seem to have a modulating function on the effect of H-NS, e.g. 
resulting in fine-tuned cross-regulation of fimbrial adhesins. 
Hemolytic activity 
UPEC strain 536 possesses two hly determinants encoding α-hemolysin. Both gene clusters 
are located on pathogenicity islands (PAII and PAIII) and the biological function of having 
two copies of hlyCABD is still unknown. Both clusters encode the RTX-toxin HlyA, the 
activator HlyC, and proteins HlyB and HlyD, involved in toxin secretion. 
On the E. coli pathoarray, both transport proteins HlyB and HlyD were significantly 
upregulated in H-NS deficient strains, and the activator HlyC showed a trend towards higher 
expression in the mutants (Fig 14; section 5.1.3.). When using the more sensitive method of 
RT-PCR, an increased amount of the hlyA transcript encoding the toxin itself could be 
detected (Fig. 33 C). Furthermore, secretion of α-hemolysin was visualized by stabbing the 
strains on blood agar plates and detecting the formation of halos around the colonies due to 
lysis of erythrocytes (Fig. 33 A). Here, the problem arose that the hns mutants did not grow to 
the same colony size as the other strains. Therefore, a quantification of hemolysis was not 
possible. However, when measuring hemolytic activity of culture supernatants from late-log 
phase cultures grown at 30 °C to ensure maximal expression of the hemolysin, the hemolytic 
units of all hns mutants were about 5 to 10 times higher compared to the wild type (Fig. 33 B; 
Table 12). 
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Fig. 33: Effects of histone-like proteins on hemolytic activity. (A) Phenotype on a blood agar 
plate containing 5 % sheep erythrocytes; (B) semi-quantitative hemolysis assay with diluted culture 
supernatants. Hemolytic units equal the dilution factor at which 50 % hemolysis occurred; (C) semi-
quantitative RT-PCR for α-hemolysin-encoding gene hlyA. 
This repressive effect of H-NS on hemolysin expression is consistent with earlier findings in 
the literature (Madrid et al., 2002; Nieto et al., 2000), where H-NS was shown to mediate 
thermoregulation by binding to the regulator Hha. In hns mutants of strain 536, the expression 
of hha itself was also increased by factor 4.7 (hns) and 2.1 (hns/stpA), respectively. This 
result confirms, that Hha requires functional H-NS protein for its activity as a repressor. 
Iron uptake systems 
UPEC strain 536 encodes five types of iron uptake systems. The salmochelin system (iro) and 
the yersiniabactin system (ybt) are both encoded on pathogenicity islands, the hemin receptor 
(chuA) locus resides on a small islet not present in E. coli K-12, whereas the determinants 
coding for the ferrichrome (fhu) and the enterobactin system (fep) are located within the 
E. coli core genome. Each system consists of proteins involved in binding of the 
siderophore/hemin by a receptor and distinct proteins for the transport of the complexes into 
the cell. 
When going back to the expression levels of the various gene detectable with the DNA arrays, 
only genes encoding the corresponding receptors had an altered expression level in the hns 
mutants (see appendix - Table 20). In detail, the expression of the salmochelin receptor iroN, 
the ferrichrome receptor fhuA, and the yersiniabactin receptor fyuA together with three other 
genes of the cluster, ybtQ ybtS and ybtX were significantly upregulated. The enterobactin 
system and the hemin receptor were not affected by the mutations. 
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However, these values derive from non-inducing conditions, were the total expression levels 
of these genes were very low. Therefore, the more sensitive method of semi-quantitative 
reverse-transcription PCR (RT-PCR) was used, which enables the detection of low transcript 
amounts. 
As already seen on the array, significant higher transcript levels of the salmochelin receptor 
gene iroN were detected by RT-PCR in the H-NS deficient strains compared to the wild type, 
whereas the transcript levels of the hemin receptor gene chuA were much lower in these 
strains (Fig. 34 D). Expression of the enterobactin receptor gene fepA was not altered by the 
mutations and expression of the yersiniabactin receptor gene fyuA was not detectable under 
these conditions. These results indicate that H-NS has divergent effects on the expression of 
the different siderophores systems, playing both an activating and a repressing role. 
 
Fig. 34: Effects of histone-like proteins on the production of siderophores. (A) UPEC strain 536 and 
mutants stabbed onto agar plates containing chrome azurole S (CAS); yellow halos are formed in the presence of 
siderophores due to degradation of the blue iron complex ; (B) CAS liquid assay on microtiter plate scale; 
degradation of the assay solution can be measured photometrically at 630 nm; the picture was taken after 45 min; 
(C) CAS liquid assay quantitation; (D) semi-quantitative RT-PCR for three siderophore receptor genes. 
To further study this effect, secreted siderophores were directly detected using a chrome 
azurole S (CAS) - based assay developed by Schwyn and Neilands (1987). First, strains were 
stabbed onto agar plates containing the blue CAS-iron complex. Secreted siderophores would 
bind the iron and result in degradation of the blue complex, thereby forming a yellow halo 
around the colonies (Fig. 34 A). As on the blood agar plates, quantitation was not possible 
due to the growth defects of the hns mutants. 
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Therefore, a chromatographic assay for the detection of siderophores was performed under 
iron-limiting conditions (see method section 4.6.2.). In this assay, the blue iron-complex in 
the assay solution is degraded gradually if siderophores are present in the supernatants and 
consequently, the absorbance decreases (Fig. 34 B). The quantitation of the assay is shown in 
Fig. 34 C. All strains reach the same absorbance at state of equilibrium, thereby indicating an 
equal amount of siderophores in the supernatants. However, the decrease in absorbance 
happens much faster in H-NS deficient strains. Taken together, our data infer a differential 
regulation of the iron uptake systems by H-NS. 
Stress resistance 
H-NS is known to be involved in adaptation to various types of stress situations (Atlung and 
Ingmer, 1997; Hommais et al., 2001). This role was also found when analyzing the expression 
pattern of hns mutants of UPEC strain 536. Many gene whose products are involved in stress 
adaptation and multidrug resistance were found among the list of upregulated genes on the 
K-12 array (see appendix - Table 23). In particular, many of these genes were involved in acid 
resistance, like the determinants coding for glutamate decarboxylases/antiporters GadA, 
GadB, XasA, and their activators GadX (YhjX) and GadE (YhjE), the lysine decarboxylase 
CadA and CadB, as well as the acid chaperones HdeA HdeB. All these genes were among the 
ten most strongly upregulated genes. Furthermore, many genes within the “acid resistance 
cluster” like yhiQ, yhiD, and yhjHJKL were upregulated in the mutants. Derepressed genes 
whose products are involved in multidrug resistance included mdtEF and emrKY, as it was 
already described by Nishino et al. (2004). 
The data obtained in this study also supported the well-known role of H-NS in 
osmoprotection. The genes coding for the glycine-betaine/proline transporter system proVWX 
were significantly upregulated in the hns mutants, with proV ranking on positions 4 (hns) and 
15 (hns/stpA) among the 50 most strongly upregulated genes (see appendix - Tables 13 & 14). 
Other osmotically inducible proteins like osmC, osmB and osmY, as well as the chaperones 
dnaKJ exhibited increased expression levels in the mutants compared to the wild type. 
To test, whether this upregulation of osmoprotection genes also resulted in increased survival 
rates at high osmolarity, LB cultures were incubated with 3M NaCl for 2 h and CFU was 
determined before and after the treatment (Hommais et al., 2001). 
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Only 4 % (±2.3) of the wild type cells and 5 % (± 3.9) of the stpA mutant cells were still alive 
after 2 h incubation at high osmolarity, whereas the survival rates were significantly increased 
in both the hns single mutant (61 ± 17.8 %) and the hns/stpA double mutant (69 ± 13.7 %). 
Multicellular behavior 
Bacterial lifestyle is rarely single celled, but in contrary, bacteria tend to aggregate and form 
complex multicellular communities. The most prominent example for such a community is a 
biofilm, per definitionem a structured community of bacterial cells enclosed in a self-
produced polymeric matrix and adherent to an inert or living surface (Costerton et al., 1999). 
One prerequisite for the formation of biofilm are direct cell-to-cell interactions. In E. coli, 
these interactions can for instance be mediated by the self-recognizing surface adhesin 
Antigen 43. At least in E. coli K-12, Ag43 was found to be important for the biofilm forming 
process because of autoaggregation (Danese et al., 2000).  
Consequently autoaggregating abilities of UPEC strain 536 and its isogenic mutants were 
measured by a simple assay (see Methods section 4.6.3.). As seen in Fig. 35 A, all H-NS 
deficient strains aggregated after some time and accumulated at the bottom of the tubes. 
 
Fig. 35: Effects of histone-like proteins on autoaggregative behavior. (A) Cultures of UPEC strain 
536 and isogenic mutants in M63BI minimal medium after 24 h static incubation at room temperature; 
(B) quantitation of autoaggregation by measuring optical densities (OD600nm) from 1 cm below the surface. 
Quantitation of the assay revealed some differences in the time course of aggregation. All 
H-NS deficient double and triple mutants settled down faster than the single mutant. 
Furthermore, lack of Hlp seemed to further enhance autoaggregation (Fig. 35 B). 
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This autoaggregative phenotype of H-NS deficient strains might also refer to an altered 
biofilm forming capacity. When testing biofilm formation using a microtiter plate assay, some 
differences were observed between the mutants and the wild type, though very much 
depending on the growth medium (data not shown). However, it was not possible to quantitate 
the assay properly, and the results were hardly reproducible. This was mostly due to the weak 
biofilm forming ability of E. coli strains in general, thereby rendering this assay a weak 
method. 
Another approach for assessing multicellular behaviour is to study the phenotype of a strain 
on plates containing the dye Congo Red. Differences in the production of curli adhesin (or 
cellulose) result in different Congo Red-binding capacities, visualized in a red/brownish 
colour of the colonies. The phenotypes of UPEC strain 536 and its mutants on such Congo 
Red agar plates incubated at different temperatures is represented in Fig. 36. 
 
Fig. 36: Effects of histone-like proteins on multicellular behavior. Congo Red-binding assay 
to test for production of curli and cellulose. Plates were incubated at room temperature (left panel), 
30 °C (middle panel) or 37 °C (right panel). 
UPEC strain 536 does not express cellulose and curli at 37 °C, therefore growing in white, 
unstructured colonies. At lower temperatures on the other hand, the wild type strain exhibits a 
brown, structured colony morphology. The same was found for all H-NS positive mutants. 
H-NS deficient strains, however, differed in their phenotype. At room temperature, all hns 
mutants grew into unstructured colonies, but some of them were still able to bind Congo Red. 
At 37 °C on the other hand, these mutants exhibited a more structured colony morphology. 
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Here, especially strains lacking both H-NS and Hlp were found to bind Congo Red in high 
amounts. This result suggests, that the expression of curli and cellulose might be altered in the 
hns/hlp and the triple mutant. Therefore, the expression levels of the corresponding genes 
were monitored by semi-quantitative RT-PCR (Fig 37). Expression of the major curli subunit-
encoding gene csgA and the gene that codes for the cellulose regulator YaiC was induced in 
the absence of both H-NS and Hlp, thereby confirming the hypothesis derived from the 
Congo Red-assay. 
 
 
 
 
Fig. 37:  Effect of H-NS and Hlp on production 
of curli adhesin and cellulose . Semi-quantitative 
RT-PCR for the cellulose regulator (yaiC) and the 
major subunit of curli fimbriae (csgA) 
 
A second hint for the involvement of both H-NS and Hlp in the composition of extracellular 
substances is the mucoid phenotype of the hns/hlp mutant and the triple mutant on ordinary 
agar plates at 37 °C (data not shown). The best visualization of the mucoid phenotype, 
however, was obtained on salicin plates. These plates are normally used to test the ability of a 
strain to utilize ß-glucosides such as salicin. The enzymes required for this metabolic pathway 
are encoded in the so called bgl operon. In wild type cells, this operon is completely silent due 
to repression by H-NS (Defez and De Felice, 1981). In the absence of H-NS, transcription of 
the bgl genes is derepressed and the cells are able to utilize the substrate in the agar plate, 
resulting in a red color of the colonies. 
 
Fig. 38: Effects of histone-like proteins on utilization of ß-glucosides. The ability to 
utilize ß-glucosides was assessed on agar plates containing 0.4 % salicin and indicator dyes. 
(The mucoid/glossy phenotype of the hns/hlp mutant should be specially pointed out) 
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As seen in Fig. 38, only H-NS deficient strains grew in red colonies, thereby indicating, that 
the other H-NS homologs are not required / or able to silence the operon. 
Speculating about the reasons for the mucoid phenotye, other factors than curli and cellulose 
have to be considered. This led us to also test the strains for the expression of the K15 capsule 
and lipopolysaccharide. 
Capsules, Lipopolysaccharide, and serum resistance 
UPEC strain 536 expresses a capsule of the K15 serotype, which has been recently described 
by Schneider and co-workers (2004). Using a K15 capsule-specific antiserum, Dr. György 
Schneider was now able to detect a significant higher signal intensity in the hns/hlp mutant 
compared to the wild type and all other mutants (Fig. 39 A). 
 
Fig. 39: Effects of H-NS and Hlp on expression of the K15 capsule determinant. (A) ELISA with 
polyclonal K15 serum (performed by G. Schneider in Pécs, Hungary); (B) semi-quantitative RT-PCR for 
capsular genes of region 1 (kpsE), region 2 (orf70), and region 3 (kpsM). 
When analyzing transcript levels of representative genes for every region of the capsule 
determinant by semi-quantitative RT-PCR, divergent effects of the mutations were revealed. 
Expression of the kpsE gene of region 1, which is involved in translocation of the capsule 
components across the periplasm and outer membrane was upregulated in strains lacking both 
H-NS and Hlp, whereas the kpsM gene and orf70 seemed to be downregulated in these 
mutants. The first gene encodes a protein involved in translocation across the cytoplasm, the 
latter one is part of the variable region 2 and its product has no homology to any known 
protein at the nucleotide level. 
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To further confirm a regulatory effect of histone-like proteins on the expression of the capsule 
determinant, binding abilities of Hlp and H-NS to the promoter regions of all three capsule 
regions, which are thought to form separate transcription units, were assessed by 
electrophoretic mobility shift assay. As seen in Fig. 40, both the H-NS and the Hlp protein 
were able to bind to all three promoter regions. H-NS exhibited the highest affinity to the 
kpsM (region 3) and ORF70 (region 2) promoters, whereas Hlp was binding to all promoter 
regions with equal affinities. 
Since we were mostly interested in possible synergistic effects of H-NS and Hlp, which might 
explain the phenotype of the hns/hlp double mutant, pre-incubated mixtures of H-NS and Hlp 
were also analyzed in the assay. No obvious differences in the band shifts of the kpsM- and 
ORF72 promoter fragments were detected with the protein mixtures (Fig. 40 B and C, 
respectively). Interestingly, the kpsF fragment shifted at much lower protein concentrations of 
the protein mixture (i.e. at 5.3 µM equimolar mixture) compared to the single proteins, where 
no binding was observed at the same concentration (Fig. 40 A). 
 
Fig. 40: Analysis of binding capacities of H-NS and Hlp to promoter regions of the K15 
determinant. Electrophoretic mobility shift assay. ~400-nt fragments upstream of kpsF (A; region1), 
kpsM (B; region3), and ORF72 (C; region2) were amplified by PCR and incubated with purified His-Hlp 
and/or H-NS protein in concentrations given below each lane. Mixtures of Hlp and H-NS were pre-
incubated prior to addition of the target DNA. 
These results indicate that the global regulator H-NS, as well as its homolog Hlp, affect the 
expression of the capsule determinant. Furthermore, it suggests, that the formation of 
heteromeric protein complexes between the H-NS paralogs might alter their DNA-binding 
properties. 
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Some enteric bacteria produce a second type of capsule, also known as M antigen. It consists 
of colanic acid, a negatively charged polymer of glucose, galactose, fucose, and glucuronic 
acid that forms a protective capsule surrounding the bacterial cell surface (Whitfield and 
Roberts, 1999). Colanic acid does not seem to be involved in urovirulence, since cps genes 
are generally not expressed at temperatures above 30 °C. 
Colanic acid biosynthesis is activated by the regulator RcsA, which itself is subject to 
repression by H-NS (Gottesman and Stout, 1991; Sledjeski and Gottesman, 1995). When 
screening our expression profiling data of the hns and hns/stpA mutants, however, we could 
not detect any derepression of the rcsA gene in H-NS-deficient strains. 
 
Fig. 41: Effect of lack of H-NS on expression of genes involved in colanic acid synthesis. Proposed 
pathway for biosynthesis of colanic acid; adapted after Stevenson et al. (1996). Genes with upregulated 
expression levels in the hns and hns/stpA mutant are depicted in bold. Fru = frucose; Fuc = L-Fucose; Gal = 
D-Galactose; GlcA = D-glucuronic acid; Glc = D-Glucose; Man = Mannose. 
Nevertheless, many genes involved in synthesis of the four building blocks were significantly 
upregulated (Fig. 41). This indicates, that lack of H-NS might – in an RcsA-independent 
manner - result in an increased amount of colanic acid polysaccharide on the cell surface. 
Finally, the effect of histone-like proteins on lipopolysaccharide (LPS) production was tested. 
LPS consists of immunogenic glycolipids, which, in contrast to capsular polysaccharides, are 
anchored in the outer membrane via the hydrophobic component lipid A, also known as 
endotoxin. The structure of LPS consisting of the lipid A moiety, the inner and outer core, and 
the O-specific side chains (O6 in UPEC strain 536), is depicted in Fig. 42 A. 
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Fig. 42: Analysis of lipopolysaccharide composition in strains deficient for histone-like proteins.  
(A) Schematic structure of LPS consisting of lipid A, core, and O-antigen; (B) Silver stain of LPS 
preparations from cells grown on plate. 
LPS of UPEC strain 536 and its isogenic mutants was purified and analyzed by denaturing 
polyacrylamide gelelectrophoresis (Fig 42 B). All strains exhibited a smooth LPS phenotype 
with no obvious differences in the O-specific side chains. Also, the total amount of LPS 
seemed to be unaffected by the mutations. The core and lipid A part, however, was altered in 
all H-NS deficient strains, with additional bands of higher molecular weight appearing on the 
gel. 
This result indicates that lipid A and the core region might be chemically modified in the 
absence of H-NS. The nature of these modifications was analyzed by Olga Ovchinnikova in 
the group of Prof. Otto Holst at the Division of Structural Biochemistry of the Leibnitz Center 
for Medicine and Biological Sciences in Borstel. The results are listed in Table 11. 
Table 11: LPS-composition of UPEC strain 536 wild type and isogenic hns mutant. 
 nmol component per ml molar ration (rel. to KdoAcP) 
Component LPS -wt LPS -∆hns LPS -wt LPS -∆hns 
KdoAcP 156 181 1 1 
KdoHCl 243 300 1.5 1.6 
P 1082 911 6.9 5.0 
C12:0 86 108 0.5 0.6 
C14:0 88 112 0.6 0.6 
3OH-C14:0 604 674 3.9 3.7 
C16:0 17 39 0.1 0.2 
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The only difference in LPS from the wild type and the hns mutant was the phosphate content. 
Wild type LPS seem to contain 7 phosphate residues, whereas LPS of the mutant only 
contained 5 phosphates. All other components, as well as the O-antigen and core composition 
did not exhibit any significant differences, as seen by 1H-NMR measurements. Nevertheless, 
no effect of H-NS on LPS synthesis is described in the literature to date. Therefore, the result 
of the 31P-NMR measurements might lead to the discovery of a so far unknown aspect of 
H-NS regulation. 
Alterations in LPS structure often result in an altered susceptibility towards chemical 
components, such as cationic antimicrobial peptides (Guo et al., 1998). Furthermore, changes 
in the extracellular polysaccharide might also affect immunostimulation or immunoevasion, 
reflected in serum resistance. 
Normally, UPEC strain 536 is resistant towards killing by human serum. Serum resistance in 
E. coli has been described to be associated with several surface structures (Johnson, 1991). 
Studies on survival rates of UPEC strain 536 and its mutants in human serum, however, 
revealed no significant differences (data not shown). Therefore, alterations of any of the 
surface structures by the lack of histone-like proteins did not seem to affect serum resistance. 
In summary, classical physiological tests confirmed the data obtained by expression profiling. 
It was shown that H-NS has a huge impact on the expression of most virulence factors of 
UPEC strain 536, acting mainly as a repressor. Therefore, mutants deficient for H-NS were 
highly hemolytic, hyper-fimbriated, very stress resistant but non-motile. Furthermore, hns 
mutants exhibited a different siderophore expression kinetic and capsule gene expression, as 
well as differences in lipopolysaccharide core phosphorylation. 
Since most of the known virulence factors of UPEC strain 536 are affected by H-NS, the 
combined effect for urovirulence of a strain lacking the global regulator cannot be predicted 
easily. Therefore, the pathogenic potential of the mutants was tested in the animal model. 
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5.3.3 Effect of H-NS on in vivo virulence 
The effects of a mutation of hns on in vivo virulence were studied in the mouse model. All 
experiments were performed by Gabor Nagy and György Schneider at the Institute of Medical 
Microbiology and Immunology of the University Medical School in Pécs, Hungary.  
Fig. 43 depicts the survival rates of mice infected intravenously at different dose rates; Fig. 44 
represents the results of a lung toxicity assay testing for α-hemolysin production. 
 
Fig. 43: Survival rates of mice infected with H-NS deficient strains. Groups of 10 mice were infected 
intravenously with UPEC strain 536 or its isogenic mutants in a dosis of either 109 CFU (A) or 108 CFU (B) 
(performed by G. Nagy; Pécs, Hungary). 
 
 
 
 
 
   Fig. 44: Time course of lethality induced 
by H-NS deficient strains. Mouse lung 
toxicity assay. Groups of 5 mice were infected 
intranasally with UPEC strain 536 and isogenic 
mutants (performed by G. Nagy; Pécs, 
Hungary)  
 
To summarize, H-NS deficient strains accelerated lethality when administered at a high 
infection dosis, which was a result of their increased acute toxicity in murine UTI and sepsis 
models. At lower infectious dose, however, the hns mutants were attenuated, probably due to 
their impaired growth rates. 
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5.3.4. Role of H-NS and its paralogs at different temperatures 
So far, only minor effects on gene expression were identified for the H-NS paralogs StpA and 
Hlp. Both proteins seem to modify the repressive effect of H-NS on expression of fimbriae. 
Furthermore, a distinct role of an H-NS/Hlp regulatory complex seems to exist for the 
expression of the K15 capsule determinant. 
Since expression levels of both hns and stpA were shown to be temperature-dependent, and 
since H-NS often mediates thermoregulation of some target genes, we also analyzed our 
mutants at different temperatures. Therefore, growth rates were assessed at a temperature 
range from 25 °C to 45 °C. 
Growth rates of the mutants at different temperatures 
Growth deficiencies of hns and hns/stpA mutants have been reported before (Sonden and 
Uhlin, 1996; Zhang et al., 1996). In UPEC strain 536, a similar growth rate of the hns and 
hlp/hns mutant was found compared to the wild type, despite a prolonged lag phase at 37 °C. 
The hns/stpA as well as the triple mutant exhibited a much longer generation time compared 
to the wild type (Table 12; section 5.3.5.). To study growth differences at various 
temperatures, mutants were grown on agar plates at 25 °C, 30 °C, 37 °C, and 45 °C.  
As expected, all H-NS-deficient strains formed smaller colonies than the wild type at every 
temperature (Fig. 45). 
 
Fig. 45: Growth of wild type UPEC strain 536 and its isogenic mutants at various temperatures.  
1 = 536 wt; 2 = 536 stpA; 3 = 536 hns; 4 = 536 hlp; 5 = 536 hns/stpA; 6 = 536 hlp/stpA; 7 = 536 hns/hlp 
At low temperatures, both the hns and the hns/stpA mutant exhibited a mucoid phenotype. 
The most interesting results, however, were obtained with the hns/stpA and hns/hlp double 
mutants. So far, both mutants behaved very similar for all factors tested. 
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Here, we found a clear difference in growth: the hns/stpA mutant had a severe growth defect 
at 45 °C, whereas the hns/hlp mutant still grew on plate, though in very tiny colonies. The 
opposite was true at 25 °C, where the hns/hlp mutant did not grow at all, but the hns/stpA 
mutant displayed a mucoid growth phenotype. The growth experiments were repeated using 
liquid cultures. The generation times determined from the growth curves confirmed the results 
obtained on agar plates (see Table 12 in section 5.3.5. and Fig. 53 in the appendix). Therefore, 
the influence of the H-NS homologs StpA or Hlp seems to vary with temperature. 
Expression of hns, hlp, and stpA at different temperatures 
To test, whether this influence of temperature is reflected in expression rates, RNA was 
extracted from 536 wild type cultures grown to mid-log phase at four different temperatures, 
and expression of hlp, hns, and stpA was determined by semi-quantitative RT-PCR (Fig. 46). 
As expected, expression of hns was cold-shock induced, resulting in higher transcript amounts 
at 30 °C compared to temperatures above 37 °C. However, at temperatures below 30 °C, hns 
expression was decreased again, therefore resulting in a clear peak at 30 °C. 
 
Fig. 46: Effect of temperature on transcript levels of hns, stpA, and hlp. (A) semi-quantitative RT-PCR 
for hns, stpA, and hlp transcripts; (B) quantitation of transcript amounts from the gel (relative to 37 °C). 
Expression of stpA increases upon temperature upshift (Sonden and Uhlin, 1996). We also 
found an increase in transcript amounts with increasing temperatures, resulting in highest 
stpA-mRNA levels at 45 °C. Finally, expression of hlp does not seem to change with 
temperature. 
Taken together, evidence was provided that the expression levels of hns, hlp and stpA strongly 
depend on growth temperature. Furthermore, the results obtained suggest that, due to these 
differences in expression levels, the composition of the nucleoid-associated protein pool 
might vary with changing temperature. 
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5.3.5. Summary – phenotypic characterization 
The results of all phenotypic tests for the expression of the major virulence factors of UPEC 
strain 536, as well as the results on growth rates are summarized in Table 12. 
Table 12: Summary of the phenotypic characterization of UPEC strain 536 and its isogenic mutants 
 536 wt 536 
stpA 
536 
hns 
536 
hlp 
536 
hns/stpA 
536 
hlp/stpA 
536 
hns/hlp 
536 hns 
/stpA/hlp  
Generation time at 37 °C 24 24 29 25 47 24 27 53 
(min)            at 25 °C 51 50 55 50 62 49 111 83 
at 45 °C 30 28 27 29 103 29 29 145 
bgl phenotype white white blue white blue white blue blue 
Motility + + - + - + - - 
Fimbriation     - P-pili + + +++ + ++ + +++ ++ 
                       - S-pili + + ++ + +++ + ++ +++ 
Hemolytic activity (units) 14 15 85 14 76 18 127 70 
Siderophore kinetic slow slow fast slow fast slow fast fast 
Autoaggregation - - + - ++ - +++ +++ 
Curli expression at 37 °C - - - - - - ++ ++ 
                       - at  RT + + - + - + - - 
Cellulose expression + + + + + + ++ ++ 
K15 capsule expression + + + + + + ++ ++ 
LPS core normal normal mod. normal mod. normal mod. not tested 
Serum resistance + + + + + + + + 
To summarize, UPEC strain 536 encodes three histone-like proteins, namely the global 
regulator H-NS, its paralog StpA, as well as the newly identified protein Hlp. Using 
expression profiling and classical phenotypic assays, H-NS was shown to affect expression of 
all major virulence factors of UPEC strain 536, acting mainly as a repressor. However, its role 
for in vivo virulence remains ambiguous. The H-NS paralogs on the other hand play only a 
minor role in this regulation, probably only by modifying H-NS function. Nevertheless, a 
distinct requirement for Hlp or StpA at low or high temperatures could be identified, which is 
reflected in their temperature-dependent expression rates. 
Therefore, these results propose that the biological role of Hlp (and StpA) does not rely on 
distinct function of the single protein, but rather on its interactions with the global regulator 
H-NS in a highly flexible pool of histone-like proteins. 
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6. Discussion 
In this study, the role of histone-like proteins on virulence of uropathogenic Escherichia coli 
was explored. The central question of this work was, whether regulatory cross-talk does exist 
between horizontally acquired pathogenicity islands, which encode many virulence factors as 
well as regulatory proteins, and the “core” chromosome, which is controlled by a well 
established cellular regulatory network. 
Since pathogenicity islands represent upon their acquisition “foreign” DNA to the cell, a 
functional regulation of the encoded gene products is a prerequisite for a stable maintenance 
in the chromosome. Moreover, especially virulence-associated genes are usually tightly 
regulated. The focus of the first part of the Discussion will be on the effects of the global 
regulatory protein H-NS, whose unique structure and effects on the architecture of the 
chromosome – all of which are exerted by relatively sequence-unspecific DNA-binding – 
render it a possible candidate for regulation of pathogenicity island-encoded genes. 
6.1. H-NS and virulence 
The role of the histone-like nucleoid structuring protein H-NS for virulence was assessed by 
using expression profiling, as well as classical phenotypic tests and in vivo experiments. It 
was the first time that a pathogenic E. coli strain was subjected to such a large scale 
monitoring including all its known virulence factors. Furthermore, the use of a specific 
pathoarray enabled the identifcation of some previously unknown members of the H-NS 
regulon encoded on the pathogenicity islands of UPEC strain 536. Thus, it was proven that 
H-NS is playing a major role in the regulation of this extragenetic material, thereby linking 
PAI-encoded gene expression to the cellular regulatory network. 
H-NS was found to be a global regulator in UPEC strain 536, affecting transcription of more 
than 500 genes, among them all classical virulence factors tested. Mutants deficient for H-NS 
expressed more fimbriae and hemolysin and differed in their siderophore expression kinetic. 
Furthermore, these mutants were non-motile and showed increased resistance to high 
osmolarity. These results suggested some benefits for the hns mutant for in vivo virulence:  
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Increased production of adhesins has undoubtable effects inside the host. For instance type 1 
fimbriae were shown to play a major role in the in vivo colonization process of the mouse 
urinary tract (Snyder et al., 2004). In our strain, however, we could not find an upregulation 
of the fim operon. This is probably due to the shaking growth conditions in vitro. 
Nevertheless, H-NS affected expression of both recombinases fimB and fimE, thereby leading 
to a rapid phase switching in the mutants, as described by Olsen and Klemm (1994). The 
consequences for the in vivo situation still need to be assessed. 
For the other two major fimbrial adhesins, the effects of H-NS were more clear. Using the 
E. coli pathoarray, the mechanism of regulation of the sfa determinat could be analyzed: 
Repression by H-NS acts on the transcription directed by both the sfaB and sfaA promoter, 
resulting in derepression of the activator SfaB and the structural genes in the hns mutant. The 
SfaB protein itself is activating both the sfaC and sfaB promoter, thereby further enhancing 
transcription of the structural genes. For the P-related fimbriae, we could not demonstrate an 
increased transcription of the structural genes on the array, even though the protein levels 
were strongly increased in the mutant. Interestingly, only the prfX gene, which encodes a  
putative regulator of the prf operon, was significantly upregulated at the transcriptional level. 
Therefore, one could speculate, that one of the effects exerted by H-NS might be indirect by 
decreasing the expression of PrfX, which then would activate the prf structural genes. 
Moreover, regulatory cross-talk between both types of fimbriae exists: the regulators of both 
gene clusters, SfaC, SfaB, PrfB, and PrfI are highly homologous and can complement each 
other (Morschhäuser et al., 1994). Therefore, upregulation sfaB in the hns mutant might also 
indirectly result in activation of the prf operon. Despite all speculation about the mechanism, 
increased amounts of fimbrial protein on the cells, as seen by AFM, presumably contributed 
during the first stages of infection by virtue of increased adhesion to the urothelium. 
Another important factor for colonization is the acquisition of iron. To date, no H-NS-
dependent regulation of iron-uptake systems has been reported. In this study, we now 
demonstrate that the effects on the five iron-uptake systems of UPEC strain 536 are divergent: 
H-NS is playing both an activating and a repressing role, as seen e.g. for the chuA and iroN 
genes encoding the hemin receptor and the salmochelin receptor, respectively. Furthermore, 
the regulatory effects seem to be restricted to the receptor-encoding genes and do not include 
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Under inducing conditions, the total amount of secreted siderophores was the same in the wild 
type and the mutants. Because of the altered kinetic in the mutant, however, one could 
speculate that the composition of siderophores differs from the wild type. For instance, the 
upregulation of a siderophore with a high affinity for iron in the hns mutant could explain the 
faster decrease in absorbance due to siderophore-mediated iron sequestration as detected in 
the photometric assay. This hypothesis is supported by the finding that both yersiniabactin 
and salmochelin, the siderophores with the highest binding constants, are the ones which were 
produced in higher amounts in the mutants. 
Finally, another aspect of the role of H-NS on virulence and fitness of UPEC strain 536 is 
stress resistance. Numerous genes involved in osmoprotection and acid resistance, as well as 
multidrug resistance, were upregulated in the hns mutant. The array data obtained in this 
study could be confirmed by demonstrating a more than 10 times higher survival rate of the 
mutant at high osmolarity, as it has already been described in E. coli K-12 (Hommais et al., 
2001). These results suggest that H-NS plays a major role in the adaptation to various stress 
situations like high osmolarity and low pH. Since uropathogenic bacteria are even more likely 
to be confronted with these stress conditions during colonization of the urinary tract than 
commensal variants living in the gut, these findings are of particular importance. 
Despite all these assumed advantages of hns mutants, an ambiguous role of H-NS in 
uropathogenesis was revelaed by experimental animal models of UTI and sepsis: At an 
infective dose highly exceeding the LD50 values, lack of H-NS resulted in accelerated lethality 
in both the UTI and the sepsis model. This was probably due to the increased α-hemolysin 
production in the hns mutants. An increased production of α-hemolysin in strains deficient for 
H-NS is already described in E. coli K-12 (Nieto et al., 2000). These results could also be 
confirmed in UPEC strain 536 by both RT-PCR and a liquid assay. Interestingly, an 
upregulated expression of the hemolysin repressor Hha was found as well. This protein 
exhibits a similar structure to H-NS and is therefore able to form heteromers. This result 
confirms that Hha alone is not able to mediate repression of the hemolysin operon, but in 
contrast, a functional H-NS/Hha complex is required (Nieto et al., 2000). Supporting this 
hypothesis, inactivation of hns resulted in a significantly higher in vivo toxicity in the α-
hemolysin-dependent mouse lung assay. This emphasizes the importance of cytotoxicity for 
urovirulence and is also reflected in the finding that more than 50 % of all extraintestinal 
pathogens are hemolytic (Ludwig and Goebel, 1991). 
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In addition to α-hemolysin, some enterobacteria express another type of pore-forming toxin, 
namely ClyA (also known as SheA or HlyE), which could also contribute to the hemolytic 
phenotype (Oscarsson et al., 1999).. This hemolysin determinant even can be found in non-
pathogenic E. coli K-12. Here, it remains phenotypically silent under most tested laboratory 
conditions. On the other hand, expression of the clyA gene  can be induced for instance in hns 
mutant strains (Gomez-Gomez et al., 1996; Uhlin and Mizunoe, 1994), thereby indicating, 
that H-NS is one of the factors that keeps the gene silent in E. coli K-12. However, in UPEC 
strain 536 as well as in most other uropathogenic isolates, a large portion (217-bp) of the clyA 
gene was found to be deleted (Kerenyi et al., 2005; Ludwig et al., 2004). Therefore, we 
assume that the α-hemolysin is solely mediating the hyperhemolytic phenotype of the hns 
mutants. 
Coming back to the urovirulence data, no significant difference in the virulence of hns 
mutants in the UTI model could be shown in comparison to the wild type strain. Moreover, 
when injected intravenously, lack of H-NS significantly reduced lethality in mice. This 
attenuation could have several reasons. The first is the complete loss of motility in H-NS-
deficient strains. However, in a recent study, Snyder and co-workers (2004) demonstrated for 
the UPEC isolate CFT073, that flagella is not needed for a successful colonization of the 
murine urinary tract. Therefore, the lack of motility does not imply a disadvantage for the 
mutants during infection in this model. 
Secondly, and even more important, one has to take into account the impaired growth rates of 
hns mutants. Although usually not considered to be a classical virulence characteristic, the 
optimal rate of bacterial replication in vivo might highly influence the outcome of an 
infection. It is hypothesized that slower growth of the hns mutants could be compensated by 
upregulation of various “classical” virulence factors. Reaching the blood stream, however, 
bacteria have to face the defence mechanisms of the immune system, which could only be 
overcome through rapid bacterial growth. Since the role of the upregulated virulence factors 
seems to be minor within the blood stream, hns mutants become attenuated compared to their 
wild type strain. These observations emphasize the role of house-keeping genes in bacterial 
fitness, which is a prerequisite for virulence. The impact of H-NS on virulence appears to be 
divergent along the infectious process. Nevertheless, a role for H-NS in virulence regulation 
is without doubt. 
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Another aspect of the influence of H-NS on virulence traits, which has not been reported so 
far, is the effect on the lipopolysaccharide. When analyzing lipopolysaccharide, modifications 
of the core fragments were detected in the LPS preparations of H-NS deficient strains as seen 
on polyacrylamide gels. In some preparations, these fragments were also found in the wild 
type, but never to the same extent as in the mutants. This suggested, that the LPS core might 
be chemically modified in absence of H-NS. 
When searching the literature for known mechanisms of LPS modifications, several scenarios 
can be imagined. The first scenario involves the alternative acyltransferase LpxP. During 
synthesis of “normal” lipid A, the lauroyl-acyltransferase LpxL catalyzes the addition of 
laureate to Kdo2-Lipid IVA precursors. At low temperatures, however, the acyltransferase 
LpxP is induced, which uses the same substrate as LpxL, but catalyzes incorporation of the 
unsaturated fatty acid palmitoleate instead of laureate (Carty et al., 1999). The resulting 
“cold-adapted” lipid A helps to maintain membrane fluidity at low temperatures, and also 
exhibits decreased permeability to antibiotics such as rifampicin and vancomycin (Vorachek-
Warren et al., 2002). Since H-NS itself is part of the cold-shock regulon, a role in regulation 
of lpxP would not be too unlikely. According to the data from expression profiling, however, 
expression of lpxP was only mildly induced in the hns/stpA mutant. 
The second scenario involves the PhoP-PhoQ two-component system. In Salmonella 
typhimurium, this system was shown to affect more than 40 genes, including some genes 
involved in lipid A modifications (Guo et al., 1997). Among them, the pagP gene, also known 
as crcA, was identified. The PagP protein catalyzes transfer of an additional palmitate from a 
phospholipid to lipid A, thereby resulting in hepta-acylated lipidA instead of the “normal” 
hexa-acylted lipid A (Gronow and Brade, 2001; Guo et al., 1998). This modification increases 
the resistance to cationic antimicrobial peptides such as polymyxin, probably by decreasing 
membrane fluidity. Activation of the PhoP-PhoQ system also induces another two-component 
system involved in polymyxin resistance, PmrA-PmrB, which in turn activates genes of the 
yfb or pmr operon, encoding a 4-amino-4-deoxy-L-arabinose (L-Ara4N) transferase YfbF, as 
well as the ugd (also known as pagA or pmrE) gene (Gunn et al., 1998). The latter encodes a 
UDP-glucose-dehydrogenase, which, like YfbF, induces addition of aminoarabinose or 
ethanolamide to the lipid A moiety, thereby also increasing polymyxin resistance. 
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In UPEC strain 536, the expression pattern of hns mutants revealed increased expression of 
pagP, udg, as well as the yfb operon. When analyzing LPS preparations of pagP, ugd, and 
yfbF mutants, respectively, in an hns+ and hns- background, however, no differences in 
presence or absence of H-NS could be observed (data not shown). All possible pathways for 
lipid A modifications are summarized in Figure 47. 
 
Fig. 47: Model for PhoP-PhoQ induced lipid A modifications due to lack of H-NS. All genes and 
operons known to be involved in modification of lipid A, as well as the expression ratios in the hns mutant of 
UPEC strain 536 derived from expression profiling are summarized in the graph. 
Analysis of the LPS composition in Borstel also did not confirm any of the lipid A 
modifications mentioned before. Instead, the LPS of the hns mutant differed from the wild 
type only in the number of phosphate residues. This could be the result of either increased 
expression of a specific phosphatase or decreased expression of a kinase in the mutant. When 
screening the array data, expression of several kinases/phosphatases was deregulated in hns 
mutants. However, none of them was known to be involved in LPS phosphorylation. 
Lipopolysaccharide, together with other factors, also affect survival rates of bacteria in human 
serum. However, significant changes in serum resistance of UPEC strain 536 after mutation 
of any of the histone-like proteins could not be detected. 
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6.2. Identification of H-NS and H-NS/StpA dependent regulons 
So far, all changes in expression of virulence-associated genes seemed to be solely dependent 
upon the lack of H-NS. The paralogous protein StpA did not seem to be important in the 
context of virulence. However, the expression patterns of the hns single mutant and the 
hns/stpA mutant differed in many other genes, especially those of the core genome. Therefore, 
the data obtained suggest the existence of two different regulons: one subset of genes is 
regulated by the H-NS protein alone, whereas a second group seems to be regulated by a 
concerted action of H-NS and StpA. 
It has been shown earlier that H-NS can exist as homodimers or as a heteromer together with 
StpA (Johansson et al., 2001; Sonden and Uhlin, 1996), and a distinct function for each 
complex has been proposed. By using DNA arrays, it was possible to identify some of the 
target genes of the two types of DNA binding complexes. In keeping with the above 
mentioned hypothesis, three different scenarios could be expected: 
First, there are those genes, which are commonly regulated in both mutants, i.e. 248 genes of 
the E. coli K-12 core-genome as well as the virulence-associated genes on the E. coli 
pathoarray, which are regulated by a H-NS/StpA heteromeric complex. This group also 
contains genes, which are repressed by H-NS, and where StpA cannot substitute for this 
function in absence of H-NS. 
The second group comprises genes, which were only deregulated in the hns/stpA double 
mutant. These genes, again, are normally regulated by the H-NS protein alone, but on such 
cases, StpA might complement for H-NS function in the hns single mutant. 
Finally, there are those genes, which are deregulated in the hns single mutant only. This cannot 
be explained by a regulation at the transcriptional level. Regulation by StpA, which is 
complemented by H-NS in the stpA single mutant, is not a very likely explanation. The 
expression level of stpA is too low to repress all 303 genes at the same time, even if they are 
part of an operon, such as genes encoding ribosomal proteins. Furthermore, these genes are 
proven to be regulated by H-NS and not StpA, as described by several authors (Afflerbach et 
al., 1998; Tippner et al., 1994). One possible explanation for this phenomenon is StpA acting 
at the post-transcriptional level due to RNA chaperon activity. In this context, Zhang and 
co-workers (1996) suggested a role of StpA for mRNA folding. 
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If some transcripts of other regulators (for instance the small RNA DsrA, wich was shown to 
counteract H-NS) are affected by StpA in their conformation and activity, absence of StpA 
could have indirect effects on H-NS regulated genes. Possible regulatory loops are summarized 
in Fig. 47. A similar classification was proposed by Zhang et al. (1996), who could also detect 
distinct protein pattern of hns and hns/stpA mutants of strain M182 by two-dimensional 
gelelectrophoresis. However, the differentially regulated proteins were not characterized. 
Altogether, it demonstrates the variety of possible interactions between the two DNA-binding 
proteins and the complexity of the regulatory network. 
6.3. Characteristics of the novel H-NS-like protein Hlp 
In this study, evidence was provided that uropathogenic Escherichia coli strain 536, in 
addition to the nucleoid-associated proteins H-NS and StpA, encodes a third member of the 
H-NS-like protein family, designated Hlp. The gene coding for Hlp and its correspondent 
product have been characterized. 
6.3.1. The hlp gene 
The gene coding for Hlp is located on a putative genomic island inserted into the serU locus. 
The insertion is about 23-kb in size and encodes 27 putative ORFs. A highly homologous 
serU-island has been characterized in UPEC strain CFT073 by Williamson and Free (2005). 
In addition to the Hlp protein (or H-NSB in UPEC strain CFT073), a truncated H-NS protein 
termed H-NST is present on the island. Unlike in EPEC strain E2348/69, where this truncated 
form is able to inhibit the repressive function of H-NS, the truncated H-NST protein of 
uropathogenic E. coli does not exhibit any anti-H-NS function (Williamson and Free, 2005). 
Nevertheless, it is a proof of principle that many regulatory proteins are encoded on mobile 
DNA, which can be acquired by horizontal gene transfer. There are many examples for 
members of the H-NS-like family encoded on such acquired genetic material. For instance, 
the Ler protein is encoded on the LEE pathogenicity island of enteropathogenic E. coli 
(Haack et al., 2003), whereas the Sfh protein of Shigella is located on a large plasmid (Beloin 
et al., 2003). All these proteins, including Hlp, are believed to fulfill a major role in the 
interplay between factors involved in regulation of genes present on the core genome and on 
the horizontally acquired DNA, therefore being of special importance for gene regulation in 
these bacteria. 
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When screening other pathogenic E. coli variants for the presence of the hlp gene, it was 
mainly present in extraintestinal pathogenic isolates from urinary tract infections, sepsis or 
newborn meningitis, but also in many faecal isolates. Since the faecal flora is considered to be 
the main reservoir for uropathogenic E. coli, tight associations and even gene transfer events 
between the pathogens and the faecal strains are very likely. However, no correlation with a 
specific serotype could be made. Therefore, the origin of the hlp gene still remains unclear. 
Nevertheless, the presence of the gene in so many different pathotypes suggests, that the 
acquisition of the hlp gene was not a recent event. On the other hand, the occurence of Hlp in 
non-pathogenic faecal isolates would imply, that the protein is not associated with virulence. 
However, the presence of the gene itself in the PCR-positive strains does not infer a 
functional protein. In the fecal E. coli isolate Nissle 1917 (EcN), for instance, sequence 
analysis of an unaligned contig revealed, that the hlpEcN gene carries two single base deletions 
of alanine residues at positions 61 and 96, resulting in frameshift mutation relative to UPEC 
strains 536 or CFT073, and thereby in a non-functional protein. 
6.3.2. The Hlp protein 
The Hlp protein of UPEC strain 536 is predicted to be very similar to the H-NS protein, both 
in size and in charge. Unlike StpA, which is much more basic, the theoretical pI of Hlp and 
H-NS are almost identical. The N-terminus of all three proteins is predicted to be mostly 
α-helical. For the H-NS protein, this prediction was confirmed by NMR spectoscropy (Bloch 
et al., 2003; Esposito et al., 2002), and was shown to mediate oligomerization by coiled-coil 
formation (Renzoni et al., 2001). The linker region (residues 63 to 79) is not conserved and 
shows a variable structure. The C-terminus, on the other hand, is supposed to be highly 
conserved between H-NS-like proteins. DNA-binding, however, happens at two loop 
structures at residues 80 to 96, and 110 to 117, which can not be accurately predicted in the 
Hlp protein. 
Nevertheless, a similar two-domain structure of Hlp can be proposed, with a C-terminal 
DNA-binding domain and an N-terminal oligomerization domain, connected by a flexible 
linker. The C-terminus of Hlp also contained the proposed core DNA-binding motif 
TWTGQGRTP (Dorman et al., 1999), and gel shift experiments confirmed, that Hlp has 
DNA binding capacity. Any additional RNA binding activity, as seen for StpA, and to a lesser 
extend also for H-NS, was not assessed in this study, but cannot be excluded.  
6. Discussion 
 
134 
 
Homology between Hlp and H-NS is highest in the N-terminal oligomerization domain, even 
higher than between H-NS and StpA. Thus, it was not very surprising to find Hlp in 
heteromers with H-NS. For StpA, it was even shown that the heteromer is the biological 
relevant form of the protein (Johansson et al., 2001). This is corroborated by the instability of 
homomeric StpA due to proteolytic degradation by the Lon protease (Johansson and Uhlin, 
1999). In the presence of H-NS, both proteins interact via two distinct domains of the H-NS 
protein, thus masking the proteolytic site of StpA. Degradation is inhibited by a single amino 
acid exchange from phenylalanine to cysteine at position 21 of the StpA protein. In contrast to 
StpA, the residue at position 21 in Hlp is threonine, thereby resulting in a more hydrophilic 
“area”. This might also be the reason for the unsusceptibility of Hlp to the protease, since no 
degradation of Hlp was observed in the absence of H-NS. 
6.3.3. Hlp activity 
Histone-like proteins are not only interacting at the protein level, but also at the 
transcriptional level. It has been described that both H-NS and StpA are subject to negative 
auto- and cross-regulation (Falconi et al., 1993; Sonden and Uhlin, 1996; Ueguchi et al., 
1993). The results obtained in this study from semi-quantitative RT-PCR confirmed this 
finding as derepression of hns transcription was detected in the stpA mutant and vice versa. 
Furthermore, electrophoretic mobility shift assays provided evidence, that this repressive 
effect relies on specific binding of the protein to the promoter sequences. 
 
Fig. 48: Model for network of negative cross-regulation by histone-like proteins. 
Current model based on the results of both semi-quantitative RT-PCR and promoter-binding 
studies, not including negative auto-regulation of hns, stpA, and hlp. 
When analyzing cross-regulatory activity of the Hlp protein, strong binding to its own and 
also to the hns promoter was found, thus confirming auto- and cross-regulatory activity. This 
was also reflected in the predicted curvature of the hlp upstream region, which is AT-rich and 
intrinsically curved, thus rendering it a potential target for H-NS binding. Binding of Hlp to 
the stpA promoter, on the other hand, only occurred at high protein concentrations. 
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Together with the finding, that stpA and hlp expression was not induced in hlp and stpA 
mutants, respectively, these results suggest that no or only weak cross-regulation between the 
two H-NS homologs exists. Therefore, a cross-regulatory network of histone-like proteins can 
be proposed as presented in Figue 48. 
Complementation studies with Hlp of UPEC strain 536 expressed from a low copy number 
vector in E. coli K-12 also served to prove the in vivo activity of Hlp. It restored motility of an 
hns mutant and was able to repress the hemolysin clyA, as well as the bgl and proU operons. 
When monitoring binding activities of Hlp to clyA by electrophoretic mobility shift assay as 
described by Westermark et al. (2000), no specific binding could be detected with the Hlp 
protein alone. On the other hand, addition of small amounts of H-NS resulted in specific 
DNA-protein complexes, thereby suggesting possible effects of Hlp on clyA. However, since 
no functional ClyA protein is expressed in UPEC strain 536, this effect is of less significance 
in wild type cells. 
Repressive effects of H-NS homologs on the bgl and proU operons have been reported 
before. Sonden and Uhlin (1996) showed that over-expressed StpA is able to repress both 
operons in absence of H-NS. In the experiments performed in this study, Hlp was acting as a 
repressor even when expressed from a low-copy number plasmid only. In case of the bgl 
operon, this repressive effect was independent from the presence or absence of StpA, since 
both hns single and hns/stpA double mutants, when complemented with Hlp, were white on 
X-Glu plates (data not shown). However, since an hns- hlp+ mutant of UPEC strain 536 still 
was blue on this plates, it can be assumed, that Hlp in its normal abundance in the cell is not 
sufficient for repression of the bgl operon. 
Interestingly, proU expression was also derepressed in the hns+ wild type strain harbouring 
the hlp-plasmid. The level of derepression was the same as seen for the hns mutant 
transformed with the vector control. One possible explanation for this observation would be 
an inhibition of H-NS-mediated repression in presence of the recombinant Hlp protein. 
Anti-H-NS factors are not uncommon. The effects of cAMP-CRP on H-NS-mediated 
silencing of the bgl operon have already been described in the introduction. Moreover, 
recombinant expression of the recently identified truncated H-NS protein encoded on the 
serU-island in enteropathogenic E. coli resulted in the same derepression of proU in presence 
of H-NS (Williamson and Free; 2005). 
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This truncated version consists only of the oligomerization domain of H-NS, therefore lacking 
DNA-binding activity. It is believed, that such truncated proteins interact with the 
oligomerization domain of H-NS, thereby preventing any higher order multimerization, which 
is for instance required for transcriptional silencing (see section 2.3.2.). Therefore, such 
“oligomerization-inhibitors” can act in a dominant-negative manner on H-NS repression.  
Lastly, a positive effect of Hlp was observed on growth of an hns/stpA double mutant, which 
normally grows only slowly compared to the wild type. However, the growth curve of the 
complemented strain resembled more that of an hns mutant, and no complementation was 
observed in the hns single mutant. These results suggest, that, in terms of growth, the Hlp 
protein is complementing the lack of the StpA protein rather than of H-NS, and that the 
presence of StpA is already mediating all feasible growth restoration in an hns mutant. 
6.4. Biological function of the H-NS paralogs 
Despite the observed ability of the Hlp protein to repress its own transcription and that of hns, 
as well as the ability to complement for the lack of H-NS in E. coli K-12, a clear phenotype of 
an hlp mutant in UPEC strain 536 could not be identified. Like the stpA single mutant, an hlp 
mutant did not differ from the wild type in all classical phenotypic tests. These results suggest 
that both Hlp and StpA are dispensible under this growth condition. However, the differences 
in the expression pattern of the hns/stpA mutant relative to that of the hns single mutant 
corroborate a biological activity of the H-NS/StpA heteromeric complex and suggest the 
existence of distinct target genes for H-NS and H-NS/StpA (see Fig. 50). 
Moreover, some obvious differences between the hns/stpA and the hns/hlp mutants were 
found, which will now be discussed in detail. 
6.4.1. Fine-tuning of fimbrial gene expression 
The presence or absence of StpA seemed to have a modulating effect on derepression of S and 
P pili in hns mutants. The upregulation of S pili in absence of H-NS was more pronounced in 
strains also lacking StpA, whereas the opposite was true for the P pili. One possible 
explanation would be that StpA might assume some repressive activity on the sfa determinant 
when H-NS is absent. Therefore, maximal expression of S pili would only occur in strains 
lacking both repressors H-NS and StpA. Since P and S pili are oppositely expressed due to 
regulatory cross-talk (Morschhäuser et al., 1994), this assumption might also account for the 
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decreased expression of P pili in the same mutants. Despite the speculation about the exact 
mechanism, we propose that StpA and/or Hlp have a modulating function on the effect of H-
NS, e.g. resulting in fine-tuned cross-regulation of fimbrial adhesins 
6.4.2. Alteration in surface structure and extracellular substances 
One striking phenotype of hns/hlp double mutants is their mucoid colony morphology on 
plate. There are various possible factors, which could account for this finding: 
Capsular polysaccharide.  A distinct role of an H-NS/Hlp complex in the regulation of the 
K15 capsule determinant was found in strains lacking H-NS and Hlp. Both proteins were 
binding to upstream sequences of all three regions of the K15 capsule determinant, but only 
binding to region 1 seemed to be cooperative. Mixtures of H-NS and Hlp had a much higher 
binding affinity to the kpsF promoter than had the single proteins. Furthermore, comparison 
of relative transcript amounts in various mutants by semi-quantitative RT-PCR revealed that 
expression of region 1 genes only was upregulated in mutants lacking both H-NS and Hlp. 
Transcription of region 2 and 3 genes, on the other hand, seemed to be slightly downregulated 
in these strains. This might be due to different functions of the Hlp protein: Regarding 
region 1 genes, the results from gel shift analysis strongly suggest, that a heteromeric complex 
of H-NS and Hlp is the active repressor, resulting in an upregulated expression of these genes 
in hns/hlp mutants. However, since both proteins are also able to bind in absence of its 
interaction partner – even though at lower affinities – this might indicate that H-NS, as well as 
Hlp, can act as a repressor of their own, thereby resulting in similar expression levels in the 
single mutants as in the wild type. For region 2 and 3 genes, no cooperative binding of H-NS 
and Hlp was detected, but still, both proteins interacted with the promoter regions. Therefore, 
the mechanism that leads to a downregulated expression in the hns/hlp mutants only is still 
not clear and needs further investigation. 
To date, only little data on the effects of H-NS on capsule biosynthesis is available. Rowe et 
al. (2000) reported, that H-NS is required for maximal expression of the K5 capsule 
determinant at 37 °C, whereas at 20 °C, H-NS acts as a repressor. For the K15 capsule, no 
such effect of H-NS could be detected. The hns single mutant did not differ from the wild 
type at 37 °C, which might be the result of compensatory effects of Hlp in the pathogenic 
strain. However, regulation of the K15 determinant seems to be more complex, depending on 
both regulators H-NS and Hlp. 
6. Discussion 
 
138 
 
Outer membrane proteins.  Theoretically, most changes in the amount of extracellular 
substances should also require changes in their transport systems, as seen for the hemolysin 
transporters HlyB and HlyD, or for the capsule transporter KpsE and KpsF. Therefore, 
alterations in the composition of other outer membrane components can not be excluded. 
Landini and Zehnder (2002) found drastic differences in the composition of outer membrane 
proteins in an hns mutant compared to the wild type. For instance, the porins LamB, OmpF, 
Tsx, and OmpX were present in lower amounts in the mutant, while two other porins, OmpN 
and OmpA, were more abundant. According to the array data obtained in this study, we could 
confirm a significantly downregulated expression of lamB and tsx in both the hns and the 
hns/stpA mutants, whereas ompX expression turned out to be elevated in our strain 
background. The gene coding for the porin OmpT exhibited the strongest upregulation in the 
hns mutant, with an 30-fold increased expression compared to the wild type. In total, 
expression of more than 100 genes assigned to the functional group of transport and 
membrane proteins was altered in the hns mutants. 
Curli and cellulose production.  There are indications for alterations of other surface 
structures than porins. As observed in the Congo Red-binding assay, hns/hlp mutants were 
dark brown even at 37 °C, where no curli fimbriae are produced in the wild type. Relieved 
expression of curli fimbriae in hns mutants grown at 26 °C has been described before (Olsen 
et al., 1993a; 1993b). In UPEC strain 536, however, both Hlp and H-NS seem to be able to 
repress curli expression. Semi-quantitative RT-PCR for the major curli subunit gene csgA 
confirmed this result, and at the same time indicated an increased expression of the cellulose 
synthesis activator-encoding gene yaiC in these mutants. Therefore, the production of curli 
fimbriae and cellulose might also contribute to the mucoid phenotype of strains lacking both 
H-NS and Hlp. 
6.4.3. Effect on growth rates 
Finally, we found differences in the requirement for the H-NS paralogs for normal growth 
depending on temperature. H-NS and StpA seemed to be indispensable at elevated 
temperatures, whereas the presence of H-NS together with Hlp was required at low 
temperatures. This differences in requirement for growth was reflected in the expression 
levels of the various nucleoid-associated proteins, which will be discussed in the next section. 
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6.5. Temperature-dependent expression of histone-like proteins 
When comparing transcript amounts of hlp, hns, and stpA at various growth conditions, a 
clear difference in temperature-dependent expression was found. Expression of hns is cold-
shock induced, due to the action of the major cold-shock protein CspA (La Teana et al., 
1991). Elevated hns transcript amounts could be detected at 30 °C compared to 37 °C. 
However, at temperatures below 30 °C, hns expression was decreased again, which has to be 
explained by additional factors not present in E. coli K-12. Expression of stpA increases upon 
temperature upshift (Sonden and Uhlin, 1996). In UPEC strain 536, almost any stpA transcript 
could be detected at low temperatures. However, the increase in expression level with 
increasing temperatures was clearly visible, resulting in fairly high stpA-mRNA levels at 
45 °C. Finally, expression of hlp does not seem to change with temperature, or might, to a low 
extent, be reciprocally regulated to stpA. This could also be the missing factor for decreased 
expression of hns at 25 °C compared to 30 °C, since the elevated levels of Hlp at low 
temperatures would result in increased repression of H-NS by Hlp. 
Referring now to the relative expression levels of each of the proteins, and assuming 
H-NS/Hlp or H-NS/StpA heteromers only, the following model of a temperature-dependent 
composition of the nucleoid-associated protein pool is proposed (Fig. 49). 
 
Fig. 49: Model for temperature-dependent composition of the pool of H-NS-like proteins. The 
model results from studies on expression levels of hns, stpA, and hlp at various temperatures, and assumes 
only H-NS /StpA or H-NS/Hlp heteromers. See text for further details. 
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At lower temperatures (25 °C), only little H-NS protein is present, and even lower levels of 
StpA. Therefore, Hlp will be preferentially found in heteromers with H-NS, which is the 
limiting factor in formation of stable complexes. Thus, H-NS/Hlp heteromers would be the 
biological active form required for normal state of the cell at low temperatures. Therefore, an 
hns/hlp double mutant would grow only poorly at 25 °C, as it was observed on agar plates and 
in liquid broth (Fig. 53; Table 12). 
At normal temperature of 37 °C, expression of both hns and stpA is elevated compared to 
25 °C, while the amount of hlp stays the same. As a consequence, the occurrence of 
H-NS/StpA heteromers in addition to the H-NS/Hlp complexes would be expected first, and 
secondly, free H-NS homodimers would occur due to an excess of H-NS protein. Here, the 
H-NS dimers would be of biological relevance. However, as seen in hns mutants, StpA 
(and/or Hlp) can substitute for some of the functions of the absent H-NS dimers. 
Finally, at even higher temperatures of 45 °C, stpA expression reaches high enough levels to 
render H-NS/StpA heteromers the prevalent form (maybe even dislodging Hlp from the H-NS 
N-terminus). Again, H-NS is the limiting factor for heteromeric interactions, and here, an 
hns/stpA double mutant is supposed to grow slowly. 
Of course, this model is only speculative. Other factors like compensating abilities of each 
paralog, degradation of free monomers by proteases, and differences in oligomerization 
abilities have to be taken into account. However, the model illustrates, how differential 
expression of only three genes can result in a variable outcome of regulatory complexes and 
expression of their target genes. 
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6.6. Implications and Outlook 
In this study, the question was addressed, whether there is regulatory cross-talk between 
pathogenicity island-encoded virulence factors or regulatory proteins, and the core 
chromosome, which is controlled by a pre-established regulatory network. The global 
regulator H-NS was found to affect the expression of many PAI-encoded virulence-associated 
genes in uropathogenic E. coli strain 536, thereby linking PAIs to the cellular regulatory 
network. Moreover, a third member of the H-NS-family, the Hlp protein, which is encoded on 
a putative genomic island, was found to be able to interact with H-NS both at the 
transcriptional, as well as at the protein level, thereby having successfully insituated itself into 
the cellular regulatory network. 
Thus, the answer to the central question of this thesis is positive, in the meaning that there 
indeed is regulatory cross-talk between pathogenicity islands and the core chromosome. 
This suggests, that acquisition of novel global regulators alter the entire global regulatory 
programm of the cell. However, the exact mechanisms of this modulation remains unclear. 
Johansson et al. (2001) proposed, that C-terminal interactions between histone-like proteins 
might alter their DNA-binding ability and cause a change in the DNA motif that is 
recognized. Thus, H-NS/StpA or H-NS/Hlp heteromeric complexes would affect different 
target genes than H-NS homomers. Moreover, as seen for anti-H-NS factors, interactions of 
the N-terminus could interfere with higher-order polymerization of H-NS along the DNA and 
with the process of transcriptional silencing. Therefore, interactions between H-NS-like 
proteins can have both a positive or negative outcome. 
Finally, the H-NS homologs can also act independently of H-NS and heteromeric complex 
formation. For some genes, both Hlp or StpA are able to complement for the lack of H-NS, 
thereby acting as molecular backups. This effects is further enhanced by the negative cross-
regulation between the histone-like proteins, since a lack of one of the proteins automatically 
results in increased expression of one of its homologs, which then can assume the function of 
the missing regulator. 
Possible regulatory loops of histone-like proteins are summarized in Figure 50. 
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Fig. 50: Regulatory loops. Dominant regulatory circuits are indicated in bold; + positve regulation; - 
negative regulation; grey boxes indicate the different classes of genes regulated either by H-NS alone, by H-NS 
or StpA, and H-NS/StpA or H-NS/Hlp comlexes, respectively. RNA mediated (indirect) regulation by StpA has 
been taken into account. Modified after Zhang et al. (1996). 
These regulatory loops include both auto- and cross-regulation of the H-NS-like proteins, as 
well as known environmental stimuli that affect their expression. Interestingly, each protein is 
subject to different stimuli. Therefore, any specific growth condition will produce a certain 
profile of nucleoid-associated proteins. As a consequence, the effects on expression of the 
distinct classes of target genes also vary with the external conditions. 
Taken together, all those variable interactions result in a very complex network between the 
histone-like proteins, and this complexity is even increased after acquisition of a novel H-NS-
like protein such as Hlp. However, since such global regulators are also subject to strong 
selective pressure, it can be assumed, that a diversification of the regulatory circuits offers 
some advantages for bacterial lifestyle. 
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Despite all speculations, the identification and characterization of Hlp also offers some 
practical possibilities. Even if sequence aligment of all H-NS-like proteins proteins results in 
only dispersed regions of complete identity, identification of any conserved region might 
provide information about features, which are crucial for function (i.e. DNA binding and 
oligomerization). For instance, by comparing the amino-acid sequences of ten different 
H-NS-related proteins of different bacterial species, Dorman et al. (1999) were able to deduce 
a consensus sequence, from which Hlp differed only in 29 out of 109 residues. Therefore, 
discovery and analysis of more H-NS homologs like Hlp can be very helpful for 
understanding the exact mode of action of these proteins. Future studies with mutagenized 
and truncated Hlp protein is another possibility to answer this question.  
In summary, it can be proposed that the biological role of Hlp (and StpA) does not rely on a 
distinct function of the single protein, but rather on its interactions with H-NS, modulating its 
regulatory activity. Therefore, the presence of several nucleoid-associated proteins in strains 
like UPEC strain 536 accounts for a highly flexible and fine tuned network of gene regulation. 
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8.2. Nucleotide and amino-acid sequence of histone-like proteins in UPEC strain 536 
(ORF numbers as in ERGO database; start and stopp codons are indicated in the sequence) 
>RECP01273 hns - Escherichia coli 536, chromosome_1315557_1315147 (n=414) 
CAATTTTGAATTCCTTACATTCCTGGCTATTGCACAACTGAATTTAAGGCTCTATTATTACCTCAACAAACCACCCCAATATAAGTTTGAGATT
ACTACAATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAGAGAATGTACACTTGAAACGCTGGAAGAAATGC
TGGAAAAATTAGAAGTTGTTGTTAACGAACGTCGCGAAGAAGAAAGCGCGGCTGCTGCTGAAGTTGAAGAGCGCACTCGTAAACTGCAGCAATA
TCGCGAAATGCTGATCGCTGACGGTATTGACCCGAACGAACTGCTGAATAGCCTTGCTGCCGTTAAATCTGGCACCAAAGCTAAGCGTGCTCAG
CGTCCGGCAAAATATAGCTACGTTGACGAAAACGGCGAAACTAAAACCTGGACTGGCCAGGGCCGTACTCCAGCTGTAATCAAAAAAGCAATGG
ATGAGCAAGGTAAATCCCTCGACGATTTCCTGATCAAGCAATAATCTTTTGTAGATTGCACATGCTAAAAATCCCGCCATCGGCGGGATTTTTT
ATTGTCCGGTTTAAGACAATATAATAAGAATAAGCTATAAAAAAACG 
 
M S E A L K I L N N I R T L R A Q A R E C T L E T L E E M L E K L E V V V N E R R E E E S A A 
A A E V E E R T R K L Q Q Y R E M L I A D G I D P N E L L N S L A A V K S G T K A K R A Q R P 
A K Y S Y V D E N G E T K T W T G Q G R T P A V I K K A M D E Q G K S L D D F L I K Q 
 
 
 
>RECP02600 stpA - Escherichia coli 536, chromosome_2773901_2773500 (n=405) 
GGACTGTAAATAGATTAAATTTTGTGGAAATATAATAAGTGATCGCTTACACTACGCGACGAAATACTTTTTTGTTTTGGGTTAAAAGGTTTT
CTTTATTATGTCCGTAATGTTACAAAGTTTAAATAACATTCGCACCCTCCGTGCGATGGCTCGCGAATTCTCCATTGACGTTCTTGAAGAAATG
CTCGAAAAATTCAGGGTTGTCACTAAAGAAAGACGTGAAGAAGAAGAACAACAGCAGCGTGAACTGGCAGAGCGCCAGGAAAAAATTAGCACCT
GGCTGGAGCTGATGAAAGCTGACGGAATTAACCCGGAAGAGTTATTGGGTAATAGCTCTGCTGCGGCACCACGCGCTGGTAAAAAACGCCAGCC
GCGTCCGGCGAAATATAAATTCATCGATGTTAACGGTGAAACTAAAACCTGGACCGGTCAGGGCCGTACACCGAAGCCAATCGCTCAGGCGCTG
GCAGAAGGTAAATCTCTCGACGATTTCCTGATCTAATTACTGAGGCCGGATGTCGCTGCTATGGCGCGTCCGGCGTCGCTTCTCAAGCTCGTTG
GTTCCACGGCATCTTATCTAACAACCTTGCCATTCCACA 
 
M S V M L Q S L N N I R T L R A M A R E F S I D V L E E M L E K F R V V T K E R R E E E E Q Q 
Q R E L A E R Q E K I S T W L E L M K A D G I N P E E L L G N S S A A A P R A G K K R Q P R P 
A K Y K F I D V N G E T K T W T G Q G R T P K P I A Q A L A E G K S L D D F L I 
 
 
 
>RECP01911: hlp - Escherichia coli 536, chromosome_1966487_1966888 (n=405) 
ACTATATTATTTACTGACTGTTTTTTTTTTTGATTTTTCCAACAGCACCGTAAGCATTATTTTTATTAATCGCCTATTTTAAAACACCGGATG
ACATACTATGAGTGAAGCTCTTAAGGCACTGAACAATATTCGTACACTTCGCGCACAGGCTCGTGAAACAGATCTGGCAACTCTGGAAGAGATG
CTGGAAAAACTCACCACAATCGTTGAAGATCGCCGTGAGGAAGAAAATTCAGCCCGTAAAGAACAAGAAGAACGTCAGGCTAAACTGGAAGCCT
TCCGCCAGAAATTGTTAGAAGACGGTATCGATCCTACAGAACTACTCGCTTCAGTTGGTTCATCCCAGCCTAAAACCAAATCAACTCGTGCTCC
TCGTCCTGCTAAATACAAATATACAGATGAAAACGGTAATGAGCAGACTTGGACGGGTCAGGGCCGTACTCCTAAAGCAATCGCCGCTGCTATC
GAAGCTGGTAAGACACTGGAAGACTTTGCTATCTAACCGCTACAGCATATCCGGGCTTCACTGTTCTCAAGATAACAGGCCCGGAAAATATTCG
ATTATTCATCCAAGACTATCCCAGTCTGGCAGGTTGTTA 
 
M S E A L K A L N N I R T L R A Q A R E T D L A T L E E M L E K L T T I V E D R R E E E N S A 
R K E Q E E R Q A K L E A F R Q K L L E D G I D P T E L L A S V G S S Q P K T K S T R A P R P 
A K Y K Y T D E N G N E Q T W T G Q G R T P K A I A A A I E A G K T L E D F A I 
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8.3. Expression profile of hns and hns/stpA mutants 
Data derived from expression profiling using both the E. coli K-12 Panorama-array and the E. coli 
pathoarray, sorted according to their level of upregulation compared to the wild type 
Table 13. Top50 genes with upregulated expression in hns mutant 
gene Function ratiob Top 50 
hns/stpAc 
ompT  outer membrane protein 3b (porin) 29.67 ++ 
III sfaA S-fimbrial adhesin 27.31 ++ 
hdeB  cons. hyp. protein 17.21 ++ 
proV  glycine betaine/proline transport protein 16.72 ++ 
hdeA  cons. protein with protein HNS-dependent expression A 16.57 ++ 
yagY  cons. hyp. protein 13.68 ++ 
yagZ  cons. hyp. protein 11.43 ++ 
yahA  put. transcriptional repressor (LuxR/UhpA family) 9.80 + 
I ORF1a unknown 9.36 ++ 
yicP  adenine deaminase 8.62 + 
III sfaE a S-fimbrial adhesin 8.48 ++ 
yddC  redox cofactor for pyrroloquinoline quinone synthesis (cryptic in K-12) 7.86  
b1785  put. membrane protein 7.32 ++ 
cadA  lysine decarboxylase 1 7.29 ++ 
proX  glycine betaine/proline transport protein 7.15 + 
b3060 put. transcriptional regulator (LysR family) 6.63  
III sfaB a S-fimbrial adhesin 6.34 ++ 
tnaA  tryptophan deaminase, PLP-dependent 6.33  
b1983 cons. protein with YebC-like domain 5.87 ++ 
hlyD-I a alpha-hemolysin 5.78 ++ 
II 17-kDa a unknown 5.74 ++ 
yhaP  L-serine dehydratase 3, part 2, fuses with b3112, one orf 5.67 ++ 
ydbA_1  split CDS, fragment 1 5.64 ++ 
b2774 put. deoxygluconate dehydrogenase with NAD(P)-binding domain 5.56  
nmpC DLP12 prophage; outer membrane porin 5.28  
ftn cytoplasmic ferritin (iron storage protein) 5.21  
dapE  N-succinyl-diaminopimelate deacylase 5.17 + 
ygiH  put. tRNA synthetase 5.16  
rplX 50S ribosomal subunit protein L24 5.08  
I ORF32 a unknown 4.82 ++ 
b2877 cons. protein with nucleotide-diphospho-sugar transferase domain 4.79  
rpsU 30S ribosomal subunit protein S21 4.71  
hha  hemolysin expression modulator 4.70  
yjeJ cons. protein 4.54  
cyoA  cytochrome o ubiquinol oxidase, subunit II 4.52  
treB PTS family enzyme IIBC, trehalose(maltose)-specific 4.51  
rplM 50S ribosomal subunit protein L13 4.47  
stpA DNA-bending protein with chaperone activity 4.44  
cyoB cytochrome o ubiquinol oxidase, subunit I 4.30  
rpsO 30S ribosomal subunit protein S15 4.30  
ykgG cons. hyp. protein 4.27  
cynS  cyanate aminohydrolase (cyanase) 4.25 + 
b0294 put. transcriptional regulator 4.24  
17.3 kD a unknown 4.23 + 
b1673 put. aldehyde ferridoxin oxidoreductase 4.22  
ykgF put. amino acid dehydrogenase with NAD(P)-binding and ferridoxin-like domain 4.22  
rpsT 30S ribosomal subunit protein S20 4.20  
glpT sn-glycerol-3-phosphate transport protein (MFS family) 4.18  
rplU 50S ribosomal subunit protein L21 4.17  
ydiF put. acetyl-CoA:acetoacetyl-CoA transferase 4.17  
a
 spotted on pathochip 
b
 Ratio corresponds to spot intensity-mutant / spot intensity-wt 
c
 A double plus indicates the presence of gene among the 50 most upregulated genes in the hns/stpA mutant;  
a single plus refers to the Top100 genes in this mutant 
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Table 14. Top50 genes with upregulated expression in hns/stpA mutant 
gene Function ratiob Top50 
hns c 
b2373  cons. hyp. protein with UBA-like domain 42.45  
b2374 unknown CDS 40.92  
b2372 cons. protein 38.76  
b2375 unknown CDS with UBA-like domain 28.43  
yciG  cons. hyp. protein 19.60 + 
hdeB  cons. hyp. protein 19.02 ++ 
b2371 put. peptidase with Zn-dependent exopeptidase domain 17.70  
asr  acid shock protein 16.67  
ydbA_1  split CDS, fragment 1 16.53 ++ 
hdeA  cons. protein with protein HNS-dependent expression A 15.97 ++ 
III sfaAa S-fimbrial adhesin 12.64 ++ 
I ORF32a unknown 12.14 ++ 
b1501  put. formate dehydrogenase, related to acid resistance 11.95  
ompT  outer membrane protein 3b (porin) 10.77 + 
proV  glycine betaine/proline transport protein 10.77 + 
I ORF1a unkown 10.58 + 
b0511 put. allantoin transport protein (NCS1 family) 10.14 + 
b1983 cons. protein with YebC-like domain 10.09 ++ 
yhaP  L-serine dehydratase 3 10.02 ++ 
I ORF26a unknown 9.41  
yagY  cons. hyp. protein 8.01 ++ 
yciF  cons. protein 7.86  
III ORF22a unknown 7.71  
hlyD Ia alpha-hemolysin 7.32 ++ 
gadA  glutamate decarboxylase A, isozyme, PLP-dependent 7.15  
emrY  multidrug resistance protein Y (MFS family) 7.13  
b1504 put. fimbrial-like adhesin protein 6.47  
yhiE  put. transport protein (MFS family) 6.40  
III sfaEa S-fimbrial adhesin 6.27 ++ 
b2028  UDP-glucose 6-dehydrogenase 5.83  
appC  cytochrome oxidase bd-II, subunit I 5.81  
hlyB Ia alpha-hemolysin 5.44 + 
gadB  glutamate decarboxylase, PLP-dependent, isozyme beta 5.44  
b1499  put. transcriptional regulator (AraC/XylS family) 5.35  
III sfaBa S-fimbrial adhesin 5.24 ++ 
III ORF23a unknown 5.03  
b1785  put. membrane protein 5.01 ++ 
b1388 put. subunit of multicomponent oxygenase,  4.96  
fimB  tyrosine recombinase, regulator of fimA 4.79 + 
I ORF31 unknown 4.69  
cadA  lysine decarboxylase 1 4.68 ++ 
yhhI  cons. protein, similar to H-repeat-associated proteins 4.55  
III sfaG S-fimbrial adhesin 4.42 + 
xasA  put. glutamate:gamma-aminobutyric acid antiporter (APC family) 4.37  
III sfaH S-fimbrial adhesin 4.35 + 
emrK  multidrug resistance protein K  with single hybrid motif 4.02  
II 17-kDa unknown 4.01 ++ 
slp  outer membrane protein, induced after carbon starvation 4.01  
b0905  cons. hyp. protein 4.00  
yagZ  cons. hyp. protein 3.98 ++ 
a
 spotted on pathochip 
b
 Ratio corresponds to spot intensity-mutant / spot intensity-wt 
c
 A double plus indicates the presence of gene among the 50 most upregulated genes in the hns mutant;  
a single plus refers to the Top100 genes in this mutant 
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Table 15: Top37 genes with downregulated expression in hns mutant 
gene Function ratiob Top37 
hns/stpA c 
fliC  flagellar biosynthesis; flagellin, filament structural protein -12,61 ++ 
flgG  flagellar biosynthesis; cell-distal portion of basal-body rod -9,29 ++ 
fliD  flagellar biosynthesis; filament capping protein, enables filament assembly -8,12 ++ 
flgN  flagellar biosynthesis; believed to be export chaperone for FlgK and FlgL -7,74 ++ 
flgK  flagellar biosynthesis; hook-filament junction protein 1 -7,65 ++ 
tsr  methyl-accepting chemotaxis protein I, serine sensor receptor -5,48 ++ 
cheW  purine-binding chemotaxis protein; regulation -5,19 ++ 
cheA  chemotactic sensory histidine kinase (soluble) in two-component regulatory system -5,09 ++ 
flgF  flagellar biosynthesis; cell-proximal portion of basal-body rod -5,07 ++ 
flgJ  flagellar biosynthesis -3,96 ++ 
flgM  anti-FliA (anti-sigma) factor; also known as RflB protein -3,80 ++ 
tar  methyl-accepting chemotaxis protein II, aspartate sensor receptor -3,68 ++ 
fliK  flagellar hook-length control protein -3,33 ++ 
flgC  flagellar biosynthesis; cell-proximal portion of basal-body rod -3,15 + 
motA  proton conductor component of motor, torque generator -2,87 ++ 
yhjH  conserved protein -2,75 ++ 
fliG  flagellar biosynthesis; component of motor switching and energizing -2,61 ++ 
fliA  sigma F (sigma 28) factor of RNA polymerase, transcription of late flagellar genes -2,57 + 
cheY  chemotactic response regulator in two-component regulatory system with CheA -2,49 ++ 
fliT  flagellar biosynthesis; putative export chaperone for FliD -2,47 ++ 
fliM  flagellar biosynthesis; component of motor switch and energizing -2,41 + 
fliZ  putative regulator of FliA -2,34 + 
motB  enables flagellar motor rotation, linking torque machinery to cell wall -2,29 + 
fliI  flagellum-specific ATP synthase -2,29 + 
flgL  flagellar biosynthesis; hook-filament junction protein -2,25 ++ 
ExPEC sapa autotranporter -2,21  
flgI  putative flagella basal body protein -2,10 + 
flgD  flagellar biosynthesis; initiation of hook assembly -2,08 ++ 
cheZ  chemotactic response, CheY protein phophatase -2,00 ++ 
III ORF28a unknown -1,93  
mviN  putative virulence factor -1,87  
air  aerotaxis sensor receptor, senses cellular redox state or proton motive force -1,83  
guaC  GMP reductase -1,69 + 
fliH  flagellar biosynthesis; putative export of flagellar proteins -1,69  
flhD  transcriptional regulator of flagellar class II biosynthesis -1,64 + 
flgA  flagellar biosynthesis; assembly of basal-body periplasmic P ring -1,56  
flgE  flagellar biosynthesis; hook protein -1,26 ++ 
a
 spotted on pathochip 
b
 Ratio corresponds to spot intensity-mutant / spot intensity-wt 
c
 A double plus indicates the presence of gene among the 37 most downregulated genes in the hns/stpA mutant;  
a single plus refers to the Top100 genes in this mutant 
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Table 16. Top37 with downregulated expression in hns/stpA mutant 
gene Function ratiob Top37 
hns c 
flgE  flagellar biosynthesis; hook protein -9,32 ++ 
fliC  flagellar biosynthesis; flagellin, filament structural protein -9,25 ++ 
flgG  flagellar biosynthesis; cell-distal portion of basal-body rod -7,29 ++ 
fliD  flagellar biosynthesis; filament capping protein, enables filament assembly -6,33 ++ 
flgK  flagellar biosynthesis; hook-filament junction protein 1 -5,20 ++ 
flgN  flagellar biosynthesis; believed to be export chaperone for FlgK and FlgL -5,02 ++ 
tsr  methyl-accepting chemotaxis protein I, serine sensor receptor -4,85 ++ 
cheA  chemotactic sensory histidine kinase (soluble) in two-component regulatory system -4,03 ++ 
lamB  maltoporin, high-affinity receptor for maltose; phage lambda receptor -3,72  
cheW  purine-binding chemotaxis protein; regulation -3,50 ++ 
frdA  fumarate reductase, anaerobic, catalytic and NAD/flavoprotein subunit -3,23  
nirB  nitrite reductase, large subunit, nucleotide-binding -3,05  
flgF  flagellar biosynthesis; cell-proximal portion of basal-body rod -3,05 ++ 
tar  methyl-accepting chemotaxis protein II, aspartate sensor receptor -3,02 ++ 
yhjH  conserved protein -3,01  
flgJ  flagellar biosynthesis -2,82 ++ 
glnH  high-affinity glutamine transport protein (ABC superfamily, peri_bind) -2,80  
flgD  flagellar biosynthesis; initiation of hook assembly -2,60 ++ 
frdB  fumarate reductase, anaerobic, Fe-S subunit -2,56  
flgL  flagellar biosynthesis; hook-filament junction protein -2,49 ++ 
glnA  glutamine synthetase -2,47  
flgM  anti-FliA (anti-sigma) factor; also known as RflB protein -2,44 ++ 
motA  proton conductor component of motor, torque generator -2,40 ++ 
fliK  flagellar hook-length control protein -2,40 ++ 
nikA  nickel transport protein (ABC superfamily, peri_bind) -2,24  
ptsI  PTS family enzyme I and Hpr components, PEP-protein phosphotransferase -2,12  
pfkA  6-phosphofructokinase I -2,05  
manX  PTS family enzyme IIA (N-terminal); enzyme IIB (C-terminal), mannose-specific -2,03  
cheY  chemotactic response regulator in two-component regulatory system with CheA -2,02 ++ 
narG  nitrate reductase 1, alpha subunit -2,00  
cheZ  chemotactic response, CheY protein phophatase -2,00 ++ 
malM  periplasmic protein of mal regulon -2,00  
yibO  phosphoglycerate mutase III, cofactor-independent -1,99  
fliG  flagellar biosynthesis; component of motor switching and energizing -1,94 ++ 
fliT  flagellar biosynthesis; putative export chaperone for FliD -1,93 ++ 
narH  nitrate reductase 1, Fe-S (beta) subunit -1,91  
dmsA  anaerobic dimethyl sulfoxide (DMSO) reductase, subunit A -1,87  
a
 spotted on pathochip 
b
 Ratio corresponds to spot intensity-mutant / spot intensity-wt 
c
 A double plus indicates the presence of gene among the 37 most downregulated genes in the hns mutant;  
a single plus refers to the Top100 genes in this mutant 
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Table 17: The 50 most abundant transcripts in wild type UPEC strain 536 from mid-log LB cultures. 
Average signal intensities were calculated from 12 data sets (4 wild type co-hybridizations per mutant; 3 
mutants) and sorted in decreasing order. The position of each gene within the top-50 list of the three mutants is 
indicated in the list (bold: among top-50 genes, normal: among top-100 genes; na: not among top-100 genes). 
# 
gene 
name gene description 
functional 
group 
signal 
intensities  
rel. 
SD 
# in 
hns 
# in 
hns/stpA 
# in 
stpA 
1 rpsD  30S ribosomal subunit protein S4 14 950 0.57 1 2 1 
2 ompC  outer membrane protein C precursor 4 757 0.54 9 9 2 
3 tufA  elongation factor EF-Tu 14 689 0.56 2 11 3 
4 rpsA  30S ribosomal protein S1 14 531 0.31 4 6 4 
5 tufB  elongation factor EF-Tu (duplicate gene) 14 500 0.28 7 20 5 
6 rplF  50S ribosomal subunit protein L6 14 439 0.59 5 14 8 
7 sucA  2-oxoglutarate dehydrogenase E1 component 5 430 0.45 13 7 6 
8 prlA  preprotein translocase secy subunit 12 422 0.51 6 12 10 
9 fusA  elongation factor EF-G 14 410 0.42 8 17 7 
10 rplL  50S ribosomal subunit protein L7/L12 14 337 0.06 37 33 9 
11 slyD  fkbP-type peptidyl-prolyl cis-trans isomerase 14 337 0.44 23 32 11 
12 trmD  tRNA(guanine-7)methyltransferase 14 307 0.51 15 37 25 
13 rplC  50S ribosomal subunit protein L3 14 302 0.59 10 23 17 
14 tsf  elongation factor Ts 14 291 0.46 20 51 14 
15 narG  respiratory nitrate reductase 1 alpha chain 5 290 0.71 51 na 22 
16 rpsS  30S ribosomal subunit protein S19 14 287 0.51 11 36 18 
17 rplB  50S ribosomal subunit protein L2 14 285 0.44 16 35 26 
18 fdoG  formate dehydrogenase-O alpha subunit 5 270 0.49 29 48 24 
19 kdgK  2-dehydro-3-deoxygluconokinase 1 267 0.18 na 13 19 
20 cspC  cold shock-like protein CspC 10 253 0.40 14 10 12 
21 sodA  manganese superoxide dismutase 3 252 0.57 22 92 38 
22 nuoE  NADH dehydrogenase I chain E 5 251 0.36 25 34 21 
23 nrdD  anaerobic ribonucleoside-triphosphate reductase 9 242 0.24 54 28 13 
24 rplV  50S ribosomal subunit protein L22 14 241 0.34 35 54 16 
25 rpmI  50S ribosomal subunit protein L35 14 235 0.59 12 16 34 
26 sucB  dihydrolipoamide succinyltransferase component 5 230 0.41 50 40 31 
27 fabB  3-oxoacyl-[acyl-carrier-protein] synthase I 6 228 0.29 65 59 15 
28 rpoA  RNA polymerase, alpha subunit 13 228 0.44 17 43 29 
29 hlpA  histone-like protein Hlp-1 precursor 4 227 0.29 56 44 28 
30 cspA  cold shock protein CspA 3 218 0.74 18 18 32 
31 yghJ  putative lipoprotein (b2974) 11 218 0.31 97 38 27 
32 nlpD  lipoprotein NlpD precursor 8 215 0.23 58 41 23 
33 thrS  threonyl-tRNA synthetase 14 214 0.45 40 46 30 
34 rnr  RNase R (VacB) 7 214 0.44 80 53 20 
35 narH  respiratory nitrate reductase 1 beta chain 5 211 0.60 98 na 36 
36 rplO  50S ribosomal subunit protein L15 14 210 0.70 19 58 35 
37 rpsB  30S ribosomal protein S2 14 207 0.64 24 81 52 
38 lpdA  dihydrolipoamide dehydrogenase 5 201 0.31 33 24 33 
39 ompA  outer membrane protein A 4 197 0.76 45 62 64 
40 rpoB  DNA-directed RNA polymerase, beta-subunit 13 186 0.38 42 60 41 
41 lamB  phage lambda receptor protein 15 182 0.58 61 na 47 
42 cpsG  phosphomannomutase 2 179 0.57 26 19 37 
43 pflB  formate acetyltransferase 1 5 177 0.58 34 63 56 
44 rplQ  50S ribosomal subunit protein L17 14 174 0.56 31 74 60 
45 cyoC  cytochrome o ubiquinol oxidase subunit III 5 170 0.39 45 42 44 
46 atpA  ATP synthase F1 alpha subunit 5 169 0.51 32 70 40 
47 sucD  succinyl-coA synthetase alpha chain 5 164 0.35 49 57 53 
48 radC  DNA repair protein radc 3 164 0.71 30 25 59 
49 fdoH  formate dehydrogenase-O beta subunit 5 163 0.37 72 79 50 
50 infC  initiation factor IF-3 14 163 0.51 47 52 43 
Functional groups: 1 Carbon compound catabolism; 2 Cell processes (incl. adaptation, protection); 3 Cell structure; 4 Central 
intermediary metabolism; 5 Energy metabolism; 6 Fatty acid and phospholipid metabolism; 7 Hypothetical, unclassified, 
unknown; 8 Membrane proteins, 9 Nucleotide biosynthesis and metabolism, 10 Other known genes, 11 Putative enzyme; 12 
Putative transport proteins; 13 Transcription, RNA processing and degradation; 14 Translation, post-translational 
modification, 15 Transport and binding proteins.  
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8.4. Expression ratios of major virulence-associated genes 
Expression ratios of hns and hns/stpA mutants relative to expression in the wild type. 
ns = not significant; na = not available; FDR = false discovery rate 
Table 18: Significantly deregulated genes involved in motility and chemotaxis 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
cheA  sensory histidine kinase in two-component regulatory system  -5,09 3,35 -4,03 0,43 
cheW  purine-binding chemotaxis protein; regulation -5,19 3,35 -3,50 0,43 
cheY  response regulator in two-component regulatory system with CheA -2,49 3,35 -2,02 0,43 
cheZ  chemotactic response, CheY protein phophatase -2,00 6,14 -2,00 0,43 
flgA  flagellar biosynthesis; assembly of basal-body periplasmic P ring -1,56 na ns na 
flgC  flagellar biosynthesis; cell-proximal portion of basal-body rod -3,15 3,35 -1,70 0,21 
flgD  flagellar biosynthesis; initiation of hook assembly -2,08 3,35 -2,60 0,43 
flgE  flagellar biosynthesis; hook protein -1,26 3,35 -9,32 0,43 
flgF  flagellar biosynthesis; cell-proximal portion of basal-body rod -5,07 3,35 -3,05 0,43 
flgG  flagellar biosynthesis; cell-distal portion of basal-body rod -9,29 3,35 -7,29 0,43 
flgI  putative flagella basal body protein -2,10 3,35 -1,56 0,21 
flgJ  flagellar biosynthesis -3,96 3,35 -2,82 0,43 
flgK  flagellar biosynthesis; hook-filament junction protein 1 -7,65 3,35 -5,20 0,43 
flgL  flagellar biosynthesis; hook-filament junction protein -2,25 3,35 -2,49 0,43 
flgM  anti-FliA (anti-sigma) factor; also known as RflB protein -3,80 3,35 -2,44 0,43 
flgN  flagellar biosynthesis; export chaperone for FlgK and FlgL -7,74 3,35 -5,02 0,43 
flhD  transcriptional regulator of flagellar class II biosynthesis,  -1,64 na -1,55 0,21 
fliA sigma F (sigma 28) factor of RNA polymerase -2,57 3,35 -1,76 0,21 
fliC  flagellar biosynthesis; flagellin, filament structural protein -12,61 3,35 -9,25 0,43 
fliD  flagellar biosynthesis; filament capping protein -8,12 3,35 -6,33 0,43 
fliF  flagellar biosynthesis; basal-body MS-ring and collar protein 4,21 3,35 2,05 0,43 
fliG  flagellar biosynthesis; motor switching and energizing -2,61 3,35 -1,94 na 
fliI  flagellum-specific ATP synthase -2,29 3,35 -1,78 0,21 
fliK  flagellar hook-length control protein -3,33 3,35 -2,40 0,43 
fliM  flagellar biosynthesis; component of motor switch and energizing -2,41 3,35 -1,85 na 
fliS  flagellar biosynthesis; repressor of class 3a and 3b operons  ns na -1,61 0,62 
fliT  flagellar biosynthesis; putative export chaperone for FliD -2,47 3,35 -1,93 0,21 
fliZ  putative regulator of FliA -2,34 3,35 -1,59 1,10 
motA  proton conductor component of motor, torque generator -2,87 3,35 -2,40 0,43 
motB  enables flagellar motor rotation -2,29 3,35 -1,77 2,07 
tar methyl-accepting chemotaxis protein II, aspartate sensor receptor -3,68 3,35 -3,02 0,43 
tsr methyl-accepting chemotaxis protein I, serine sensor receptor -5,48 3,35 -4,85 0,43 
Table 19: Significantly deregulated genes of hemolysin operon 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
hlyC I ORF39 2,60 2,32 1,99 na 
hlyD I ORF40 5,78 2,32 7,32 1,67 
hlyA  ns na ns na 
hlyB I ORF41 4,04 2,32 5,44 1,67 
Table 20: Significantly deregulated genes involved in iron uptake 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
iroN III orf27; salmochelin receptor 3,40 2,32 3,54 1,67 
IV ybtQ yersiniabactin; transporter 1,74 na 1,98 na 
IV ybtS yersiniabactin 2,08 2,32 2,51 1,67 
IV ybtX yersiniabactin 2,09 2,32 2,39 na 
fhuA = tonA; ferrichrome receptor 2,18 9,44 1,54 0,21 
tonB energy transducer; uptake of iron, cyanocobalimin; sensitivity 
to phages, colicins 
2,42 3,35 ns na 
8. Appendix 
 
164 
 
Table 21: Significantly deregulated genes involved in adhesion 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
Type 1 fimbriae     
fimB tyrosine recombinase, regulator of fimA 3,59 3,35 4,79 0,43 
fimE tyrosine recombinase, regulator of fimA 2,05 3,35 2,05 0,43 
S-fimbrial adhesin     
 sfaA III orf19 27,31 2,32 12,64 1,67 
 sfaB III orf18 6,34 2,32 5,24 1,67 
 sfaC III orf17 1,66 na 2,45 1,67 
 sfaD III orf20 2,58 2,32 2,29 1,67 
 sfaE III orf21 8,48 2,32 6,27 1,67 
 sfaF III orf22 3,50 2,32 3,54 1,67 
 sfaG III orf23 3,79 2,32 4,42 1,67 
 sfaH III orf25 3,62 2,32 4,35 1,67 
 sfaS III orf24 3,05 2,32 2,80 1,67 
P-related fimbriae     
prfX II orf6 5,74 2,32 4,01 1,67 
curli adhesin     
csgD putative transcriptional regulator in curly assembly/transport,  2,14 3,35 1,76 0,21 
putative adhesins     
I ORF26 putative CS12 fimbria-like major fimbrial protein subunit 2,08 2,32 9,41 1,67 
I ORF29 FasD-like protein 1,63 na 2,61 1,67 
I ORF30 FasE-like protein 1,62 na 3,39 1,67 
I ORF31 FasF-like protein 2,59 2,32 4,69 1,67 
I ORF32 FasG-like protein 4,82 2,32 12,14 1,67 
I ORF6 putative F17-like fimbril adhesin subunit 3,11 2,32 2,56 1,67 
II yjhW = hek; involved in adhesion ns na 2,07 1,67 
ydeS putative fimbrial-like adhesin protein ns na 6,47 0,43 
yehA  putative fimbrial-like adhesin protein ns na 2,28 0,43 
Table 22: Significantly deregulated genes involved in generegulation 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
phoP  response regulator in two-component regulatory system with PhoQ, 
regulates gene expression at low [Mg+] (OmpR family) 
2,20 3,35 2,15 0,43 
phoQ  sensory histidine kinase in two-component regulatory system with 
PhoP, regulates gene expression at low [Mg+], senses Mg+ 
2,11 3,46 2,13 0,43 
dpiA response regulator in two-component regulatory system with DpiB, 
regulation of citrate fermentation and plasmid inheritance 
ns na 1,98 0,21 
dpiB  sensory histidine kinase in two-component regulatory system with 
DpiA; senses citrate; OmpR-family 
2,85 3,35 2,16 0,43 
yahA  putative transcriptional repressor (LuxR/UhpA family) 9,80 3,35 3,41 0,43 
yedV putative sensory kinase in regulatory system 2,32 3,35 ns na 
yedW putative response regulator in two-component regulatory system 
(OmpR family) 
3,82 3,35 2,21 0,43 
ygbI putative transcriptional repressor with DNA-binding Winged helix 
domain (DeoR family) 
2,33 3,35 2,03 0,21 
ygeV putative transcriptional regulator protein with GAF, PYP-like 
sensor, NTP hydrolysis, and FIS-like domains 
2,81 3,35 ns na 
ygiP putative transcriptional regulator with periplasmic binding protein 
domain (LysR family) 
6,63 3,35 1,14 na 
yidL putative transcriptional regulator with homeodomain-like DNA 
binding domain (AraC/XylS family) 
2,45 3,35 1,51 0,21 
ykgK 
 
putative transcriptional regulator 4,24 3,35 1,89 0,21 
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Table 23: Significantly deregulated genes involved in resistance/adaptation 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
low pH resistance     
asr  acid shock protein 2,19 3,35 16,67 0,43 
gadA glutamate decarboxylase A 2,27 3,35 7,15 0,43 
gadB glutamate decarboxylase 1,97 na 5,44 0,43 
gadC  = xasA; glutamate:GABA ntiporter  ns na 4,37 0,43 
cadA lysine decarboxylase 1 7,29 3,35 4,68 0,43 
cadB lysine/cadaverine transport protein 2,78 3,35 1,75 na 
hdeA acid chaperone 16,57 3,35 15,97 0,43 
hdeB acid chaperone 17,21 3,35 19,02 0,43 
yhiQ putative proteins encoded on 15kb „acid cluster“  2,08 3,35 ns na 
yhiD  putative proteins encoded on 15kb „acid cluster“  2,34 3,35 2,38 0,43 
yhjH putative proteins encoded on 15kb „acid cluster“  -2,75 3,35 -3,01 0,43 
yhjJ putative proteins encoded on 15kb „acid cluster“  3,37 3,35 ns na 
yhjK putative proteins encoded on 15kb „acid cluster“  2,41 3,35 ns na 
yhjL putative proteins encoded on 15kb „acid cluster“  2,76 3,35 ns na 
yhiM putative proteins encoded on 15kb „acid cluster“  2,22 3,35 ns na 
gadE = yhjE; activator 2,50 3,35 6,40 0,43 
gadX = yhjX; activator of gadAB 3,14 3,35 3,81 0,43 
multidrug resistance     
mdtE multidrug resistance protein ns na 1,80 0,21 
mdtF  putative transport protein; multidrug resistance ns na 2,31 0,43 
emrK multidrug resistance protein K ns na 4,02 0,43 
emrY multidrug resistance protein Y 2,23 3,35 7,13 0,43 
evgA response regulator in two-component regulatory system for 
multidrug resistance 
ns na 1,61 0,21 
evgS sensory histidine kinase in two-component regulatory system for 
multidrug resistance 
ns na 2,36 0,43 
osmoprotection     
proV glycine betaine/proline transport protein 16,72 3,35 10,77 0,43 
proW glycine betaine/proline transport protein (ABC superfamily) 3,30 3,35 1,77 0,21 
proX glycine betaine/proline transport protein (ABC superfamily) 7,15 3,35 2,86 0,43 
osmC resistance protein, osmotically inducible ns na 1,79 0,21 
osmB lipoprotein, osmotically inducible ns na 1,71 0,21 
osmY hyperosmotically inducible periplasmic protein 2,01 3,35 1,56 0,21 
danK chaperone Hsp70; osmoprotection 2,64 3,35 2,18 0,43 
dnaJ heat shock protein (Hsp40), co-chaperone with DnaK 2,33 3,35 2,09 0,43 
mdoB periplasmic glucans biosynthesis protein 2,07 3,35 ns na 
mdoG periplasmic glucans biosynthesis protein 2,07 3,35 ns na 
mdoH periplasmic glucans biosynthesis protein 2,07 3,35 ns na 
tufA protein chain elongation factor EF-Tu 2,11 3,40 ns na 
tufB protein chain elongation factor EF-Tu 2,21 3,72 ns na 
ydcG putative enzyme invlved in osmoprotection 2,89 3,35 1,68 0,21 
betI transcriptional repressor for the cellular response to osmotic stress ns na 1,64 0,21 
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Table 24: Significantly deregulated genes involved in synthesis of extracellular components 
gene 
name gene description 
ratio 
 hns FDR 
ratio 
hns/stpA FDR 
Cellulose     
yaiC putative membrane protein 2,09 3,35 ns na 
bcsA cellulose synthase, catalytic subunit 2,81 3,35 ns na 
bcsC = yhjL; putative cellulose synthase with tetratricopeptide repeats 2,76 3,35 ns na 
M-antigen (colanic acid)     
cpsB = manC; mannose-1-phosphate guanyltransferase 2,44 3,35 3,42 0,43 
cpsG = manB; phosphomannomutase 2,95 3,35 1,95 0,21 
wcaE putative transferase, colanic acid synthesis, with nucleotide-
diphospho-sugar transferase domain 
ns na 2,36 0,43 
wcaJ putative UDP-glucose lipid carrier transferase 1,84 na 2,14 0,43 
yefA = gmd; GDP-D-mannose dehydratase 2,62 3,35 3,21 0,43 
yefB = fcl; bifunctional GDP-fucose synthetase; 2,54 3,35 2,79 0,43 
yefC = wcaH; GDP-mannose mannosyl hydrolase ns na 1,78 0,21 
ugd UDP-glucose 6-dehydrogenase 3,13 3,35 5,83 0,43 
galU UDP-glucose synthesis; TolC export 2,90 3,35 ns na 
galF putative glucose-1-phosphate uridylyltransferase 2,78 3,35 ns na 
Lipopolysaccharide (LPS)     
cld = wzz; regulator of length of O-antigen component of LPS chains 3,89 3,35 1,82 0,21 
crcA = ybeG, pagP; palmitoyl transferase for Lipid A 2,72 3,35 2,36 0,43 
lpxD UDP-3-O-(3-hydroxymyristoyl)-glucosamine N-acyltransferase 2,57 3,35 ns na 
tolA required for outer membrane integrity, uptake of group A 
colicins, translocation of filamenous phage DNA to cytoplasm, 
role in surface expression of O-antigen 
2,04 3,35 1,82 0,71 
lpxP palmitoleoyl-acyl carrier protein (ACP)-dependent 
acyltransferase, LPS modification, cold-induced gene 
ns na 1,50 2,07 
K15 capsular polysaccharide     
kpsF PAI V-region1 2,33 2,32 2,78 1,67 
kpsE PAI V-region1 2,38 2,32 2,66 1,67 
kpsD PAI V-region1 2,28 2,32 2,30 1,67 
kpsU PAI V-region1 1,82 na 1,90 na 
kpsC PAI V-region1 1,64 na 1,50 na 
kpsS5 PAI V-region1 1,38 na 1,33 na 
kpsS10 PAI V-region1 1,29 na 1,23 na 
kpsT PAI V-region3 ns na ns na 
kpsM PAI V-region3 1,85 na 1,88 na 
ORF1 PAI V-region2 1,36 na 1,22 na 
ORF2 PAI V-region2 1,31 na 1,17 na 
ORF3 PAI V-region2 1,29 na 1,10 na 
ORF4 PAI V-region2 1,54 na 0,95 na 
ORF5 PAI V-region2 1,94 na 2,61 1,67 
 
8.5. Supplementary material  (tables and figures) 
More tables and figures such as more AFM micrographs, growth curves, and plasmid maps 
are following in this section. 
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Table 25: E. coli strains used for PCR screening and detailed results on the occurrence of the hlp gene. 
Strain Serotype Group hlp  Strain Serotype Group hlp 
536 O6:K15:H31 UPEC +  764 O18:K5:H5/11 Faecal  + 
CFT073 O6:K2:H1 UPEC +  20A1 na Faecal  + 
RZ422 O6:K14:H- UPEC +  20A2 na Faecal  + 
RZ451 O6:K+:H31 UPEC +  3D5 na Faecal  - 
RZ479 O6:K+:H- UPEC +  13A1 na Faecal  - 
RZ505 O6:K14:H- UPEC +  1H1 na Faecal  + 
RZ532 O6:K-:H31 UPEC +  19A1 na Faecal  + 
RZ454 O6:K2:H- UPEC -  1G1 na Faecal  - 
J96 O4:K:H5 UPEC +  8B1 na Faecal  - 
AD110 na UPEC +  AE5 na Faecal  - 
2980 O18ac:K5 UPEC +  2A1 na Faecal  + 
E-B35 na UPEC +  2A2 na Faecal  + 
7521/94-1 na UPEC +  3B5 na Faecal  + 
RZ-439 O6:K5:H1 UPEC +  3N5 na Faecal  - 
RZ-441 O6:K5:H1 UPEC +  5A1 na Faecal  - 
RZ-443 O6:K5:H- UPEC +  8B2 na Faecal  + 
RZ-446 O6:K53:H1 UPEC +  8F4 na Faecal  - 
RZ-468 O6:K5:H1 UPEC +  16A3 na Faecal  - 
RZ-475 O6:K5:H1 UPEC +  16B1 na Faecal  - 
RZ-495 O6:K5:H- UPEC +  19B1 na Faecal  - 
RZ-500 O6:K5:H1 UPEC +     DSM6601 na Faecal  + 
RZ-525 O6:K5:H1 UPEC +  EcoR-53 na Faecal  + 
RZ-526 O6:K5:H1 UPEC +  EcoR-57 na Faecal  + 
EcoR-60 na UPEC +  EcoR-58 na Faecal  + 
4405/1 na UPEC -  EcoR-63 na Faecal  + 
S5 na UPEC -  EcoR-65 na Faecal  - 
EcoR62 na UPEC -  EcoR66 na Faecal  - 
EcoR50 na UPEC +  EcoR7 na Faecal - 
RZ411 O6:K-:H1 UPEC +  F18 na Faecal  + 
20A1U na UPEC +  EcoR61 na Faecal  - 
22B2U na UPEC +  EcoR-1 na Faecal  - 
1G1U na UPEC +  EcoR-23 na Faecal  - 
1H1U na UPEC +  EcoR-25 na Faecal  - 
2E1U na UPEC -  EcoR-28 na Faecal  - 
16A2U na UPEC +  EcoR-32 na Faecal  - 
5A1U na UPEC -  EcoR-42 na Faecal  - 
A284 na UPEC +  EcoR-55 na Faecal  - 
EcoR-40 na UPEC -  EcoR-59 na Faecal  - 
EcoR-48 na UPEC -  E2348/69 O127:H6 EPEC - 
EcoR-56 na UPEC +  179/2 na EPEC - 
EcoR-71 na UPEC -  156A na EPEC - 
BK658 na NBM +  37-4 na EPEC - 
IHE3034 O18:K1:H7/9 NBM -  933W na EHEC -   
IHE3036 na NBM -  86-24 na EHEC - 
IHE3080 na NBM -  SF493/89 O157:H- EHEC - 
RS226 na NBM -  3574/92 na EHEC - 
B13155 na NBM -  2907/97 na EHEC - 
Ve1140 na NBM -  5720/96 na EHEC - 
B10363 na NBM(blood sample) -  3697/97 na EHEC - 
RS176 na NBM -  ED142 na EHEC - 
Ve239 na NBM -  PIG E57 na EHEC - 
HK8 na Sepsis +  2-45 na EHEC - 
HK24 na Sepsis +  EDL 880 na EHEC - 
AC/I na Avian Sepsis -  5714/96 na EHEC - 
E642 na Sepsis +  189 na AAEC - 
HK54 na Sepsis -  DPA065 na EAEC - 
B616 na Sepsis -  5477/94 na EAEC - 
HK2 na Sepsis -  17-2  na EAEC - 
HK1 na Sepsis -  042   na EAEC + 
HK58 na Sepsis -     O149:K88 na ETEC - 
E457 na Sepsis +  C9221a O6:K15:H16 ETEC - 
HK4 na Sepsis +  258909-3  na ETEC - 
HK17 na Sepsis -  H10407  na ETEC - 
HK19 na Sepsis -     EDL-1284 O124:H- EIEC - 
HK25 na Sepsis -  76-5 na EIEC - 
RB9 na Sepsis -  MG1655 OR:H48:K- K-12 - 
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Fig. 51: Cell morphology of UPEC strain 536 and isogenic mutants visualized by AFM in tapping mode. (Bars represent 1 µm in length)
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Fig. 51 – continued  
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Fig. 51 - continued 
 
170 
 171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 52: Predicted curvature 
of promoter regions. 400-bp 
upstream of translation start 
codon were used for 
calculation of AT-content and 
curvature prediction (using the 
model.it software retrieved at 
http://hydra.icgeb.trieste.it/ 
~kristian/dna/model_it.html) 
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Fig. 53: Growth curves of UPEC strain 536 and isogenic mutants at different temperatures.  
  Three independent LB cultures of each strain were grown with aeration (200 rpm) at 45, 37, and 25 °C.
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Fig. 54: Maps of plasmids constructed during this work.  
Plasmid pASK75-His-hlp was constructed by cloning a PCR-generated fragment encoding a (His)6 sequence 
followed by a factor X cleavage site and the CDS of the hlp536 gene into the XbaI/HindIII sites of the inducible 
expression vector pASK75. 
Plasmid pWSK30-hlp was constructed by cloning a PCR-generated fragment containing the CDS ± 175-bp 
of the hlp536 gene into the XbaI/HindIII sites of the low copy number vector pWKS30. 
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8.8. Abbreviations 
 
 
µg = microgram 
µl = microliter 
µM = micromolar 
µm = micrometer 
A = adenine 
a.a. = amino acid 
ABU = asymptomatic bacteruria 
AFM = atomic force microscope 
Ap = Ampicillin 
APS = ammonium persulfate 
BLAST = Basic Local Alignment Search Tool 
bp = base pairs 
ß-ME = beta-mercaptoethanol 
BSA = bovine serum albumin 
C = cytosine 
cAMP = cyclic adenosine monophosphate 
CAS = chrome azurole S 
cat = chloramphenicol acetyltransferase 
CbpA/B = curved DNA-binding protein A/B 
CDS = coding sequence 
CFU = colony forming unit 
Cm = chloramphenicol 
cm = centimeter 
CRP = cAMP receptor protein 
dATP = desoxyadenosin-5'-triphosphate 
DEPC = diethyl pyrocarbinate 
DNA = desoxyribonucleic acid 
DnaA = DNA-binding protein A 
DNase = Desoxyribonuclease 
Dps = DNA-binding protein of starved cells 
DR = direct repeat 
DRE = downstream regulatory element 
EAEC = enteroaggregative E. coli 
EDTA = Ethylendiamintertraacetat 
EHEC = enterohemorrhagic E. coli 
EIEC = enteroinvasive E. coli 
EPEC = enteropathogenic E. coli 
EPS = extracellulat polymeric substance 
et al. = et altera (and others) 
ETEC = enterotoxigenic E. coli 
EtOH = ethanol 
ExPEC = extraintestinal pathogenic E. coli 
FDR = false discovery rate 
Fig. = figure 
Fis = factor for inversion stimulation 
FPLC = Fast protein liquid chromatography 
FRT = Flp recognition target 
g = gram 
G = guanine 
GEI = genomic island 
h = hour 
HDTMA = hexadecyl-trimethyl-ammonium bromide 
Hfq = host factor for phage Qß 
Hlp = H-NS-like protein 
H-NS = histone-like nucleoid structuring protein 
 
 
HU = heat-unstable nucleoid protein 
IciA = inhibitor of chromosome initiation A 
i.e. = id est (this means) 
IHF = integration host factor 
IPEC = intestinal pathogenic E. coli 
IRD = infrared fluorescence dye 
IS = insertion sequence element 
kb =  kilo bases 
kDa = kilo Dalton 
Km = Kanamycin 
l = liter 
LB = lysogeny broth 
Lrp = leucine-responsive regulatory protein 
M =  molar 
mA = milliampere 
mg = milligram 
min = minute 
ml = milliliter 
mM = millimolar 
mm = millimeter 
MOPS =  
NBM = newborn meningitis 
ng = nanogramm 
NMR = nuclear magnetic resonance 
nt = nucleotides 
OD = optical density 
oligo = oligonucleotide 
ONPG = o-Nitrophenyl-ß-galactopyranoside 
ORF = open reading frame 
PAI = pathogenicity island 
PBS = Phosphate buffered saline 
PCR = polymerase chain reaction 
PIPES = 1,4-piperazine-diethane-sulfonic acid 
RNA = ribonucleic acid 
RNase = Ribonuclease 
Rob = replication origin binding protein 
rpm = rounds per minute 
RT = reverse transcription 
SD = standard deviation 
SDS = sodium dodecyl sulfate 
sec = second 
Spec = Spectinomycin 
SSC = standard saline citrate 
StpA = suppressor of td- phenotype A 
T = thymine 
TAE = Tris-acetate-EDTA 
TBS = Tris-buffered saline 
TEMED = N,N,N`,N`-tetramethyldiamin 
Tet = Tetracyclin 
Tris = Trishydroxylmethylaminomethan 
U = unit 
UPEC = uropathogenic Escherichia coli 
UTI = Urinary tract infection 
V = Volt 
wt = wild type 
